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Abstract
The objectives of this thesis have been focussed in two main areas. The first 
involved the isotopic labelling of gibberellins (GA's) at the C(17) position to enable 
metabolic tracking, isotope dilution assays and confirmation of tentative structural 
assignments. A number of GA's were labelled: these included the tricarboxylic acids 
GA13 and GA25, which were labelled with deuterium at the C(17) position by cleaving 
the 16,17-methylene by oxidation to the norketone, and incorporating a deuterated 
methylene unit via the Lombardo-Oshima reaction; GA20 was also labelled at the C(17) 
position, but with a 14C-radio isotope via Wittig methylenation. This compound was 
then utilised as a model for the major objective which involved the 17-14C-radio isotope 
labelling of GA95, a recently discovered gibberellin isolated from Prunus cerasus 
(flowering cherry). This necessitated many functional group manipulations to give the 
correct skeletal requirements. It became imperative to perform the skeletal changes in a 
particular sequence, in order to preserve the very labile A!-ene, which is highly prone to 
undergo rearrangement to the isolactone in an acidic environment.
The second area of research dealt with the expansion of the B-ring in gibberellins 
to give access inter alia to the Rabdosia family of kaurenes. Kaurenes are a complex 
group of tetracyclic diterpenoids which have shown interesting therapeutic potential, such 
as antibacterial and antitumour activity. Their complexity makes them an attractive target 
for synthesis due to the dense array of functionality and multiple stereogenic centres.
A study was therefore undertaken to explore the prospect of utilising gibberellins 
as a source of semi-synthetic kaurenes, drawing on the experience already gained in the 
manipulation of gibberellins. This was achieved by the Lewis acid-catalysed 
rearrangement of a 6ß-hydroxy-gibberellin-7oc-carboxaldehyde derived (a) from GA3, 
resulting in acyloin rearrangement (ring expansion) to give the 6-membered B-ring of an 
ewr-20-norkaurene derivative, and (b) from GA15 to afford an advanced intermediate for 
the preparation of the Rabdosia family of kaurenoids.
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Chapter 1
introduction to
Gibberellins
and
Kaurenoids
1
1.1 The Discovery of Gibberellins
1.1.1 History
Gibberellins were originally discovered in 19261 in Japan, when a pathologist, 
Kurosawa was investigating the 'bakanae' disease of rice seedling plants. The disease, 
which was reported in the early part of the 19th Century2, caused infected plants to grow 
abnormally tall and spindly. Many of the mature plants died before reaching the stage of 
fruiting, resulting in seriously reduced crop yields (up to 40%) throughout Japan and the 
Asian area. This disease was shown to be caused by an infection from the fungus 
Fusarium moniliforme . In 1912, Sawada demonstrated that a substance produced by 
Gibberella fujikuroi, the 'perfect', or sexual stage of the fungus Fusarium moniliforme 
caused the infection3. When this fungus was cultured on a synthetic medium, the filtrate, 
when applied to healthy plants, caused the same effects of bakanae disease as those 
observed in infected plants1. Some years later, in 1938, the Japanese agricultural 
chemists, Yabuta and Sumiki4 succeeded in isolating from the culture filtrate a crystalline 
fraction with the same biological activity as that of the fungus. Work was disrupted 
during World War II, but in 1954, an ICI group5 reported the isolation of an active 
principle from the fermentation of G. fujikuroi which proved to have plant 
growth-promoting activity. They named this substance gibberellic acid, which was later 
given the trivial name of GA3 (Figure 1). In 1958, MacMillan and Suter6 reported the 
isolation of a gibberellin (GAO from immature seeds of scarlet runner bean Phaseolus 
multifloris, and it is now established that Gibberellins control many aspects of plant 
growth and development. They have been shown to be widely distributed throughout the 
plant Kingdom, with over 120 naturally occurring gibberellins now known.
Figure 1. Structure o f  GA3
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1. 1 . 2  Structure and Nomenclature
Gibberellins are a group of highly functionalised tetracyclic diterpenoids arranged 
in the form of four fused carbocyclic rings which are designated as A, B, C and D 
(Figure 2). The nomenclature of the gibberellins throughout the experimental section is 
based on the e/rf-gibberellane carbon skeleton (a)7 (Figure 2), which is related to ent- 
kaurene (b) and the steroids.
Figure 2. (a) Numbering system used for Gibberellins based 
on enr-gibbereliane, (b) numbering system used for kaurenes.
Once the structure of a new gibberellin is established, it is allocated a number in 
the series, GAi to GAn8.
Gibberellins are divided into two subgroups. The 19-carbon atom gibberellins 
form the majority of gibberellins (approximately two thirds) and possess a 19,10-y- 
lactone bridge, of which GA9 may be regarded as the parent compound (Figure 3). 
Differences within the group are mainly accounted for by the location and number of 
hydroxy groups, and additional double bonds. Those gibberellins possessing the full 20- 
carbon skeleton of the diterpenoids are enr-gibberellanes, of which GA12 may be 
regarded as the parent compound (Figure 3). The carbon at position 20 exists in a 
number of oxidation levels, ranging from methyl through to carboxyl. Further variations 
arise through the addition of one or more hydroxyl groups to various positions on the 
gibberellin skeleton.
Figure 3.
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1.1.3 The Value of Gibberellin Research
For socio-economic reasons, it has become desirable to control some aspects of 
plant growth and development. This has been achieved to some extent, by the bulk use 
of fertilisers, pesticides and herbicides. However, environmental concerns now 
discourage the use of such chemicals. Since GA's are recognised as one of the most 
important classes of plant bioregulators, playing a central role in plant growth and 
development, their use may have many potential commercial applications9' 12. With the 
availability of reasonable quantities of some gibberellins from the fermentation of the 
fungus Gibberella fujikuroi, plant hormone research has escalated, bringing forth an 
understanding of the intricate action of these bioregulators. However, as yet commercial 
applications have been limited, mainly due to cost. Those applications that have been 
commercially successful include inducement of flowering in ornamental plants; reduced 
time required for malting in the brewing of beer; increased berry size of seedless grapes; 
increased storage life of fruit; and control of russet, a scablike skin disorder in apples13. 
Other useful applications have been to change the sex expression of plants, increase 
vegetative growth, and induce sprouting. Gibberellins can induce flowering in "long 
day" plants (i.e. flower buds are induced by a photoperiod of a minimum duration)14-15, 
and also in plants that require a low temperature (vernalisation) for flower induction, 
when these conditions are not operating. Seeds usually have a dormant period either due 
to a hard seed coat which must First be removed, or the seed embryo is not fully 
developed at the time of shedding. There may also be the presence of germination 
inhibitors. This dormant period for some species may be broken by exposure to red 
light, dark, or low temperature. Gibberellins can replace the red light/dark requirement or 
the low temperature requirement (vernalisation) and terminate dormancy16. In the case of 
fruiting plants, once pollination and fertilisation have occurred the ovary develops into a 
fruit containing seeds. However, some plants can develop a seedless fruit from an ovary 
that has not been fertilised (parthenocarpy). Gibberellins, auxin, and cytokinin can cause 
parthenocarpy to occur, and have been used commercially on tomatoes, cucumbers, 
peachs, apples, pears and grapes17.
Some commercial success has also been obtained by suppressing the production 
of gibberellins by GA antagonists or inhibitors, to enhance cultivated crop yields. With 
increased knowledge o f these compounds comes greater understanding of their 
biosynthesis, bioactivity and metabolism. This leads naturally to the design of synthetic 
gibberellins which would possess particular properties, or the production of inhibitors of 
GA biosynthesis. Therefore, it would seem that we are possibly at the dawn of their 
large scale use throughout agriculture.
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1.2 Structure /  Activity Relationships
Although shoot elongation in intact plants, caused by cell elongation and cell 
division, is the most prominent physiological effect of Gibberellins, GA's play a role in 
almost every aspect of plant growth and development. The relationship between structure 
and biological activity is extremely important, and many inroads into this area have been 
made.
It has been observed that the most biologically active gibberellins possess a free 
7-carboxyl group, a 19,10-y-lactone bridge and a 3ß-hydroxy function with or without a 
1,2-double bond18'20. Examples of GA's exhibiting these features are G A\, GA3, GA4, 
GA7, GA30, and GA32# . In general, the C20 gibberellins show lower bioactivity than 
their C19 counterparts21, activity probably being due to metabolic conversion into 
Ci9-GA's. G A 's such as G A s, GA29, GA34 and GA30, all of which possess a 2ß- 
hydroxy group have very low bioactivity, while GA's possessing additional carboxyl 
groups at C-4 and C-10 (tricarboxylic acids) similarly show extremely low biological 
activity. In fact, the GA's of this class (ie. GA13, G A n , GA25, GA28, GA39), are 
thought to be artefacts or end products of biosynthesis. Also, the presence or absence of 
a 13-hydroxy has an effect on bioactivity and has been found to be species dependent.
1.3 Biosynthetic Pathways of Gibberellins
1.3 .1  Fungal GA's
The biosynthesis of GA's in the fungus, Gibberella fujikuroi was first studied by 
Birch et a ß 2, in the late 1950's. Feeding 2-14C-acetic acid and 2-14C-mevalonic acid 
(MVA) to the culture media, revealed that both labelled carbons were incorporated into 
GA3. It has since been established that the GA biosynthesis in the fungus G. fujikuroi 
consists of three stages: (A) the conversion of mevalonic acid into ent-kaur-16-ene; (B) 
the conversion of ewr-kaur-16-ene into GAj2-7-aldehyde; and (C) the conversion of 
GAi2-7-aldehyde into C20 and C19 GA's with hydroxylation at various carbon 
atoms23-26.
# See Appendix I for GA structures.
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1.3.1.1 Stage A: Mevalonic Acid to ent-kaur-16-ene
Schecter and West27, during their studies, identified the intermediates between 
MVA and ^rct-kaur-16-ene by preparing a soluble enzyme system from a cell-free extract 
of mycelia from G. fujikuroi. By incubating with 2-14C-mevalonate (MVA), adenosine 
triphosphate (ATP) and MgCl2, they effected the conversion of 2-14C-MVA into ent- 
kaur-16-ene. Copalol and geranylgeraniol were also isolated, but are not intermediates, 
as their resuspension into a G. fujikuroi culture did not yield GA's. Both trans- 
geranylgeranyl pyrophosphate and ent-copalyl pyrophosphate, (Scheme 1) were 
converted successfully by this enzyme system into e«/-kaur-16-ene. Many studies on 
higher plants have also shown the above view to be correct28. There has been evidence 
for the intermediacy of mevalonic acid-5-phosphate, mevalonic acid-5-pyrophosphate and 
isopentyl pyrophosphate (Oster and West, 196829).
mevalonic acid (MVA)
en/-kaur-16-ene ercr-copalyl pyrophosphate
Scheme 1. Conversion of MVA into ent-kaur-16-ene.
1.3.1.2 Stage B: ent-Kaur-16-ene to GAj2-7-aldehyde
There are two processes at this stage, the first being the sequential oxidation of 
C(19) from g«r-kaur-16-ene to e«r-kaur-16-en-19-oic acid, and the introduction of a 
7ß-hydroxyl into the ent-kaurene skeleton. The second stage is the contraction of the
6
six-membered B ring of ent-kaurene to a five membered ring to form the gibberellin 
skeleton.
The conversion of enf-kaur-16-ene25, £«r-kaur-16-en-19-ol28’30’31, 
ent-kaur-16-en-19-al32, ent-kaur-16-en-19-oic acid33 and enr-7a-hydroxykaur-16-en- 
19-oic acid34’35 into GA3 (Scheme 2), was shown by feeding these 14C-labelled 
substrates to the culture media of G. fujikuroi. The products were identified by 
combinations of radio-thin layer chromatography (RTLC), gas chromatography-radio 
chromatography (GC-RC), and isotope dilution.
enf-kaur-16-ene
CH2OH
ent-kaur-16-en-19-ol ent-kaur-16-en-19-al
c o 2h
ent-kaur-16-en-19-oic acid
Scheme 2. Biosynthesis of en/-kaur-l 6-en-19-oic acid from enr-kaur-16-ene.
A branching in the pathway occurs during the oxidation of the B ring. This 
branching determines whether GA's or other metabolites, such as kaurenolides and 
fujenal are biosynthesised. It was shown that ent-kaur-16-en-19-oic acid can be 
converted to enr-7oc-hydroxykaur-16-en-19-oic acid or ercr-kaur-6,16-dien-l 9-oic acid 
(Scheme 3)36. It is presumed that the latter is converted to the enf-6a,7a-epoxide 
intermediate, and further modified to the kaurenolides. ewf-7a-Hydroxykaur-16-en- 
19-oic acid is converted into GA12-aldehyde, and also e«t-6a,7a-dihydroxykaur-16-en- 
19-oic acid, by microsomes from G. fujikuroi37. The dihydroxy acid is not a precursor 
to GA's but is converted to fujenal.
7
£rtf-kaur-16-en-19-oic acid
'H h
G A 1 2 -7-aldehyde m-7<x-hydroxykaur-
16-en-19-oic acid
enr-6cc,7a-dihydroxykaur- 
16-en-19-oic acid
oc-o
fujenal
ent-kaur-6,16-dien- 
19-oic acid
enr-6a,7oc-epoxykaur- 
16-en-19-oic acid
i
I r2
OC— O H
kaurenolides
Scheme 3.
The ring contraction step has received considerable attention38-40, using 
microsomal enzyme preparations from higher plant systems and cultures of G. fujikuroi 
with isotopically labelled substrates. The results show that the formation of 
GA]2-aldehyde occurs with the loss of the ent-6a and 7a-hydrogens, with retention of 
the e«r-6ß-hydrogen. The ring contraction involves the abstraction of the ent-6a-H 
followed by the migration of C(8) to C(6) with the extrusion of C(7), affording the 
GA]2-7-aldehyde (Scheme 4).
8
enzyme
Scheme 4. Formation of GA12-aldehyde through B-ring contraction.
1.3.1.3 Stage C: GAj2-7-aldehyde to C2 0 -  and C i9 -G A's
This stage also involves two processes: the loss of C(20) during the formation of 
QVGA's from C2o-GA's; and the introduction of hydroxyl(s). The detailed mechanism 
for the loss of the C(20) is unknown, but the variation in substituent at C(10) (ie, methyl 
through to carboxyl) show a stepwise oxidation with the eventual release of CCb. 
However, experiments to elucidate the fine detail still remain inconclusive41-42.
Through the use of different wild type strains of G. fujikuroi and from single 
gene mutants blocked for GA biosynthesis, a number of routes have been established for 
the pathway from GAi2-7 -aldehyde. The most comprehensive of these comes from 
feeding studies with the mutant strain, Bl-41a43, which arrests endogenous GA 
biosynthesis by 97.5% at the e«f-kaur-16-en-19-al to e«r-kaur-16-en-19-oic acid stage. 
The major pathway in the fungus involves the early 3ß-hydroxylation of GA]2-7 - 
aldehyde to GA14, via the aldehyde, (Scheme 5). C(20) is then lost to give GA4, 
although the steps involved have not yet been identified. GA37, GA36 and GA13 have 
been isolated as possible intermediates41, but none are formed from GA14, nor 
metabolised to GA4 in cultures of the mutant B1-4la. GA4 can then undergo 1,2 - 
dehydrogenation to GA7, la-hydroxylation to GAi641’44, or 2a-hydroxylation to 
GA4745. This is in direct contrast with the lß and 2ß-hydroxylations found in higher 
plants. GA3 is then obtained from the 13-hydroxylation of GA7. It was also shown 
during the study that GA] was not converted to GA344.
9
GA! 2-7-aldehyde
Scheme 5. Early 3ß-hydroxylation pathway in G.fujikuroi using mutant Bl-41a.
The early 3ß-hydroxylation pathway is accompanied by a minor non-early 
3ß-hydroxylation pathway (Scheme 6). GAj2-7-aldehyde is converted to GA9 via 
G A 1241 in a similar fashion to that by which GA14 is converted to GA4. The 
1,2-dehydrogenation of GA9 gives A]-GA9, parallel to the metabolism of GA4 to GA7 in 
cultures of the mutant, Bl-41a46, but late 3ß-hydroxylation of GA9 to GA4 does not 
occur. GA9 does, however, undergo 2a-hydroxylation to give GA40, or 13- 
hydroxylation to give GA2q.
GAj 2-7-aldehyde
1,2-dehydro GA9
Scheme 6. Non-early 3ß,13-hydroxylation pathway in G. fujikuroi using mutant B 1-4la.
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The biologically inactive tricarboxylic acids have been found to be artefacts of GA 
biosynthesis in the fungus G. fujikuroi, and as such, accumulate as waste products or are 
catabolised4748.
1 .3 .2  Higher Plants
1 .3 .2 .1  Stage A and Stage B
The biosynthetic pathway from MVA to GA]2-7-aldehyde is the same for both G. 
fujikuroi and higher plants. Information on the intermediates in the pathway was 
obtained from higher plant sources such as the endosperm-nucellus of immature seeds, 
cell free preparations of young seeds, young fruit, young seedlings and shoot tips from 
different species including Marah macrocarpus28, Cucurbita maxima49, Zea mays5®, 
Hordeum vulgare51, Pisum sativum52, Phaseolus coccineus53, and many more.
However, the pathway from GA]2-aldehyde depends upon the organism in 
question, and so GAi2-aldehyde is more or less at a branch point from which many 
systems have been studied and different pathways observed. A brief outline of the major 
pathways follows.
1 .3 .2 .2  Stage C
There is a common sequence for the conversion of C20 GA's to C19 GA's. This 
involves the progressive oxidation of C(20) to the 20-hydroxy derivative (isolated as the 
5-lactone), followed by oxidation to the 20-aldehyde, and finally oxidation to the 
y-lactone, with loss of C(20) as CO2. The progressive oxidation of C(20) may occur 
before or after 3ß-hydroxylation and 13-hydroxylation of GA 12-aldehyde and GA12, 
giving rise to three main pathways to C19 GA's: (i) non early 3ß, 13-hydroxylation; 
(ii) early 13-hydroxylation and (iii) early 3ß-hydroxylation. These pathways were 
identified by making use of in vitro and in vivo studies of higher plants. In vitro studies 
were carried out using extracts of seeds containing relatively high concentrations of 
GA's. Isolating and studying the enzymes from seed homogenates also made it possible 
to establish specific steps in the pathways. Much of the information obtained from in 
vivo metabolism studies has been gathered using the shoots of Z. mays54. It has been 
observed that most of the endogenous GA's are formed via the early 13-hydroxylation 
pathway indicated by the in vitro studies.
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The non-early 3 ß, 13-hydroxylation pathway from GAi2-aldehyde to GA9 may be 
seen in Scheme 7, (Pathway A). Oxidation of GA12 occurs at C(20) to give the 
20-alcohol, isolated as the 6-lactone, GA15. GA15 is further oxidised at C(20) as the 
opened lactone during in vitro studies55’56 to form the aldehyde, GA24, or as the 
8-lactone during in vivo studies57. GA24 is then converted to GA9 with the loss of C(20) 
as CO2. 3ß-Hydroxylation of GA9 to GA4, and 13-hydroxylation of GA9 to GA20 have 
been shown to occur in vivo only.
The early 3ß-hydroxylation pathway from GAi2-aldehyde to GA4 was 
established using C. maxima58_60 for studying all but one of the in vitro steps (Scheme 7, 
Pathway B). 3ß-Hydroxylation occurs before C(20) oxidation to form GA14, via the 
aldehyde. This is then followed by the progressive oxidation of C(20), until it is lost as 
CO2 to give GA4. It has not been concluded how GA36 is formed from GA37, but that it 
may involve the opened lactone is a possibility59. 13-Hydroxylation of GA4 occurs to 
give GAi, only during in vivo studies (Scheme 8).
For the early 13-hydroxylation pathway to GA20 it has been observed that GA53 
is not formed from GA53-aldehyde, but from GAi2-aldehyde via GA12 (Scheme 7, 
Pathway C). The system used to establish the steps from GAi 2-aldehyde to GA19 was 
the germinating grain of H. vulgare in vitro51. The conversion of GA19 to GA20 is only 
assumed due to the metabolism of GA44 to GA20 as well as GA19. Again, GA19 is 
formed from the opened lactone of GA44 in vitro, and from the 8-lactone in vivo. GA20 
can be further metabolised to give GAi, and may also undergo 2,3-dehydrogenation to 
give GA558’59. GA9 gives 2,3-dehydro-GA961 with some in vitro and in vivo systems 
(Scheme 8) but has not yet been isolated as a naturally occurring GA. GA5 is then 
converted to GA3 by the unique ene-hydroxylation rearrangement reaction62’63.
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Pathway B
HO’
h o 2c CHO
GA^-aldehyde
Pathway A
.....OH
OH
Scheme 7. Biosynthetic Steps established from GA12-aldehyde 
to C19-GA's for Higher Plants.
The C(20)-aldehydes are the immediate precursors of the Q q-GA's but can also 
be oxidised to the inactive C20-GA tricarboxylic acids such as GA25 from GA2459, GA13 
from GA3659, and G A n from GA1964 (Scheme 7).
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Scheme 8. Further Metabolism of C19-GA's.
After further hydroxylation of the gibberellin skeleton (recorded at the lß, 2a, 
3ß, 12a and 18 positions) and the introduction of olefinic bonds, there are two sequences 
that lead to gibberellin inactivity. The first is 2ß-hydroxylation which has been observed 
in both in vitro and in vivo systems62. This is generally the last step in the biosynthetic 
sequence and may lead to degradation via catabolism to give GA29, GA51, and GAs and 
their 2-oxo-catabolites (Scheme 8). There are also other catabolites, such as the 16ß, 17- 
dihydrodiols which are probably the products of non-specific oxidation of the 16,17- 
double bond65’66.
Conjugation, as glucosyl esters or glucosyl ethers67, is the second method of 
removing GA activity. It is thought that these GA conjugates may be storage forms of 
GA's, and that enzymatic hydrolysis should release the active GA moiety when it is 
required67. However, this hypothesis has not yet been proven.
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1.3.3 Conclusion
By knowing the various pathways of Gibberellin biosynthesis, and the enzymes 
involved in transformations, a better understanding of plant growth regulation is 
obtained. Since certain GA's trigger different plant growth responses, the relationship 
between GA structure and their bioactivity is an area of research interest, per se, while 
underpinning the development of commercial applications.
1.4 Synthesis
1.4.1 Identification and Characterisation
In order to study the biosynthesis, structure, and the role gibberellins play in plant 
growth and development, many techniques of analysis have been adopted. If enough 
material is available then full structural analysis is carried out, including nuclear magnetic 
resonance (NMR) spectroscopy and single crystal X-ray diffraction. Unfortunately, 
gibberellins are usually only available in very small quantities (micrograms to 
nanograms), often as a complex mixture of a number of GA's. The isolation of pure 
material is very laborious and the quantities of material obtained are frequently extremely 
low. It therefore, becomes less feasible to get full spectroscopic data. However, it is 
possible to glean information as to the molecular structure of a gibberellin based on its 
chromatographic behaviour and its mass spectrometric (MS) fragmentation pattern by 
comparison with the fragmentation patterns of fully characterised GA's. The proposed 
gibberellin structure can then be synthesised from the more readily available fungal GA's. 
In some circumstances the molecule may be isotopically labelled in order to study its 
metabolic pathway.
1.4.2 Synthesis of Gibberellins using Fungal Cultures
Fungal cultures can produce a wide range of gibberellins in reasonable quantities. 
The rarer GA's can be obtained by making use of the fact that the enzymes of the fungus 
G. fujikuroi are not substrate specific, making it possible to produce many non-fungal 
GA's. This process can be enhanced by using mutant strains, such as B l-41a43, in 
which normal GA biosynthesis is blocked at an early stage.
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1.4.3 Total Synthesis of Gibberellins
The total synthesis of Gibberellins has proven to be a challenging research area 
and has excited a great deal of competitive creativity68’69. A number of research groups 
have focussed their attention on the total synthesis of these types of compounds and so 
many different approaches have been ventured. One of the greatest difficulties associated 
with total synthesis lies in establishing the correct stereochemistry at the ring junctions, 
that is, a trans ring junction between the A and B rings, while the CD-ring junction is cis, 
and the relationship between H-9 and the C-10 substituent is anti (Fig 2a). There are also 
other asymmetric centres to consider, and the additional problem of introducing 
functionality into the rings. Many approaches have not proceeded to a successful 
conclusion, and those that have, are lengthy (requiring more than 20 steps), and are 
extremely inefficient (producing only a few milligrams of the target compound).
1.4 .4  Partial Synthesis of Gibberellins
As mentioned previously (section 1.1.3) some gibberellins, namely GA3, GA4 
and GA7, are available in reasonable quantities by fermentation, and may therefore be 
utilised as starting materials. Partial synthesis from such compounds has been the most 
successful way of confirming tentative new structures. Over 120 naturally occurring 
gibberellins have been found to exist and most of these are accessible through 
interconversion of the more available GA's. Almost every carbon atom in the gibberellin 
skeleton has been hydroxylated, and double bonds have been placed at various positions.
These highly functionalised compounds are sensitive to a wide range of reaction 
conditions and can readily undergo rearrangement; manipulation of these types of 
compounds is rarely straight forward. Although a considerable amount of synthetic 
methodology and experience concerning gibberellins has built up over the past few 
decades, gibberellins never fail to surprise the organic chemist. A subtle structural 
change can affect the reactivity of functional groups, even at a remote distance.
1.4.4.1 General Procedures for Gibberellin Manipulation
There are a number of standard procedures that exist for the chemical 
manipulation of GA's. Protection and deprotection are widely used throughout GA 
chemistry to facilitate other chemical manipulations. The use of protecting groups, 
particularly the conversion of the 7-carboxylic acid to the 7-methyl ester, also makes 
handling these compounds considerably easier, (ie. improved solubility, reduced
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polarity). However, removal of the ester protecting groups can prove troublesome. For 
example, the hydrolysis of a C 19 gibberellin, proceeds extremely slowly since the 10,19- 
lactone is preferentially hydrolysed, retarding hydrolysis of the 7-methyl ester function to 
an even greater extent than that due to steric hindrance. The process becomes even more 
complicated for a A^eneGß-ol derivative, such as in GA3. For this type of compound 
(1), the lactone is converted into the isolactone (3) through the 2ß,3ß-epoxy 19- 
carboxylate intermediate (2), (Scheme 9). In this case, it becomes necessary to protect 
the 3-hydroxyl first. Under normal circumstances (without the A^ene-Sß-ol), the lactone 
can be re established by heating at reflux in acetic acid. An alternative hydrolysis 
procedure which is usually successful, is O-alkyl cleavage using iodide ion70 or lithium 
propanethiolate in H M P A 71’72.
Another problem associated with GA chemistry is discrimination between the two 
double bonds in each of the GA3 and GA7 molecules, and considerable effort has been 
spent on this area, the main problem being the selective reduction of the A^ene. This can 
be accomplished to a certain extent by hydrogenation in the presence of an amine base73 
(Scheme 10), but the major product is the diene acid (5). The GAj-type skeleton can, 
however be obtained through iodolactonisation to form 6 , followed by removal of the 
halogen, however.
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Scheme 10. Hydrogenolysis of the allylic lactone.
Alternatively, the 17-methylene group may be epoxidised before hydrogenation, 
and then re-established by deoxygenation7475. Another common procedure is to cleave 
the 17-methylene by ozonolysis or osmium tetraoxide, allowing the formation of the 
16-norketone. The 17-methylene can be reintroduced at the appropriate time by utilising 
the Wittig reaction with methylene triphenylphosphorane76’77. In some cases it may be 
advantageous to use the Lombardo/Oshima78 procedure for methylenation using 
dibromomethane/titanium chloride/zinc metal. Both of these reactions provide an ideal 
opportunity for introducing an isotopic label into a molecule.
Another quite common procedure used in the partial synthesis of GA's is removal 
of the 3-hydroxyl and/or 13-hydroxyl. This is usually done by the conversion of the 
hydroxyl to either a halide79, thioester80, thioamide81, mesylate82 or methyloxalyl 
ester83, followed by reduction using rc-tributyltin hydride under standard free radical 
reaction conditions. The latter ester function has proven particularly useful for removing 
the 13-hydroxyl83.
As mentioned above, most of the carbons in the gibberellin skeleton have been 
hydroxylated. Many procedures and chemical manipulations have been employed to this 
end, the details of which, have been highlighted in a review on gibberellin research13.
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1.5 Aims and Goals of This Project
1 .5 .1  Isotopic Labelling of Gibberellins
One of the objectives of this work was to partially synthesise 17,17-dideutero- 
GA13 (8), and 17,17-dideutero-GA25 (9) for the purpose of checking their concentration 
in plants by isotope dilution analysis using GC-mass spectrometry. Deuterated GA13 
was required in order to compare catabolism between C19- and C2o~GA's, whereas 
deuterated GA25 was to be used in the quantification of GA25 in transgenic plants, in 
which a pumpkin gene overexpresses GA 20-oxidase, causing the production of 
tricarboxylic acids. Through the synthetic scheme used, a naturally occurring GA was 
also partially synthesised. The deuterium labels were introduced by utilising the 
Lombardo/Oshima procedure78.
A further objective was to produce 14C labelled GA20 which was required by a 
research group in Minnesota, to help in tracking the metabolic pathway involved in the 
conversion of GA19 to GA20 Other planned studies include observing the effect on 
GA20 metabolism by varying the conditions operating on certain plant systems, such as 
photoperiod and auxin levels. This synthesis also served as a model for 14C labelling the 
fairly recently discovered GA95, a significantly more difficult task. It was hoped that a 
study using labelled GA95 (Figure 5) may shed some light on the formation of 
gibberellins possessing a 3ß-hydroxyl and A^ene, such as GA3, and to uncover the 
mechanism involved in C(3) oxygenation of GAs possessing ring-A alkene bonds.
(8) (9)
Figure 4. Deuterated GA13 and GA25.
Figure 5. 14C-labelled GA95.
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1.5.2 Conversion of Gibberellins into Kaurenoids
Access to the kaurenoids, (the biosynthetic precursors of GAs) has been 
facilitated by the availability of several kaurenolides produced during the commercial 
fermentation of G. fujikuroi. Moreover, these kaurenolides have served as useful 
substrates for the preparation of a variety of C2 0 -GAS (Scheme 11).
i) NaBH4
ii) TsCI, Pyridine7 ß-hydroxykaurenolide
KOH, t-BuOH
GAi2-7-aldehyde
Scheme 11. Synthesis of GA^-aldehyde from 7ß-hydroxykaurenolide.
Current strains of the fungus, however, produce only trace amounts of these 
useful compounds. It was therefore, of interest to determine whether it would be 
possible to convert gibberellins back into kaurenoids as a means of gaining access to 
these important intermediates. In addition, there was also the prospect of gaining better 
access to biologically active kaurenoids obtained from plant sources in very small 
amounts. Some notable kaurenoids which have shown therapeutic potential84 and form 
an attractive goal for synthesis are enmein85, oridonin86 and shikodonin87 (Figure 6).
enmein oridonin shikodonin
Figure 6. Interesting kaurenoids from the Rabdosia family 
which have antibacterial and antineoplastic properties.
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Chapter 2
Isotopic Labelling
of
Gibberellins
2.1 Labelling Studies
Isotopically labelled gibberellins have been used extensively to study the 
biosynthetic pathways involved in gibberellin transport, metabolism and the mode of 
action of gibberellins, as well as locate where these processes are taking place88'92. 
These studies are performed by applying a suitably labelled substrate to an intact plant, 
fungal culture or cell-free preparation. Analysis of the products is usually performed by 
GC-mass spectrometry. However, labelling studies are often not as straightforward as 
one would wish, for several reasons. First, it must be made certain that the correct 
substrate is applied in the correct concentration, such that it is similar to that of the native 
compound. Secondly, GA biosynthesis can be activated or deactivated during the life 
cycle of the plant, thus necessitating the incorporation of the labelled substrate at the 
correct stage of the plant's development. Thirdly, biosynthetic pathways may differ from 
species to species of a given plant, and also from organ to organ of the same species. 
Therefore, anomalous results can easily be obtained if great care is not exercised in the 
choice of plant or the organ of the plant used. Fourthly, many enzymes are non-specific, 
which may result in the formation of products from the metabolism of the labelled 
substrate which correspond to endogenous GA's, but which are artefacts of the "feeding" 
process. It is therefore, necessary to ensure that the metabolites are also normally 
endogenous to the system studied.
The type of isotope used and the position into which it is incorporated in the 
gibberellin largely depends on the purpose of the study. The choice, however, is 
somewhat limited by the availability of methods of incorporating the isotopic label into the 
required substrate. Stable isotopes, such as deuterium, 13C and 180  have the advantage 
of being less troublesome to manage, and also a high incorporation can be achieved, 
making identification by MS easier. However, detection is limited to MS or NMR. 
Tritium, although an unstable isotope, has been found to be very useful in labelling 
studies. Tritiated compounds may be prepared with a very high specific activity, so for 
low metabolic conversions where the product is at low concentration, it makes detection 
easier. 14C has a specific activity of up to 1000 times less than tritium, but is more easily 
detected, making it perhaps more widely accepted where specific activity is not an issue. 
It is generally used both as a radiotracer and as a heavy isotope for MS detection.
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There are a number of points to consider when choosing the site for an isotopic 
label; will the isotope be retained by the substrate throughout the GA metabolism, or is 
the site likely to be lost during an enzymatic reaction? There is also the possibility of 
rearrangement occurring at the labelled site, making identification of the labelled product 
quite difficult. It has been found that the C(17) position usually remains intact throughout 
GA metabolism, so this site is eminently suitable for isotopic labelling. In this way the 
label serves not only as a radiotracer, but allows quantification studies to be done. 
Conversely, if the mechanism of a certain enzymatic reaction is being studied, it would be 
best to place a heavy isotope of carbon or oxygen at the reaction site, and investigate the 
fate of the label after the reaction (eg, fate of C(20) during the conversion of C20 GA's to 
C 19 GA's)93.
2 .1 .1  Methods of Incorporation of Isotopic labels into Gibberellins
Biochemical methods of incorporating isotopic labels have involved feeding 
labelled acetate and/or labelled mevalonate to the fungus Gibberella fujikuroi. Product 
analysis was initially executed by degradative studies and later by chromatographic 
techniques94. Chemical methods of incorporating a label generally involve the 
introduction of the label at the latest possible stage of a synthetic scheme so as to contain 
costs or, in the case of 3H and 14C, to minimise handling of radioactive materials..
Since the labelling studies involved in this work are only concerned with labelling 
at the C(17) position, the following discussion will only mention procedures of 
incorporating a label at this site.
The D-ring is the site most used for the introduction of heavy isotopic labels, 
namely 13C and 14C, although deuterium and tritium may also be incorporated. The 17- 
methylene group can be cleaved oxidatively as previously mentioned (1.4.4.1) and 
re-established with an isotopically labelled Wittig salt. In this way deuterium, tritium, 
13C or 14C may be introduced. Some caution is required, however, as the basic 
conditions of the Wittig olefination can cause scrambling of the deuterium or tritium label 
between the C(15) and C(17) positions and may also lead to epimerisation in the case of a 
3ß-hydroxyl, unless it is protected. If a 13-hydroxyl is present, protection may be 
required to prevent acyloin rearrangement (C/D-ring rearrangement)95. However, a 
bulky protecting group may result in extended reaction times, and so acetates or TMS 
ethers are usually employed as C(13)-protecting groups. For deuterium labelling of the 
terminal olefin, an effective alternative is the Lombardo/Oshima reaction78 which can give
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greater than 95% incorporation of two deuterium atoms. No scrambling of the label 
between C(15) and C(17) occurs, and the 3ß-hydroxyl is not epimerised. However the 
yields are not always good, especially if a 13-hydroxyl is present.
Once the label has been incorporated, the only step usually remaining is the 
deprotection of functional groups, and so the handling of the labelled substrate is kept to a 
minimum and the radioactivity is well contained.
25
Chapter 3
17,1 7-Deuterium 
Labelling 
of
GAi3and GA25
3.1 Protection of GA13 and Removal of the 3ß-Hydroxyl
A research group at Long Ashton Research Station at the University of Bristol 
required deuterated GA25 (9) for the purpose of monitoring its concentration in plants by 
isotope dilution analysis using GC-mass spectrometry. In order to synthesise GA25, the 
closely related GA13 (1 0 ) was envisaged as an appropriate precursor since it can be 
obtained from the fermentation of Gibberella fujikuroi. Moreover, the only structural 
change required for the conversion of GA13 to GA25 is the removal of the 3ß-hydroxy 
group.
The C(17) position in GA25 was chosen as the labelling site as it would not be 
lost due to metabolism. It is also quite convenient to label C(17) since this terminal 
methylene group can be cleaved and reinstated using a variety of methods, namely the 
Wittig reaction or the Lombardo procedure78, both of which lend themselves to isotope 
incorporation.
The first step in the partial synthesis was to protect the three carboxy groups in 
GA13. The substrate was therefore, protected as the trimethyl ester 11 (Scheme 12). 
Methylation was achieved using diazomethane, and the methyl esters appeared as three 
singlets between 3.5 and 3.8 ppm in the lH nuclear magnetic resonance (nmr) spectrum. 
The next step was removal of the 3ß-hydroxyl to give the GA25 derivative. A well 
investigated procedure for deoxygenation of gibberellins involves the conversion of the 
hydroxyl to a phenoxythiocarbonyl ester96 followed by deoxygenation by means of 
stannane reduction97. However, attempts to produce the phenoxythiocarbonyl derivative 
(12) using phenyl chlorothionoformate failed, and the 3ß-hydroxy derivative was re­
isolated and purified. A second attempt to form a suitable carbonyl derivative was made 
using A,AAthiocarbonyl-diimidazole98’99. This proved to be successful, producing the 
thioester 13 in high yield (92%, after purification), as a white crystalline solid. The *H 
nmr spectrum showed that the 3a-H had shifted downfield from 4.0 ppm to 5.9 ppm.
h o 2c  n  c o 2h
(9)
Figure 7. Deuterated GA25
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Free radical based deoxygenation using tri-rc-butyltin hydride in benzene at reflux 
with azoisobutyronitrile (AIBN) as a radical initiator97, afforded the 7,19,20-trimethyl 
ester GA25, ( 14) in 77% yield. The success of the 7V,AP-thiocarbonyldiimidazole over 
phenyl chlorothionoformate in producing a thioester, may be due to the imidazolide being 
a better leaving group than chloride.
M e02C
CH2CI2 X
phenyl chlorothionoformate
Et3N
DMAP
CH2N2
GO) ( ID
/V,/V'-thiocarbonyldiimidazole
CICH2CH2CI
(13)
Scheme 12.
3.2 Formation of GA25-16,17-Diol and the 16-Norketone
It was envisaged that the deuterium label would be incorporated using a 
Lombardo reaction. This necessitated the conversion of the 16-methylene group to the 
17-nor-16-one function.
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This was accomplished by dihydroxylation to form the 16,17-diol trimethyl ester 
of GA25 (15) first, using a catalytic amount of osmium tetroxide with a co-oxidant. The 
procedure followed, used 4-methylmorpholine-A-oxide to re-oxidise the osmate ester 
according to the procedure of VanRheenen et al.100. The 16,17-diol of the GA25- 
trimethyl ester was of some interest after isolation and structure confirmation. It was 
used to confirm a tentative structure for a naturally occurring gibberellin recently isolated 
from plant extracts by Dr Patrick Blake of Horticultural Research International.
Pb(OAc)4, PhCH3
(93%)
C 02Me
Scheme 13.
M e02C
Subsequent treatment of the diol with lead tetraacetate oxidatively cleaved the 
C(17)-hydroxyl to give the GA25-trimethyl ester-16-norketone (16). This two-step 
oxidation procedure proved to be highly efficient and superior to the more direct method 
using osmium tetroxide-periodate101.
3.3 Deuterium Labelling
As mentioned earlier, the Lombardo/Oshima methylenation reaction has distinct 
advantages over the Wittig methylenation when deuterium labelling is involved. Specific 
deuterium incorporation can be obtained using this procedure, whereas scrambling of the 
label between C(15) and C(17) can occur during Wittig methylenation. The active species 
(thought to be similar to the Tebbe reagent102, Cp2TiCH2AlCl(CH3)2) is preformed by 
the addition of TiCU to a suspension of activated zinc dust in THF at -40°C with CD2Br2
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(Scheme 14). A thick grey slurry is formed which can be stored at 4°C, but which gives 
best results after approximately 36-48 hours. The reagent is added portion-wise to the 
substrate and the reaction is monitored by thin layer chromatography (tic). GA25- 
trimethyl ester was labelled successfully using this procedure ( 17). Although the 17,17- 
deuterium atoms do not show up in the l H  nmr spectrum, the C(17) should be seen in the 
13C nmr spectrum as a doublet of triplets due to the spin-spin coupling between the 
deuteriums and the carbon atom. However, the intensity was much diminished and in the 
13C nmr spectrum obtained, the two triplets were hidden in the base line. C(16), on the 
other hand, was observed at 156.3 ppm as expected for a quaternary methylene, as 
opposed to 220.9 ppm for the 17-nor-16-one. The mass spectrum also showed a 
molecular ion peak for 406, corresponding to the expected mass of the labelled GA25- 
methyl ester.
Scheme 14.
3 .4  Deprotec t ion
The last remaining step was the deprotection of the three methyl esters. A 
common procedure used for the hydrolysis of methyl esters from similar substrates, is to 
heat at reflux in aqueous 2M sodium hydroxide and methanol. This procedure, however, 
was not effective in removing the protecting groups, since after one week the major 
constituent was starting material with a mixture of mono and dimethyl esters. The 
procedure was repeated in diglyme to boost the temperature, but this also gave a mixture 
consisting mainly of starting material. Treatment of ester 17 with potassium tert-butoxide 
in DMSO at room temperature, and also at reflux also proved ineffective at removal of the 
protecting groups. In an attempt to transesterify the trimethyl ester to a compound which 
might be more easily deprotected, the ester 17 was dissolved in acetonitrile, and treated 
with sodium iodide and chlorotrimethyl silane, but no reaction took place. The difficulty 
encountered for the demethylation can possibly be explained by the fact that C(19) and 
C(20) lie in a sterically hindered environment accentuated by the concave shape of the a- 
face of the gibberellin skeleton. The Johnson-Bartlett procedure103 using lithium
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propanethiolate in HMPA was contemplated, but in view of the difficulties expected in 
isolation of the very polar tricarboxylic acid, more labile protecting groups were 
employed instead.
3.5 Protection /  Deprotection of GA13 as the Tris- 
Methoxymethyl Ester
Since the methyl ester protecting groups proved to be so difficult to remove, a 
new approach seemed necessary. Methoxymethyl (MOM) esters have proven to be quite 
useful throughout gibberellin partial synthesis. Their formation is fairly simple and their 
removal has been readily achieved using a variety of procedures.
GA13, was dissolved in dichloromethane and treated with triethylamine and 
chloromethylmethyl ether for 10 minutes to afford the tris-MOM ester 18 (Scheme 15). 
A trial deprotection was investigated as the next course of action before continuing any 
further with the partial synthesis. Thus, the tris-MOM ester 18 was treated with a known 
amount of hydrochloric acid generated from trimethylsilyl chloride and methanol. This 
resulted in the partial deprotection of GA13 tris-MOM ester, but total deprotection was not 
achieved. The soft Lewis acid, magnesium bromide, in ether at room temperature104 has 
been shown to cleave MOM esters, but this proved to be ineffective towards the 
compound under investigation, which showed no change when subjected to this 
treatment. However, 1M zinc chloride in methanol at reflux overnight was successful in 
fully deprotecting the ester to give GA13 ( 10). Having established that MOM protecting 
groups can be satisfactorily removed, the synthesis of the deuterated GA25 was 
continued.
MOMCI, Et3N 
CH2CI2/1I
Scheme 15.
The GA13 tris-methoxymethyl ester was deoxygenated at C(3) as for 11 by 
treatment with A^N’-thiocarbonyldiimidazole to form the 3ß-imidazolide 19 in a 94% 
yield, followed by deoxygenation with n-tributyltin hydride to give the GA25 tris-MOM
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ester (20), then the 16-norketone (21) was formed as before by treatment with osmium 
tetroxide-NMMO followed by lead tetraacetate.
/V,/V'-thiocarbonyldiimidazole
C 0 2M 0 M
n-Bu3SnH
AIBN
Scheme 16.
3.6 Deuteration /  Deprotection of GA25-tri-MOM Ester
The norketone 21 was treated with the Lombardo/Oshima reagent drop wise until 
no starting material remained as indicated by tic analysis. Following the work-up 
procedure, 17,17-d2-GA25 tris-MOM ester (22) was purified by flash column 
chromatography to give a colourless oil in 62% yield, (Scheme 17). The deprotection 
step was carried out as for the trial deprotection with 1M zinc chloride in methanol at 
reflux overnight. A small amount of starting material, mono and diesters remained and 
were separated by flash column chromatography from the deuterated GA25 parent acid. 
The 17,17-dideutero-GA25 (8) was characterised and gave satisfactory spectroscopic 
data.
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1M ZnCI2 in MeOH 
reflux
CD2
Schem e 17.
3 .7  Deuterated G A j3
GAj3 was also required as an isotopically labelled substrate for the purpose of 
quantifying C20-GA catabolism relative to C19-GA catabolism for fast growing plants 
such as sugar cane, which appear to be metabolised via the early 3ß-hydroxylation 
pathway. To this end, GAn-tri MOM ester (11) was oxidised to the 17-nor-16-one (24) 
via the 16,17-diol (23), (Scheme 18).
OH
Pb(OAc)4, PhCH3
Schem e 18.
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The norketone 24 was subsequently methylenated using the Lombardo/Oshima 
reagent, incorporating two deuterium labels at C(17) in 57% yield, (25). Deprotection 
afforded 17,17-dideutero-GAi3 (9) which was characterised spectroscopically, (Scheme 
19).
Scheme 19.
3.8 Quantification of GA25 in Studies on Transgenic Plants
The deuterated GA25 substrate(9) is currently being used in the quantification of 
GA25 in plants, which have been transformed with a pumpkin gene that over-expresses 
GA 20-oxidase. This enzyme produces biologically inactive tricarboxylic acids rather 
than Ci9~GA's, leading to accumulation of GA25 and reduction in growth.
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Chapter 4
C-Labelling 
of GA2 0
4.1 Introduction
GA20 is a product of the early 13-hydroxylation pathway during the metabolism 
of gibberellins in higher plants. A 14C radiolabelled derivative of GA20 (26) was 
required by a number of research groups for the purpose of tracking this metabolic 
pathway and studying how certain enzymes and environmental factors influence the levels 
of GA20 production in different plant species. The 14C-GA2o would also be used as an 
internal control. As the label was required to be preserved in the substrate throughout the 
metabolic processes in order to follow the pathway involved, the C(17) position was 
chosen as the site for the 14C-label.
OH
Figure 8.
Initial investigations were centred upon the incorporation of the 14C-label utilising 
a Wittig methylenation using labelled methyl triphenylphosphonium iodide. In order that 
manipulations of radiolabelled material were kept to a minimum, the Wittig methylenation 
step was proposed as one of the last synthetic operations, followed by deprotection of the 
7-carboxylic acid and the 13-hydroxy group. The removal of protecting groups on the 7- 
carboxylic acid of gibberellins can sometimes prove to be problematical. Thus, protection 
and deprotection of a suitable substrate was investigated before looking at the desired 
synthesis of GA2o- GA9 was chosen for this model investigation and was protected as 
the 7-MOM ester. Although deprotection of this molecule was forthcoming, the MOM 
ester did not withstand the reaction conditions of the Wittig methylenation. Protection of 
the 7-acid as its methyl ester was next investigated. The 7-methyl ester was completely 
stable during the methylenation step, but deprotection with sodium hydroxide in methanol 
opened the A-ring lactone as well as removing the methyl ester. The lactone could be 
closed again by refluxing in acetic acid, and this "two step" procedure gave good yields 
of the free acid. Hence, this latter approach was adopted.
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4.2  Partial Synthesis of GA20 from GA3
The partial synthesis of GA20 fr°m GA3, involved the hydrogenolysis of the 
1,2-double bond in the A-ring, and deoxygenation of the 3ß-hydroxyl.
GA3 was protected as the 7-methyl ester 27 and then reduced with hydrogen 
using palladium on barium carbonate in the presence of piperidine to form the 
hydrogenolysis product 28.73 Iodolactonisation was carried out on 28 by treatment with 
potassium hydrogen carbonate, potassium iodide and iodine in tetrahydrofuran (THF) for 
30 minutes. The iodolactone (29) was isolated as a white crystalline solid in 84% yield. 
A nmr spectrum showed H(l) to be a doublet at approximately 4.4 ppm, indicative of 
a proton geminal to an iodo substituent.
1 n  C02Me 
(29) 84% yield
Scheme 20.
The next step involved the removal of the 1-iodide and 3ß-hydroxyl, (Scheme 
21). This was achieved by first converting the 3ß-hydroxyl into a thiocarbamate group 
by treatment with A,A'-thiocarbonyldiimidazole.81 This gave thiocarbamate 30, as a 
white crystalline solid (87% yield) which was dissolved in benzene and heated at reflux, 
followed by the addition of tri-rc-butyltin hydride and AEBN as initiator. This procedure 
successfully reduced both the iodide and thiocarbamate functions to give the desired 
GA20 methyl ester (31) in 70% yield.
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OH A/,/V'-thiocarbonyl- 
diimidazole
n-Bu3SnH, AIBN 
PhH, reflux
C 0 2Me
Scheme 21.
4,3 Protection of the 13-Hydroxyl
The 13-hydroxyl in 31 was protected using trimethylsilyl chloride (TMSC1) and 
diisopropylethylamine in dichloromethane to give ether 32, (Scheme 22). Unfortunately, 
the TMS ether is extremely acid sensitive and had not only been known to hydrolyse 
during the work up procedure, but also upon storage. For this reason, flash column 
chromatography was performed using silica gel which had been buffered with 
triethylamine in the eluting solvent.
Scheme 22.
4.4 Formation of the 16-Norketone
Ozonolysis was chosen as the method for cleaving the 16,17-methylene group. 
Thus, olefin 32 was dissolved in dichloromethane/pyridine (4:1) and the temperature 
lowered to -78°C. Ozone was bubbled through the solution until the olefin could no
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longer be detected by tic, which was 4 minutes. It was found that the addition of excess 
ozone resulted in the decomposition of the substrate. Four equivalents of 
dimethylsulphide were added dropwise and the reaction mixture was allowed to warm to 
room temperature. After flash column chromatography, again using a buffered eluting 
solvent, only 35% yield of the desired 16-norketone 33 was obtained as a white foam. 
Some losses occurred due to the fact that the trimethylsilyl ether hydrolysed during 
ozonolysis and during chromatography. The GA2o-7-methyl ester (31) was recovered 
(20%) and a small amount of GA2o-7-methyl ester-16-norketone (34) was also 
recovered. No other products were isolated or identified (Scheme 23).
Scheme 23.
4.5 Wittig Methylenation Followed by Deprotection
The Wittig methylenation involved the use of 14C-labelled methyl 
triphenylphosphonium iodide. Trial reactions were performed with unlabelled 
phosphorane to ascertain the optimal reaction conditions required. Salt-free conditions 
were required to prevent side reactions taking place. Because of the expense and the 
nature of the isotopically labelled phosphorane, any excess had to be kept to an absolute 
minimum, and approximately three equivalents were determined to be sufficient. Only a 
very small quantity of the labelled GA20 substrate was required, (approximately 1-2 mg), 
and so the Wittig methylenation was conducted on a small quantity of the protected 
norketone. The model reaction using the unlabelled ylide was performed on the same 
scale as that required for radiolabelling. Ylides are moisture and air sensitive, and 
because of the small scale of the reaction, all moisture had to be excluded and great care
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was required to maintain anaerobic conditions. The bright yellow ylide was pre-formed 
in a separate flask by the addition of 35 equivalents of sodium hydride to the 
phosphonium salt in THF. The mixture was heated to 30°C to ensure that all of the 
phosphorane had been formed. The stirrer was then switched off and any particulate 
matter was allowed to settle, so that the yellow solution could be cannulated into a flask 
containing the dry norketone (33). As soon as tic analysis indicated that no starting 
material remained, the solvent was removed. The nmr spectrum of the crude product 
showed the protons of the olefin 35 resonating at 4.9 and 5.2 ppm (Scheme 24).
Scheme 24.
The deprotection was carried out by the addition of a 6:1 mixture of 2M sodium 
hydroxide and methanol respectively to the crude olefin 35. The mixture was heated to 
110°C overnight, cooled, and brought to pH 3-4 by 2M hydrochloric acid. Of course, 
the 19,10-lactone was hydrolysed under these conditions to give the 19-carboxylic acid 
and the 10-hydroxyl, but the methyl ester and the TMS ether functions were also 
successfully removed.
2M NaOH, MeOH,
(35) (36)
AcOH, 100°C, 1 hr
....OH
Scheme 25.
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Once the solvent had been removed from the reaction vessel, acetic acid was 
added to the residue which was then heated with stirring to 100°C for 1 hour. After 
filtering and column chromatography, GA20 was obtained as the free acid 37, 
(Scheme 25).
4.6 Incorporation of the Radio-Isotope
The above Wittig procedure was repeated using the 14C - m e t h y l  
triphenylphosphonium iodide. All glassware and reagents were thoroughly dried and 
placed under an argon atmosphere. The 7-methyl ester 13-TMS ether 16-norketone (33) 
was azeotroped with dry, distilled benzene to remove any moisture that may have been 
present. The labelled phosphonium salt was also azeotroped with dry, distilled benzene 
and heated overnight at 60°C under high vacuum. It was found to carry a high static 
charge and difficulty was encountered in weighing out the material. THF was added to 
the Wittig salt followed by potassium hydride, and the mixture was stirred as for the trial 
reaction (Section 4.5). After settlement of particulate matter the solution was cannulated 
into the flask containing the norketone 33 and a very faint yellow colour persisted. 
Unfortunately, the labelled phosphorane contained a yellow dye, possibly as a visual aid 
during handling. This interfered by masking the bright yellow colour of the ylide being 
formed, and made it difficult to tell whether the ylide had been formed at all. 
Unfortunately, no product was observed by tic analysis. Considering that the trial 
reaction with unlabelled phosphorane proceeded well, the only conclusion that could be 
made from this lack of reaction, was that the labelled methyl triphenylphosphonium 
iodide was contaminated. However, no steps to prove this could be taken at the time, as 
nmr, mass spectroscopy or elemental analysis were impossible to perform due to the 
radioactivity of the substance. The phosphorane was later found to contain a large 
amount of water as an impurity. Although an attempt was made to dry the phosphonium 
salt by azeotroping with dry benzene, it was not soluble, and so any water trapped within 
the crystals had not been removed. Despite having added 35 equivalents of sodium 
hydride to form the ylide, this most likely only partially dried the phosphorane. In fact, 
no ylide (or very little) had been formed at all. It appeared that about half the mass of the 
weighed labelled phosphorane was actually taken up by water and coloured dye. The 
problem was eventually overcome by using an extremely large excess of sodium hydride 
(>1000 equivalents) to dry the phosphorane and to also form the ylide. Although the 
phosphorane still contained the yellow dye, the ylide once formed could be distinguished 
by a brighter yellow colour. The ylide was then cannulated through a needle, tightly 
packed with glass wool to act as a filter into a solution of the norketone 33. This proved 
to be highly effective, allowing no sodium hydride to pass through. Tic analysis showed
41
that the labelled olefin 38 had indeed been formed. However, it was thought necessary 
to chromatograph the crude olefin (even though this would involve more handling), to 
remove the yellow dye and the triphenylphosphine oxide. This resulted in a 74% yield of 
the radiolabelled olefin being isolated. The deprotection step was then carried out. The 
deprotected radiolabelled GA20 (26) was purified by reverse phase high pressure liquid 
chromatography (HPLC) to give 2.5 mg (45% yield) of the 14C-labelled GA20 over the 
three steps (labelling and deprotection). This afforded 263 jaCi of GA20 with a specific 
activity of 56 pCi/|imole.
i) 2M NaOH, MeOH, 
110°C, 12 hrs
ii) AcOH, 100°C, 1 hr
Scheme 26.
4.7 Biological Studies Using 14C-GA20
A  research group in Minnesota require the 14C-GA2o to help track the metabolic 
pathway involved in the conversion of GA19 to GA2o- Other uses of this radiolabelled 
substrate include: observing the effect of seeds and auxin on GA20 metabolism in pea 
pericarp; comparing GA20 metabolism in light-independent photomorphogenetic (lipl) 
mutant with that of the wildtype; use as an internal standard and marker in plant extracts 
and during GA purification, as well an for injections into eucalyptus trees and hybrid 
aspen to study GA metabolism and transport in vivo; and observing the effects of 
photoperiod on GA metabolism in hybrid aspen.
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Chapter 5
C-Labelling
OF GA9 5
5.1 Introduction
GA95 (39) is a recently discovered gibberellin, isolated from Prunus cerasus 
(sour cherry). Its structure determination was confirmed by partial synthesis, and the 
identification of endogenous material was made possible by the preparation of the 
17,17-deuterated derivative105. There was speculation that this unique structural type 
might be involved in one or more biosynthetic pathways. It was expected that metabolic 
studies with labelled GA95 would give insight into A-ring hydroxylation and some 
understanding of the oxidising enzymes involved in the formation of GA3 (42), GA7 
(43), etc106.
Figure 9.
The combination of a 3ß-hydroxyl and a A^double bond that is present in GA3, 
(42) has been shown to be formed biosynthetically in maize from a A2-double bond. 
Although GA5 (40) possesses a A2-double bond, it appears not to be the precursor of 
GA3, or GA32 (45) (the most potent GA plant bioregulator) in Prunus persica107>108.
(40) R=OH; GA5 y (42) R=OH; GA3
(41) R=H; 2,3-dehydro GA9 /  (43) R=H; GA7
?
(44) R=H; 1,2-dehydro GA9 
(39) R=OH; GA95
Scheme 27.
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Sim ilarly, GA7, 43 has also been shown to be formed in vitro from the 
2,3-dehydro GA9, 41 in Marah and Malus109. This GA9 derivative has not been isolated 
as a natural gibberellin, however, perhaps because it does not accumulate due to its slow 
formation and fast metabolism. Alternatively, its A1-isomer 44 (GA120) may be the 
precursor of GA7. In fact, 44, has very recently been found in P. persica by 
Koshioka110. It therefore follows that the analogue of 44, namely GA95 (39), may be 
the precursor to GA3, and perhaps GA32, which has been isolated along with GA95 in 
several Prunus species105.
The objective of this study was to prepare 14C-labelled GA95, which would then 
be used in feeding studies, so that its metabolism in Marah macrocarpus and various 
Prunus species may be followed.
It was hoped that through these feeding studies, an understanding of the 
mechanism involved in 3ß-hydroxylation would be gained. Another objective was to 
study the effect of some semi-synthetic gibberellin growth retardants, such as 
dihydro-GAs (46), and dichloromethano-GAs (47) on 3ß-hydroxylation. It has been 
proposed that these growth retardants act as competitive inhibitors of the enzyme 
responsible for effecting 3ß-hydroxylation1H.
Figure 10.
The proposed route for preparing the radiolabelled GA95 was based on an earlier 
synthesis105, but changed slightly in order to minimise handling of the gibberellin after 
incorporation of the 14C-isotope at the C(17) position. The readily available GA3 was 
used as starting material, which required removal of the 3ß-hydroxy group as one of the 
major transformations. The allylic lactone in the A-ring of GA95 was found to be 
especially labile and easily rearranged to the isolactone. Thus, it was necessary and 
convenient to mask the A1-double bond through part of the synthesis. For the same 
reason, the 7-carboxylic acid was protected as the methoxymethyl ester in the hope that its 
eventual removal would not disturb the allylic lactone.
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5.2 Reductive Elimination in the A-Ring
GA3 was protected as the 3ß,l 3-bismethoxy methyl ether 7-methoxymethyl ester, 
48 by treatment with methoxymethyl chloride and diisopropylethylamine in 
dichloromethane in the presence of DMAP. The protected GA3 derivative (48) was then 
subjected to reduction by dissolving lithium in liquid ammonia112. For the methyl ester, 
it is usual for these types of dissolving metal reductions to turn a persistent blue colour 
for a few seconds upon the addition of a slight excess of lithium, which indicates that 
complete reduction of the A-ring has occurred but that the ester group is still intact. 
However, in the system being studied, once the A-ring functionality had been reduced, 
the 7-MOM ester began to be reduced also. Hence, it was very difficult to establish the 
correct end-point for the reduction of the 3ß-MOM ether. It was, therefore, necessary to 
follow the reaction by tic analysis. The best yield was obtained when tic indicated that no 
starting material remained. A 1:1 mixture of the desired acid 49 with carbinol 50 was 
then obtained, which could be separated by flash column chromatography.
GA3
MOMC!
i-Pr2NEt
DMAP
(48) (49) (50%)
h o 2c  n  c h 2o h  
(50) (50%)
Scheme 28.
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5.3 lodolactonisation
The reduction product was then transformed into the iodolactone 51 , by 
dissolving the acid 49 in THF and treating with potassium hydrogen carbonate, 
potassium iodide and iodine. The reaction proceeded smoothly to afford the 1-iodo 
lactone as a white solid in 88% yield. Evidence for the formation of the desired product 
could be seen in the nmr spectrum with the H(l) resonance at approximately 4.5 ppm, 
and in the 13C nmr spectrum, the resonance from C(10) at 93.9 ppm.
5.4 Ozonolysis
Because of the poor yield obtained during ozonolysis in section 4.4 using 
dimethyl sulfide as the reducing agent, alternative procedures were investigated for the 
GA95 substrate. At first ozonolysis was carried out in ethanol using zinc and acetic acid 
to decompose the ozonide. However, the crude ]H nmr indicated that the major product 
was the 13-ketone-16-ethyl ester, (52), due to oxidative cleavage of the C(13)-C(16) 
bond.
(49) (51) (88%)
Scheme 29.
(51) (52)
Scheme 30.
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The procedure was repeated using a mixture of dichloromethane/methanol as the 
solvent, and triethylamine to decompose the intermediate peroxy methyl acetal. 
Unfortunately, cleavage of C(13)-C(16) bond occurred again, the crude nmr 
indicating that the 13-ketone-16-methyl ester was the major product. In order to 
circumvent this problem, a solvent mixture of dichloromethane/pyridine (4:1) was used 
with triethylamine as the reducing agent which alleviated the problem. However, to avoid 
decomposition products the reaction was not driven to completion; yields for ozonolysis 
were then reasonable, although still not very high: 56% for the desired norketone 53 and 
16% of recovered starting material.
i) 0 3, -78°C  
CH2Cl2/pyridine
ii) Et3N
(51) (53)
Schem e 31.
5 .5  Removal of 13-MOM Ether
Because of the extreme sensitivity of the allylic lactone structure in GA95, it was 
vital to remove the 13-MOM ether prior to introducing the A1-double bond, as treatment 
of the didehydro derivative 54 with Dowex resin113, necessary for 13-MOM removal, 
rearranged the A-ring to afford the isolactone 55, as experienced by Nakayama et al. 
when isolating GA95106.
The norketone 53 was treated with Dowex resin in methanol/water (5:1) which 
removed both the 7-MOM ester and 13-MOM ether after heating at reflux overnight. To 
reinstate the 7-MOM ester selectively, the deprotected compound 56 was again treated 
with MOMC1, but triethylamine was used as the base instead of diisopropylethylamine 
and DMAP. Elimination of HI from 57 was achieved by treatm ent with 
l,8-diazabicyclo[5.4.0]undec-7-ene (DBU) in dichloromethane. Once the A1-double 
bond had been reinstated, the excess of DBU was removed by carefully washing with 
cold 1M HC1. GA95-7-methoxymethyl ester-16-norketone (58) was isolated as a white 
crystalline solid (81% yield). H(2) was observed in the ]H nmr spectrum as a doublet 
split into a triplet at approximately 5.9 ppm, and H (l) as a broad doublet at approximately 
6.2 ppm.
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Dowex, MeOH/H20  
reflux
(53)
DBU, CH2CI2 
reflux, 16 hrs
.,„» OMOM
Dowex, MeOH/H20  
reflux
.,„» OH
Scheme 32.
k....OH
Et3N, MOMCI 
CH2CI2, rt, N2
.„.»OH
DBU, CH2CI2 
reflux, 16 hrs
The TMS ether was successfully incorporated by treating the norketone with 
TMSC1 in the presence of DMAP. An excess of diisopropylethylamine was also used to 
remove free HC1 formed during the reaction, thus reducing the possibility of rearranging 
the A-ring. Purification was carried out by flash column chromatography using a 
buffered solvent system, thereby affording the TMS ether (59) as a colourless oil (73% 
yield).
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5.6 Methylenation and Deprotection
The Wittig methylenation of the 7-MOM ester-13-TMS ether was carried out first 
with the non-labelled methyltriphenylphosphonium iodide in exactly the same way as 
GA20 was methylenated. This resulted in an 80% yield of GA95-7 -MOM ester-13-TMS 
ether (60 ), with the 17,17 protons resonating at 4.9 and 5.2 ppm in the !H nmr 
spectrum. However, all attempts to deprotect the ester by acid catalysed hydrolysis 
resulted in the formation of a high percentage of the GA95-isolactone 61, as evidenced by 
resonances at 4.87 ppm for H(2) occurring as a triplet and 5.95 ppm of H (l) occurring as 
a doublet in the ]H nmr spectrum . Dimethylboron bromide was also used at -78°C in 
dichloromethane for a very short period of time (approximately 5 mins.), but this resulted 
in a mixture o f GA95 and the isolactone, and did not succeed in removing the 13-MOM 
ether. Because purification techniques (ie. HPLC) resulted in the formation of more 
isolactone formation, this route was therefore, considered inappropriate and it was 
decided that the 7-carboxylic acid should be protected as the methyl ester prior to Wittig 
olefination and then removed by the lithium thiolate procedure103.
C H 3P P h 3l, KH
T H F.rt
1 H  c o 2m o m 1 H c o 2m o m
(59) (60) (80%)
,...OH
■ n co2h 
(61) (major)
■ n  C02H 
(39) (minor)
Scheme 34.
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5.7  Protection as the 7-Methyl Ester-13-TMS Ether
After deprotection of 53 using Dowex resin, the free acid 56 was protected as the 
7-methyl ester 62 using diazomethane in methanol.
,....OH
CH2N2, MeOH
.,i>" OH
Scheme 35.
The 1-iodide was eliminated as HI by treating 62 with DBU in dichloromethane 
to afford the 1,2-double bond in the GA95 derivative 63. The 13-TMS ether was 
incorporated as before (section 5.5) with the same precautions to prevent isolactone 
formation.
i-Pr2NEt, TMSCI 
CH2CI2, rt
Scheme 36.
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5.8 Methylenation-lncorporating 14C Isotope label; and 
Deprotection
The radiolabelling procedure was carried out with all necessary precautions taken 
into consideration. This step was a replica of that described in section 4.6. Anhydrous 
conditions were maintained throughout the procedure, which was successful in producing
4.9 mg (74%) of the 17-14C-radiolabelled GA95 derivative 65 after flash column 
chromatography.
The methyl ester was carefully treated with lithium thiolate by taking a solution of 
ester 65 in hexamethylphosphoramide (HMPA) and adding lithium thiopropoxide 
according to the standard procedure used in the Mander research group103. The 
14C-labelled GA95 substrate was purified by reverse phase HPLC. Any isolactone (67) 
which had formed throughout the reaction procedure or during HPLC was successfully 
removed at this time. The solvents used throughout HPLC were removed by freeze 
drying the labelled compound, as previously105, since removal under reduced pressure 
resulted in isolactone formation due to acetic acid being present in the solvent system. 
This procedure afforded 180 pCi of the pure labelled GA95 (6 6 ) with a specific activity 
of 56 pCi/pmole. Throughout the synthesis, reaction conditions and yields were not 
optimised due to the urgency of the required labelled GA95.
(64) (65)
n-PrSLi
HMPA
(67) (minor) (6 6 ) (major)
Scheme 37.
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5.9 Results of Feeding Study
The 14C-labelled GA95, prepared above was incubated in tris buffer with a cell 
free enzyme preparation from Marah macrocarpus. GCMS analysis showed that only one 
product was formed, namely GA3114.
When observing the formation of GA7, (43) from 41 (section 5.1, Scheme 27), 
it has been shown that the enzyme abstracts the lß-hydrogen109. There are two possible 
pathways for this observation: (i) suprafacial oxygenation at C(3) concerted with 
hydrogen removal; or (ii) initial abstraction of hydrogen to form an allylic free radical, 
delocalised over carbons 1,2 and 3 with quenching by an oxygen ligand at C(3), as seen 
in Scheme 38.
(41) 2,3-dehydro GA5 (43) GA7
Scheme 38.
Formation of GA3 (42) from GA95 (39) is consistent with the formation of an 
allylic free radical with initial abstraction of the C(3) hydrogen shown in Scheme 39.
Scheme 39.
The radiolabelled GA95 will be used again in collaboration with Teikyo University 
Utsunomiya, Japan, to ascertain if GA95 is the biosynthetic precursor of GA3 and/or 
GA32 in Prunus cerasus and other Prunus species.
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Chapter 6
Conversion of GA 's into 
Kaurenoids by 
Expansion of the B-Ring
Background
6.1 Introduction
Kaurenoids are a complex group of tetracyclic diterpenoids that have proven their 
utility in traditional Chinese medicine for the treatment of a range of conditions (especially 
those from the Rabdosia genus), from gastrointestinal disorders to cancer therapy84, and 
anti-HIV a ctiv ity 115’116. Their isolation from plant species is restricted to very small 
quantities, sparking investigations into the chemical synthesis of these compounds. 
Thus, the preparation of semi-synthetic kaurenoids from gibberellins was an attractive 
possibility with the experience already gained in transformations of GA3 to reinforce this 
approach.
6.2 The Kaurenoids: Activity and Isolation
Many kaurenoids were available in the past as by products of GA production from 
the fermentation of G. fujikuroi. However, in recent years with the use of current 
strains, only trace amounts of kaurene derivatives are being produced. In 1958, enmein 
(68 ) one of the major diterpenoid constituents of the Rabdosia genus was isolated, 
prompting an investigation into its structure85.
(68) R = H (69) (70)
(72) R = Ac
(71)
Figure 11.
Kubota and co-workers117 reported high antibacterial activity for enmein (68), 
isodonal (69), nodosin (70), oridonin (71), and enmein-3-acetate (72) against Gram­
positive bacteria. It was concluded that antibacterial activity depended upon the presence 
of the a-methylene-cyclopentanone moiety due to a Michael-type addition by a sulfhydryl 
containing enzyme (Scheme 40).
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Scheme 40. Michael-type addition of a sulfhydryl enzyme to 
the a-methylene-cyclopentanone moiety.
In vivo antitumour activity against Ehrlich ascites carcinoma in mice was also 
examined and it was assumed that the a-methylenecyclopentanone moiety also played a 
role in antitumour activity by deactivating S-H enzymes (or S-H coenzymes)116’119. 
Oridonin (71) and lasiokaurin (73) were shown to possess even greater activity, which 
was attributed to H-bonding between the C(6)-OH and C(15)-carbonyl groups; the 
hydroxy groups at C(7) and C(14) were assumed to play a role as binding sites to 
specific enzymes in the tumour cells. Spirolactone-type diterpenoids have also been 
studied and shikodonin (74) has shown antitumour activity87.
(71) R = H 
(73) R = Ac
Figure 12.
Some kaurenes have also been shown to be efficient inhibitors of gibberellin 
biosynthesis in G. fujikuroi, and so may provide a basis for the design of novel plant 
growth regulators120. The potential of stevioside (75) and related rubosides as non­
nutritive sweeteners has been investigated for a number of years121 with patents being 
registered for their isolation and applications.
Ri = ß-D-glucosyl 
R2 = ß-D-sophorosyl
Figure 13.
(75)
Rl— O
(74)
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The above brief outline illustrates the therapeutic potential and possible industrial 
uses for kaurenoids and provides an impetus to produce these compounds synthetically. 
As a consequence, our attention has been focussed upon the conversion of the more 
accessible gibberellins into kaurene derivatives. Moreover, by extending the availability 
of kaurenes, access to the complete set of intermediates in the biosynthetic sequence in 
plants would then be provided, from kaurene through to GA3.
6.3 Biological and Chemical Transformations of Kaurenes 
into Gibberellins
In the past, when kaurenes were produced as byproducts from the fermentation of 
G. fujikuroi, they were utilised in the formation of rare gibberellins. Transformations of 
kaurenes to GA's were possible by either (a) biological means or (b) chemical synthesis.
(a) By feeding isotopically labelled kaurene derivatives to the fungus, G. 
fujikuroi, it has been possible to trace the biosynthetic pathway of the labelled 
gibberellins produced122. These studies were made possible through the use of plant 
growth retardants which blocked normal GA biosynthesis at the stage between 
mevalonate and e«/-kaur-16-ene. Hence, any gibberellins isolated should only have been 
biosynthesised from the labelled kaurene derivative.
(b) The first partial synthesis of a naturally occurring gibberellin was that of 
GA12 from 7ß-hydroxykaurenolide, which was made available by isolation from the 
fermentation of G. fujikuroi123. The 7ß-hydroxykaurenolide was converted in three 
steps to the 7a-toluene-/?-sulphonate 76 which then underwent a pinacol-like B-ring 
contraction using potassium hydroxide in boiling r-butyl alcohol. This resulted in the 
formation of GAj2-7-aldehyde which was oxidised to acid 77 with Jones' reagent 
(Scheme 41).
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ii) TsCI/pyridine
7-hydroxy kaurenolide
KOH/t-BuOH
Scheme 41.
For the ring contraction step to occur it proved essential to have the 7-tosylate 
group aligned antiperiplanar with the migrating C(6)-C(7) bond. It was therefore, 
necessary to invert the stereochemistry at C(7) by oxidation followed by borohydride 
reduction. Incorporating a 14C-label into the C(17) position of the gibberellin after ring 
contraction, has allowed for the partial synthesis of labelled GA12123. This five step 
sequence still remains the best procedure to obtain GA 12 and its labelled derivative. 
G A i5-norketone has also been partially synthesised from 7-hydroxykaurenolide124, 
through the transanular oxidation of the acetate-amide (79), Scheme 42.
i) photolysis
Pb(OAc)4, l2) 
benzene
O ii) base hydrolysis 
iii) Jones' oxidation
GAi5-norketone
i) acetylation
ii) thionyl chloride
iii) NH3
Scheme 42.
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6.4 Proposed Synthesis of Kaurenoids from Gibberellins
There are many challenges to be met in the synthesis of kaurenes. First, the need 
to address the densely arrayed functionality found in the biologically active members of 
this family of molecules. Secondly, the kaurenoids provide a challenging goal from a 
stereochemical standpoint with their multiple stereogenic centres. These factors make 
total synthesis extremely difficult and so it has been achieved only with long multi-step 
sequences and often poor overall yields. Moreover, in the main, the targets have been the 
simpler derivatives.
A study was therefore, proposed which would explore the prospect of utilising 
gibberellins as a source of semi-synthetic kaurenes. Such a conversion would take 
advantage of the extensive knowledge and wealth of experience already gained in the 
transformations of GA's, exploiting their highly functionalised nature to facilitate the 
preparation of the more complex kaurenoids.
To convert a GA into a kaurenoid requires a one carbon expansion of the B-ring. 
Initial investigations were centred upon a GAß-type skeleton due to its ready availability. 
The main objective was to extend the methodology to a C20 gibberellin, with a view to 
synthesising the more complex compounds which characteristically show greater 
therapeutic potential. Comprehensive reviews are available on the vast literature 
surrounding ring expansion methods that have been developed125’126’127. Therefore, 
only a selection of some of the more salient methods that may be of use in the context of 
the synthetic aims of this investigation are presented.
6.5 Ring Expansion Reactions
There are a number of procedures in which ring expansion can be effected. Often 
the main driving force for ring rearrangements is the release of energy from ring-strain.
6.5.1 Diazoalkane: Carbon Insertion
Diazomethane may act as a carbon nucleophile and functions by the insertion of a 
methylene unit followed by a migration step similar to that of a pinacol rearrangement as 
illustrated in Scheme 43.
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Scheme 43.
The main disadvantages of using diazoalkanes for ring expansion are that their use 
on unsymmetrical ketones can give rise to two products, with the result that control of 
regioselectivity can become a problem. The products can also continue to react with the 
diazomethane. Sometimes an epoxide can be the main product (Scheme 44).
The initial addition of diazoalkane to the carbonyl carbon can be catalysed by a 
variety of Lewis acids. For bridged bicyclones (at least), the regiochemistry of the 
carbon bond migration is largely dependent on conformational, rather than electronic 
factors127.
The Tiffeneau-Demjanov reaction is similar to the diazomethane based carbon 
insertion, in that a single carbon atom is inserted into a ring, and has often been 
successful where reactions with diazomethane have proven to be problematical. First of 
all, the ketone must be converted to an amino alcohol via the cyanohydrin. Ring 
expansion is brought about by treating this amino alcohol with nitrous acid. This 
procedure has provided one route to D-homosteroids128.
Scheme 44.
6 . 5 . 2 Tiffeneau-Demjanov Carbon Insertion
HO
H
Scheme 45.
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6 . 5 .3 Pinacol Rearrangement
The Pinacol rearrangement is the migration of a functional group to a cationic 
carbon atom by acid catalysed rearrangement of 1,2-diols. For migration to take place the 
starting material must be able to adopt a conformation in which the leaving group is 
antiperiplanar to the group which is migrating. The migratory aptitude is of the order Ph 
> M e3 C > Me2 CH 2 > OMe > H. However, it must be noted that the hydroxyl which 
leaves is the one which can give the more stable carbonium ion, and this takes precedence 
over migratory aptitude.
Mei
Ph2C -C -M e
h2oQ oh
-h2o z-Jv le  
+ I
Ph2C^;C-Mea:oh
Ph2C-CM e2 
HO OH
-h2o
------► Ph— C-CMe2
i O
HOX
Me
Ph2C - c '
O
PK
PhI
C-CMe2
ii
O
Scheme 46.
Thus, in the above example it is the methyl group that is found to migrate and not 
phenyl as would otherwise be expected.129
There are a great many examples of pinacol-like rearrangements in the 
literature130' 137. The ring expansion of the D-ring in steroids has been facilitated by a 
number of methods of pinacol-like (acyloin) rearrangements promoted by Lewis acids or 
alkaline catalysis. One rearrangement which generated a lot of interest was the 
rearrangement of the 17a-hydroxy-20-keto steroids into ketols130.
Scheme 47.
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The geometry about carbon 17a was determined and found to be dependent on the 
reagent used to catalyse the rearrangement, by manipulating the orientation of the 
carbonyl group in the transition state. The reasoning behind these reagent-controlled 
rearrangements can be explained in the following way. Base-catalysed homoannulation 
(a) involves the removal of the 17ß-hydroxy proton and produces a trans alignment due 
to the repulsion by the resulting negative charge on the oxygen, forcing the polarised 
carbonyl oxygen to assume a remote position(a, Scheme 48). Conversely, a Lewis acid 
such as borontrifluoride etherate coordinates with the two oxygen functions forcing them 
into a cis relationship with respect to each other (b, Scheme 48).
Scheme 48.
6.6 Strategy for the B-Ring Expansion of GA3
Given the literature precedent for ring expansion using pinacol rearrangements, it 
was expected that this protocol could be employed for the ring expansion of the 
gibberellins. To this end, initial investigations focussed on the pinacol-like 
rearrangement of a 6,7-diol with the primary alcohol activated as a mesylate to promote 
the rearrangement. Initially, GA3 was chosen as a suitable model compound with as 
much functionality protected or removed in order to reduce the possibility of any side 
reactions.
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Chapter 7
Ring Expansion of a 
GA3-Type
Derivative
7.1 Functional Group Protection and 
Formation of the 7-Hydroxyl
The 3,13-hydroxy groups of GA3 were first protected as acetates using acetic 
anhydride, DMAP and diisopropylethylamine in dichloromethane. The next step in the 
synthesis was to form a carbinol at the C(7) position. It was envisaged that the simplest 
way to do this was by first forming the 7-acyl chloride138, (in comparison to the 
formation of the anhydride139), and then to reduce this product to the 7-hydroxy 
derivative. To this end, the acyl chloride 81 was formed by the addition of the diacetate 
80 in THF containing pyridine, via cannula, to a solution of oxalyl chloride in THF at 
-40°C. The acid chloride was filtered through celite and no other purification was carried 
out due to its sensitivity. C(7) was associated with a resonance at 173.9 ppm in the 13C 
nmr spectrum, corresponding to an acid chloride. Reduction of the acid chloride was 
carried out by dissolving 81 in dry dimethoxyethane to which sodium borohydride was 
then added at 0°C, with some effervescence being observed. After 4 hrs the acid chloride 
had been reduced to the alcohol 82, which was isolated as a white crystalline solid. The 
two protons attached to C(7) gave a multiplet between 3.67 and 3.85 in the nmr 
spectrum.
Scheme 49.
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7.2 7-Hydroxyl Elimination to the 6-Ene
The next step in the sequence was the formation of the A6-ene. Differentiation 
between the C(6) and C(16) enes would be required, and so it was found necessary to 
mask the A16-ene prior to formation of the former function. This was effected by 
forming an epoxide at the C(16), C(17) position which could be reduced back at a later 
stage in the synthesis. Epoxidation was effected using ra-chloroperbenzoic acid in 
dichloromethane, giving rise to a white crystalline solid in 77% yield after work-up. The 
respective C(17) protons were observed as doublets at 2.76 and 3.07 ppm, respectively, 
in the ]H nmr spectrum. Since the A^ene could also prove problematic, and since this 
double bond was not required at a later stage, it was hydrogenated using a palladium 
catalyst under a hydrogen atmosphere to give the GAi-type skeleton (84). The ]H nmr 
spectrum showed the "disappearance" of protons H(l) and H(2) from 6.38 and 5.82 ppm 
respectively.
Scheme 50.
Formation of the A6-ene was first attempted by forming the 7-mesylate, followed 
by treatment with DBU in toluene. However, this led to decomposition, and the starting 
material could not be recovered.
Elimination of the hydroxy group to form the exocyclic alkene was eventually 
carried out according to the procedure of Grieco et a /140. This involves the direct one- 
step conversion of a primary alcohol to an alkyl aryl selenide using o-nitrophenyl 
selenocyanate141 in THF at room temperature in the presence of tri-n-butylphosphine. 
The proposed mode of reaction is as follows:
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ArSeCN + BU3P
©  ©
ArSePBu3CN + RCH2OH
©  ©
RCH2OPB113 + ArSe
©  ©
ArSePBu3CN
©  ©
PCH2OPBu3 + HCN + ArSe
RCH2SeAr + Bu3P=0
The GA-o-nitrophenyl selenide (85) was formed in 89% yield as a yellow 
powder, the aromatic protons showing up very distinctly in the l H  nmr spectrum between 
7.36 and 8.28 ppm.
Elimination142 of the derived primary alkyl o-nitrophenyl selenoxide was effected 
by stirring the selenide in a mixture of THF and 30% hydrogen peroxide at 0°C for 1.5 
hrs, and warming to room temperature over 10.5 hrs, by which time no starting material 
was detected by tic. The alkene (86) was isolated as a white solid in 90% yield. The 
protons of C(7) were located at 5.17 and 5.31 ppm in the *H nmr spectrum and C(7) 
itself was observed at 113.0 ppm in the 13C nmr spectrum with C(6) at 151.5 ppm.
(85) Se
Scheme 51.
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7.3 Formation of the 6,7-Diol
Dihydroxylation was performed on the 6-exocyclic methylene with OSO4 using 
Af-methylmorpholine N-oxide as a co-oxidant100. The mixture was stirred in 
acetone/water at 30°C for 9 days, after which time, a small amount of starting material 
still remained. However, the reaction mixture was worked up, the two compounds 
separated by flash chromatography, and the starting olefin recycled.
The 16-exocyclic methylene was then reinstated by deoxygenation of the epoxide 
using 3-methylbenzothiazole-3-selone in the presence of trifluoroacetic acid. First of all, 
an episelenide is formed (88) in the presence of the acid, then extrusion of selenium from 
88 gives the alkene:
+ Se
Scheme 53.
Unfortunately this procedure resulted in only a modest yield of the olefin, (48%), 
and no other compounds were recovered.
3-methylbenzothiazole-
2-selone
CF3COOH, ch2ci2
Scheme 54.
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In order to determine the stereochemistry of this diol, NOE experiments143’144 
were performed. Carbon and proton assignments were made through COSY and 
HETCOR spectra143’144. Prior to a NOESY experiment, a GNOE experiment was 
conducted (one dimensional gradient NOE experiment). In this experiment, a one 
dimensional spectrum is obtained showing only the resonances to which there is an NOE. 
The resulting spectrum has a large negative peak for the peak of interest at the centre, and 
small positive peaks indicating the resonances to which there is an NOE. When 
observing the H(7) protons a number of peaks were observed including 6-OH, H(15)a, 
H(5), H(15)ß, H(14)a, H (l) and the largest of these H(14)ß. An approximate 50% 
enhancement of H(14)ß over the other peaks indicated that the 7-methylene was on the a- 
face of the molecule. To expand on this result, a NOESY experiment was also 
conducted. This clearly showed a cross peak correlating to an NOE between the 7- 
methylene and the H(14)ß indicating that these protons are in close proximity to one 
another, but no cross peaks were observed for H(5) or the H(15) protons. This indicated 
that the OSO4 would have approached the gibberellin molecule from the ß-face, which is 
consistent with the reported protonation of a GA-6-enolate to afford a 6-epi-GA 
derivative139.
7,4 Mesylation and Ring Expansion
Corey et al131 used a variation of the pinacol rearrangement in their total synthesis 
of longifolene (90). The synthetic plan was to begin with a simple homodecalin 
precursor (91) which would cyclise to (92) by means of an intramolecular Michael 
addition.
The authors decided to form the secondary mono-/?-toluenesulfonate derivative 
(93), (Scheme 56), in order to form a better leaving group and in effect, activate the site 
for pinacol rearrangement. Because of the sensitivity of the ketal functionality and the
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allylic tert-hydroxyl which could undergo acid catalysed elimination, the ring-expansion 
was to be carried out under essentially neutral conditions. The solvent used was THF, 
and lithium perchlorate was added until saturation occurred to facilitate ionisation of the p- 
toluenesulfonyloxy function. Calcium carbonate was also added to buffer the solution. 
The reaction mixture was heated at 50°C for 60 hrs, after which time a mixture of 
stereoisomers having different orientations of the methyl a  to the carbonyl group were 
obtained in 48% overall yield (94). The alternative ring expansion product (95) was 
obtained in 5% yield. The authors had anticipated that the ring expansion would favour 
94 over the alternative 95 because of the n  electron participation of the migrating group, 
as opposed to the less favourable alkyl rearrangement for 95.
several
steps
several
steps
+
(95) (5%)
Scheme 56.
Prompted by this success, the 7-carbinol in 89 was to be derivatised so as to 
establish a good leaving group. An attempt to form the tosylate failed, and so the 
mesylate was produced by dissolving the diol in dichloromethane and adding 
triethylamine and methanesulfonyl chloride at -10°C145. The mesylate protons resonated 
as a large singlet at 3.15 ppm in the ]H nmr spectrum.
(89)
Scheme 57.
Ring expansion of the mesylate was attempted via Corey's131 ring enlargement 
procedure. The mesylate in THF was added to a suspension of lithium perchlorate and 
calcium carbonate in THF, followed by heating at 60°C for 5 days. However, after 
work-up and inspection of NMR spectra, in addition to starting material, only the 6,7- 
epoxide (97) could be detected.
Scheme 58
The C(7) protons of the ß-epoxide and a small amount of its epimer were 
observed in the *H nmr as two doublets at 2.73 and 3.16 ppm respectively.
The preparation of the analogous triflate was also attempted, but proved to be too 
unstable, eliminating to form the epoxide. Following Nagai's146 procedure for ring 
enlarging an epoxide with boron trifluoride etherate, the 6,7-epoxide (97) was dissolved 
in benzene and treated with 3 equivalents of boron trifluoride etherate at room 
temperature. This resulted only in the formation of the aldehyde, however.
7 .5  Acyloin Rearrangement of the Hydroxy Aldehyde
With the above ring expansion procedures showing no promise, attention was 
now focussed on the acyloin rearrangement that had been used for ring expansion of 
steroids130 and which was also undertaken by Magnus and co-workers132 for the 
formation of the eight membered B-ring of Taxol (Scheme 59). They had treated triflate 
98 with CF3CH2OH-H2O which had successfully resulted in conversion into the spiro- 
hemiketal 99, but they had also formed aldehyde 100, which underwent ring expansion 
followed by an acyloin-like rearrangement when treated with BF3-OEt2 to give ketone 
101 .
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NMMO
O — "o—
3 days
Scheme 59.
It was hoped that the strain in the GA skeleton would be of a sufficient magnitude 
as to favour rearrangement. In preparation for an acyloin rearrangement, the diol 89 was 
oxidised to the hydroxy aldehyde 102 using the Dess-Martin procedure. This proved 
successful as assessed by the observation of the proton on the 7a-aldehyde as a singlet at 
9.67 ppm in the ]H nmr spectrum of the product.
Scheme 60.
The hydroxy aldehyde (102)was then dissolved in dry dichloromethane and 
boron trifluoride etherate was added at room temperature. The mixture was stirred 
overnight and tic indicated three new products. At least two of the products proved to be 
ring expanded compounds, one of which appeared to be a ring expanded compound that 
had also undergone C/D-ring rearrangement (105), (Scheme 61).
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The structures of these products were determined by nmr spectra. For the 
main product, it was rationalised that the C(5)-C(6) bond was the migrating bond, giving 
(103), since H(5) was shown to be a doublet, and H(6)§ a doublet of doublets in the 
expected chemical shift range, with a vicinal coupling constant of 10 Hz in the nmr 
spectrum147. The structure of (105) was determined by the obvious lack of the C(17) 
methylene protons, loss of the 13-acetate, and the appearance of a second methyl peak at 
1.35 ppm. The C(5)-C(6) bond was again the migrating bond as the chemical shift and 
coupling pattem for H(5) and H(6) was similar to that of (103). The third product, could 
not be identified immediately, since it could not be isolated and was only observed by tic.
It is not surprising that the beyerane analogue (105) is obtained, as it would be 
expected that the labile D-ring would undergo rearrangement when exposed to Lewis 
acids. The prolonged exposure to boron trifluoride etherate engenders D-ring 
rearrangement and so it was hoped that a shorter reaction time would prevent this process 
from occurring.
(104) (<5%)
CO H
Scheme 61.
§ The carbon and proton numbering system of the ring expanded products is based on the kaurene
numbering system.
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The reaction was repeated exactly as before except that the reaction time was 
reduced to 30 mins. No starting material remained after this time, and no C/D-ring 
rearrangement was observed. When the reaction was repeated on a larger scale, the third 
product mentioned above, was isolated and identified as 104, resulting from the 
alternative migration of the C(8)-C(6) bond.
Figure 15.
The assignment of 103 was confirmed by a single crystal X-ray structure£ which 
clearly showed a C(7) carbonyl and a 6ß-hydroxyl (Figure 15). It was also instrumental 
in showing a change of conformation in the C-ring. In gibberellins, the C-ring is 
normally in a quasi boat conformation148. But following the ring expansion, the C-ring 
had adopted a chair conformation.
See Appendix II for X-ray Structure Report.
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The energy released by this conformational change would contribute to additional 
strain relief in the gibberellin skeleton. The X-ray structure clearly shows 103 to possess 
a chair conformation for the B-ring. If 103 is assumed to be the kinetic product of the 
ring expansion, then its formation may be regarded as the more favourable due to the 
chair-like transition state for the C(5)-C(6) bond migration (a). Whereas, migration of the 
C(8)-C(6) bond (b) would lead to a boat conformation for the B-ring, a less favourable 
pathway in terms of strain which is exhibited by the less than 5% yield for this process 
(Scheme 62).
Scheme 62.
The steps in this synthetic sequence are generally high yielding, apart from the 
deoxygenation of epoxide 87. However, this step could be avoided by either protecting 
the 16-methylene with a different function or by preparing the hydroxy aldehyde (102) 
by an alternative route. It would indeed, improve the synthesis if the hydroxy aldehyde 
could be prepared directly from aldehyde ( 106). 106 was formed by oxidising the 
alcohol 82 with Dess-Martin reagent in dichloromethane. The r-butyldimethylsilyl enol 
ether 107 was then prepared by dissolving the dry aldehyde 106 and r-butyldimethylsilyl 
chloride in dry THF at -78°C. Potassium hydride was added to the mixture, which was 
allowed to warm to room temp with stirring. An attempt to oxidise the enol ether with 
dimethyldioxirane to the hydroxy aldehyde failed however, and aldehyde 106 was 
recovered. Oxidation of the enol ether with m-chloroperbenzoic acid was attempted, but 
was also unsuccessful.
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(107)
Scheme 63.
7 .6 D-Ring Expansion
To further probe these ring expansions, an attempt was made to expand the 5- 
membered D-ring of a gibberellin. GA4-methyl ester, 3ß-acetate was readily available 
and so was chosen as a suitable substrate for investigation. A three step synthesis was 
all that was required in order to obtain a suitable intermediate, as the 16-methylene group 
needed only to be dihydroxylated, oxidised to the hydroxy aldehyde, and then treated 
with boron trifluoride etherate. Using standard reaction conditions, the 16-ene (108) 
was oxidised to the diol (109) in a quantitative yield using OsC>4 with NMMO as 
co-oxidant.
The diol was then oxidised using the Dess-Martin procedure, which afforded the 
hydroxy aldehyde (110) in 30% yield and also the 16-norketone (111) due to over 
oxidation (22% yield).
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Scheme 65.
The hydroxy aldehyde was taken up in dry dichloromethane and treated with 1.3 
equivalents of boron trifluoride etherate which, after 30 mins, furnished a 1:1 mixture of 
ketols, 112 and 113 in a quantitative yield. The two epimers could not be completely 
separated by chromatography and only tentative ]H nmr assignments could be made. In 
both cases, it was proposed that the C(15)-C(16) bond migrates to C(17) forming a 
6-membered ring supposedly in a chair conformation. Approximately 50% of the 
material has the C(17)-OH on the a-face of the molecule with the remainder on the 
ß-face.
BF3 Et20, CH2CI2
( 112)
C 02Me
Scheme 66.
7 .7  Continuing Studies
Having successfully ring expanded the B-ring to a 6-membered ring, a 
further study designed to explore the accessibility of the C20 kaurenoid lactones was 
considered, making it possible to synthesise some of the more complex kaurenoids from 
a C2o-gibberellin.
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Chapter 8
Ring Expansion 
in GAIS
77
8.1 Introduction to C20-Kaurenoids
Following on from the success of the B-ring expansion model study in Chapter 7, 
our attention was now focussed on the preparation of a C20 kaurene derivative, with the 
intention of producing complex kaurenoids that show interesting therapeutic potential84. 
Of particular interest are the seco-B-ring diterpenoids of the Rabdosia family (see Chapter 
6.2) which have shown antibacterial and antitumor activity such as enmein85, 
nodosin149, oridonin86, and shikodonin87.
oridoninnodosin shikodoninenmein
Figure 16.
By starting with a C2o-gibberellin, most of the skeletal requirements for the above 
complex derivatives are already in place. It was hoped that ketol 114 could be prepared 
from the gibberellin, GA15 (Scheme 67), using the methodology established in 
Chapter 7. Ketol 114 could then be transformed into 116, via the hemiacetal 115, by 
following the strategy used in the synthesis of 15-desoxyeffusin150, a shikodonin-type 
spirosecokaurene. This synthetic strategy would then give access to kaurenoids 
macrocalyxoformin ( 117)151 and longirabdolactone ( 118) 152, thus establishing a 
potential pathway to the more complex derivatives above (Fig. 17).
oxidative 1 
cleavage of 
C (6FC m  etc.»
CO H
CHO O
Scheme 67.
78
(117)
Figure 17.
It was unclear if a C2o-gibberellin would ring expand under the conditions used in 
Chapter 7, as the C(20)-lactone is orientated differently to the model compound studied 
and the driving force necessary for ring expansion may be different. However, the ease 
with which ring expansion was achieved on the model compound gave us confidence that 
a B-ring expansion in a C20 substrate was feasible, and so a synthetic route was mapped 
out.
It was proposed that the synthesis would begin with GA3, which would be 
converted to GA 19, through a well established pathway for preparing C2o-gibberellins. 
After removal of the 13-hydroxy group, a similar route would be followed to that in 
Chapter 7.
8.2 Synthesis o f GA1 9
The stereoselective synthesis of the 13-hydroxy-C2o gibberellin (GA19) derivative 
124 from readily available GA3 methyl ester di-MOM ether 119 was accomplished by 
Dawe et a lu l  in 1985. This synthesis involves an intramolecular cyclopropanation of 
diazoketone 121 to give the cyclopropylketone 122. The C(20) carbon is introduced in 
its correct position by a regioselective lithium/ammonia reduction of the cyclopropyl 
ketone to produce the cyclopentanone 123, (Scheme 6 8 ).
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(119) ( 120)
i) (COCI)2l Py, DMF, Et20
ii) CH2N2, Et20
... OMOM
C° 2 Me
( 121)
v
i) KH, THF, DMF
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Scheme 68.
Reduction of the GA19 derivative (125)* to GA44 was accomplished by 
dissolving this compound in dimethoxyethane at 0°C and adding sodium borohydride. 
After 4 hours the mixture was worked up in the usual way giving 8 8 % of the lactone 
(126). In the lH  nmr spectrum the 20-pro-S proton occurred at 4.09 ppm as a doublet of 
doublets with a geminal coupling of 12.3 Hz and a 4J  coupling of 2.3 Hz to H(l). The 
20-pro-R proton occurred at 4.40 ppm as a simple doublet.
NaBH4, DME 
0°C -> rt
(125)
Scheme 69
The GA19-7-methyl ester-13-MOM ether was a greatly appreciated donation from Mr Bruce Twitchin.
C 0 2Me
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8.3 Removal of the 13-Hydroxyl
The 13-hydroxyl is not present in the seco-kaurenes of interest, and so the 
decision was made to remove it early on in the synthesis. First, the methoxymethyl ether 
was removed by heating the substrate in methanol/water for 3 hours with Dowex (H+) 
resin. The mixture was then filtered to remove the resin and worked up in the usual way 
to afford methyl ester 127 in good yield.
Scheme 70.
Two different procedures were tried in order to deoxygenate the 13-hydroxyl. At 
first the 13-hydroxyl was converted to the 13-iodide by heating the substrate in toluene 
with triphenyl phosphine, imidazole and iodine at reflux. After 1.5 hours, no starting 
material remained and a dark blue spot at a higher Rf value was visualised by tic after 
spraying with vanillin. The iodide was isolated in 59% yield after chromatography and 
was subjected to radical reduction conditions to give the GA15 derivative in 72% yield. 
However, due to the low yield obtained for the iodide a different procedure was studied.
The free alcohol 1 2 7  was taken up in dichloromethane with 
diisopropylethylamine and DMAP. Methyloxalyl chloride was added, and after stirring 
overnight at room temperature, no starting material remained. After work up and 
chromatography, this procedure yielded approximately 90% of the methyloxalyl product 
128. The methoxy 1 of the methyloxalyl group gave rise to a singlet at 3.87 ppm in the 
*H nmr spectrum. This compound then underwent radical deoxygenation with tributyltin 
hydride in toluene at reflux with the initiator AEBN for 3 hours153. This produced the 
G A15 derivative in 88% yield (129) with some recovered starting material (approx. 
10% ).
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m ethyl oxalyl chloride 
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n-B u3SnH, AIBN 
to luene, reflux
Scheme 71
8.4 Reduction of the 7-Carboxylic Acid
To prevent the formation of a 16,17-diol during dihydroxylation of the A6-ene, 
the 16,17- exocyclic double bond required some form of protection. To avoid the 
problem encountered during the model study (Chapter 7.3) of obtaining a low yield on 
removal of the epoxide, the 16-methylene was instead oxidised to the 16-norketone by 
ozonolysis (with the intention that the methylene group could be restored in high yield by 
means of a Wittig reaction). This was initiated by dissolving the olefin 129 in 
dichloromethane/ methanol, lowering the temperature to -78°C and bubbling ozone 
through the solution. The resulting methoxyhydroperoxide 130 was treated with 
dimethyl sulfide with the expectation of obtaining the norketone 131, but was recovered 
unchanged. The hydroperoxy acetal eventually did decompose to the 16-norketone, 
however, by removing all solvent, dissolving the residue in dichloromethane only, and 
stirring the mixture with triethylamine for 20 hours.
82
The 7-methyl ester was hydrolysed using methanol/sodium hydroxide at reflux, 
and then acidifying to pH 3-4 to form the 7-carboxylic acid 132 in 94% yield.
The acid chloride was synthesised and reduced in the same way as for the 
Ci9-model compound (Chapter 7.1) to give the 7-carbinol 134 in 82% overall yield. 
During reduction of the acid chloride, the 16-norketone was also reduced to the 
16ß-hydroxyl, as indicated by the doublet of triplets at 4.2 ppm in the 2H nmr spectrum.
(COCI)2, pyridine 
THF, -40°C
Schem e 74.
COC1
NaBH4, DME
8.5 Formation of the 6-Ene by Elimination
Elimination via the Grieco procedure140 successfully produced the A6-ene. The 
alcohol was dissolved in THF and o-nitrophenyl seleno-cyanate was added, followed by 
rc-tributylphosphine. After one hour of stirring at room temperature the 7-selenyl ester 
135 was formed selectively, being a primary alcohol and less sterically hindered than the 
16ß-hydroxy group. The selenyl ester 135 was isolated as dark orange crystals in 90% 
yield. The C(7) protons occurred at 2.83 and 3.50 ppm as multiplets in the ]H nmr
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Spectrum. Subsequent oxidative elimination with 30% hydrogen peroxide at 0°C in THF 
afforded the 6-methylene derivative 136 in 78% yield.
o-N 02C6H4SeCN
n-Bu3P
THF, rt
(135) Se
(136)
Scheme 75
8.6 Formation of the 6,7-Diol
To form the 6,7-diol, the 6-methylene 136 was dissolved in acetone/water (5/1), 
and osmium tetroxide was added with NMMO. Tic analysis showed product formation 
with a very low Rf value. However, the 6,7-diol could not be successfully purified by 
flash column chromatography due to its polarity. Alkene 136 was therefore, oxidised to 
the 16-ketone prior to dihydroxylation with osmium tetroxide. Treatment of 136 with the 
Dess-Martin reagent in dichloromethane furnished the 16-ketone 137, which was then 
dihydroxylated with osmium tetroxide and NMMO as previously described, over four 
weeks to give the 6,7-diol 138 in 76% yield. The C(7) protons were seen as doublets at 
3.76 and 3.85 ppm with the 6-hydroxy group (which was H-bonded) at 3.65 ppm in the 
]H nmr spectrum.
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Dess-Martin
periodinane
CH2CI2, rt
(136) (137)
O s0 4, NMMO 
acetone/H20
Scheme 76.
8.7  Oxidation to the Hydroxy Aldehyde and Rearrangement 
to the Ketol
The 6,7-diol 138 was then oxidised to the hydroxy aldehyde 139, again using 
the Dess-Martin procedure in 89% yield.
Dess-Martin
periodinane
CH2CI2, rt
Scheme 77.
The ring expansion was carried out in dichloromethane at room temperature with 
the addition of 1.3 equivalents of boron trifluoride etherate. After 30 minutes of stirring, 
a new product was formed as seen by tic analysis. Although the ring expansion had 
proceeded smoothly, the expected 6-hydroxy-7-one had not been formed. Instead, the 
isomeric 7-hydroxy-6-one 140 was the only product isolated in 100% yield. This was 
apparent by examination of the nmr spectrum which showed H(5) as a singlet at 2.26 
ppm, H(7a) as a broad singlet at 3.86, and 7ß-OH (hydrogen bonded) as a singlet at 
3.49 ppm.
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Scheme 78.
The difference in outcome for the C20 rearrangement may be attributed to different 
steric factors caused by the repulsion between C(20) and C(11). This interaction appears 
to be relieved more effectively and rapidly by migration of the C(8)-C(6) bond even 
though this leads to a boat conformation for the B-ring. For the Ci9-series (Chapter 7), 
this steric demand is reduced because of the smaller lOa-oxygen substituent, which is 
also angled away from C (ll) due to the 19,10-y-lactone bridge [ie. in the 5-membered 
ring, the lOa-oxygen is "pulled" towards C(4)]. Thus, for the C 19-series a chair-like 
transition state [C(5)-C(6) bond migration] takes precedence over steric repulsion 
between the lOa-oxygen and C(11).
8.8 Rearrangement to the Hemiacetal
Although ketol 140 can not undergo direct rearrangement to the hemiacetal 
(142), base catalysed isomerisation of the ketol might afford the desired ketol 141. This 
could then undergo methanolysis and rearrangement to afford the hemiacetal (142).
Scheme 79.
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Methoxide attack directly on 140 to afford a 20,6-acetal would also be possible, 
but the product appears from molecular models to be more highly trained than 142. 
Unfortunately, time did not allow further investigations. However, the rearrangement 
has since been achieved by Dr George Adamson154. The ketol 140 was treated with 
sodium methoxide in methanol for 20 hrs, followed by diazomethane, thereby affording a 
2:1 mixture of acetals 142 and 143.
8.9 Incorporation of the 15-Hydroxyl
Preliminary investigations were undertaken to ascertain the feasibility of 
introducing a carbonyl group at the C(15) position which is present in many of the more 
complex kaurenoids. This had previously been attempted in the synthesis of effusin150. 
The 15-desoxyeffusin derivative had been subjected to allylic oxidation using selenium 
dioxide and te/T-butylhydroperoxide155. However, this failed to furnish the 15-hydroxy 
derivative. Thus, incorporation of a 15-hydroxy group at an earlier stage was examined 
by taking the ring expanded product of Chapter 7.5 (103) and treating it with r-butyl- 
dimethylsilyl triflate (TBDMSOTf), Scheme 80.
(103)
TBDMSOTf,
i-Pr2EtN,
DMAP, CICH2CH2CI
OTBDMS
Scheme 80.
Having protected the secondary alcohol, the ring expanded product underwent 
allylic oxidation with selenium dioxide and r-butylhydroperoxide under sonication to 
afford the 15a-hydroxy derivative (145), (Scheme 81). The 15ß-proton appeared as a 
broad singlet at 4.40 ppm in the !H nmr spectrum.
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OTBDMS
S e 0 2, t-BuOOH
CH2CI2
ultrasound
OTBDMS
Scheme 81.
This last step has proven that a 15-hydroxy group and thence a 15-oxo function 
could be incorporated after the ring expansion step.
8.10 Conclusion
The synthetic sequences illustrated in this chapter demonstrate a viable route to 
obtaining kaurenoids from gibberellins and offers many opportunities for preparing some 
of the more complex and interesting examples of this family of compounds. Synthetic 
studies are continuing in this area, in the hope of manipulating acetals 142 and 143 to 
form macrocalyxoformin (117) and longirabdolactone (118), as well as endeavouring to 
shorten the number of steps required in the existing transformations.
Having paved the way to synthesising complex kaurenoids from gibberellins, 
there now exists great potential for expanding on this research area, such as assigning 
tentative new structures, derivatising particular compounds in order to produce 
heightened biological activity, and isotopic labelling for the purpose of metabolic 
tracking. The highly functionalised nature of gibberellins, and the wide range of 
synthetic methodology already existing for further functionalising these complex 
compounds, allows for numerous possibilities. For example, the optional retention of 
functionality at C(3) and/or C(13), plus procedures for introducing functionality into the 
GA molecule at C (l)156' 158, C ( ll)159-160, C(12)161d62? C (1 4 )163d 64 and C(18)165 in 
combination with those described above could give access to the complete range of 
known kaurenoids.
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Chapter 9
Experimental
89
9.1 General Experimental
9 . 1 . 1  Instrum entation
Melting points were recorded on a Reichert hot-stage apparatus and are 
uncorrected. All infrared spectra (vmax) were recorded on a Perkin-Elmer 683 Infrared 
Spectrophotometer and referenced to the characteristic peak at 1601 cm -1 for polystyrene.
and 13C nmr spectra were recorded on a Varian Gemini 300 MHz instrument. 
Chemical shifts are reported as values in parts per million (6  ppm). For proton spectra 
recorded in chloroform, the residual peak of CHCI3 was used as the internal reference 
(7.26 ppm), while the central peak of CDCI3 (77.0 ppm) was used as the reference for 
carbon spectra. Multiplicities are abbreviated: s = singlet, d = doublet, t = triplet, q = 
quartet, m = multiplet, and br = broad. Distortionless enhancement by polarisation 
transfer (DEPT) and the attached proton test (APT) were used in the assignment of carbon 
spectra143’144. Two dimensional NMR experiments were used to assign the molecular 
fram ew ork143’144. Low resolution El mass spectra (70eV) were recorded on a VG 
Micromass 7070F double focussing mass spectrometer. High resolution mass spectra 
(exact mass) were also determined on the 7070F instrument by peak matching. 
Microanalyses were carried out by the Australian National University Analytical Services 
Unit, Canberra. C,H,N analyses were measured on a Carlo Erba EA 1106 CHN-O 
instrument.
9 . 1 . 2  C hrom atography
Analytical thin layer chromatography (tic) was conducted on Merck glass backed tic plates 
coated with 0.2 mm thick silica gel 60 GF254, or Merck aluminium backed tic sheets with 
silica gel 60 F254. The developed plates were visualised under shortwave ultraviolet 
light, exposure to iodine vapour, or stained with 13% (w/v) vanillin in concentrated 
sulfuric acid at 180°C. All flash column chromatography was carried out using the flash 
technique as reported by Still166 using Merck Kieselgel 60 and distilled analytical reagent 
(AR) grade solvents as indicated.
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9 .1 .3  Reaction Conditions
All reactions requiring dry solvent were performed in flame dried flasks, under a 
dry nitrogen atmosphere. Syringes and needles were pre-dried in an oven (110°C) and 
cooled in an anhydrous atmosphere prior to use. Stirring was by internal magnetic 
follower. After filtration of solutions from drying reagents, the bulk of the solvent was 
removed on a Biichi rotatory evaporator. The last traces of solvent were removed under 
high vacuum.
9 .1 .4  Reagents and Solvents
Many reagents were commercially available (Aldrich, Merck) and were used as 
supplied. Where necessary, solvents and reagents used in reactions were purified 
according to well established procedures167. Tetrahydrofuran (THF), diethyl ether, 
benzene, and dimethoxyethane (DME) were purified by distillation from sodium 
benzophenone ketyl under nitrogen. Dichloromethane was distilled from calcium hydride 
under nitrogen. Triethylamine and diisopropylethylamine were stored under nitrogen 
over activated molecular sieves. Ethanol-free ethereal diazomethane was prepared from 
Diazald® (A-methyl-iV-nitroso-p-toluenesulfonamide) purchased from Aldrich.
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9.2 Experimental for Chapter 3
Trimethyl ew/-3a-Hydroxygibberell-16-ene-7,19,20-trioate (11)
MeOH
To a stirred solution of GA13 (1.00 g, 2.64 mmol) in MeOH (10 ml) was added 
dropwise, an ethereal solution of diazomethane until the yellow colour persisted. The 
solvent was removed under reduced pressure, and the residue was chromatographed on 
silica gel using ethyl acetate:hexane (1:2) as eluting solvent to give GA13-7,19,20- 
trimethyl ester (911 mg, 82%) as a white foam.
Rf 0.46 (ethyl acetateihexane, 1:2). mp 157-159°C (Lit.30 117-119°C). IR (KBr disc) 
1703, 1725, 3460 cm-1.
*H NMR (300 MHz, CDC13): Ö 0.92-1.09 (1H, m), 1.23 (3H, s, H18), 1.23-2.32 
(12H, m), 2.58 (1H, d, J = 12.6 Hz, H5), 2.58 (1H, m, H13), 3.59 (3H, s, -C02CH3), 
3.65 (3H, s, -CO2CH3), 3.75 (3H, s, -C02CH3), 3.88 (1H, d, J = 12.8 Hz, H6), 3.97 
(1H, br s, H3), 4.79 (1H, br s, H17), 4.88 (1H, br s, HT7).
13C NMR (75 MHz, CDC13): 6 18.6 (C ll), 22.6 (C18), 28.9 (Cl), 30.0 (C2), 31.5 
(C12), 36.1 (C14), 39.3 (C13), 46.0 (C15), 49.2 (C4), 49.9 (C5), 50.0 (C8), 50.6 
(C6), 50.9, 51.3, 51.4 (3x-C02CH3), 56.1 (C9), 56.9 (CIO), 70.3 (C3), 105.9 (C17), 
156.7 (C16), 174.6, 175.2, 175.3 (C7, C19, C20).
MS (El) m/z 420 (M+, 7%), 388 (45), 360 (17), 328 (100), 310 (41), 300 (60), 282 
(60), 268 (55), 241 (28), 223 (43).
HRMS (El) m/z: calc'd for M+ C23H320 7: 420.2148; found: 420.2154.
Microanalysis C23H320 7 requires: C 65.70, H 7.67; found: C 65.45, H 7.72.
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Trimethyl ^ «t-3a-Im id azol-l'-y lth iocarb on yloxygib b erell-16-en e- 
7,19, 20-trioate (13)
/V,/V'-thiocarbonyldiimidazole
To a solution of the starting alcohol (20 mg, 0.048 mmol) in dry 
1,2-dichloroethane (3 ml), under an atmosphere o f N 2 was added 
Af,iV-thiocarbonyldiimidazole (44.1 mg, 0.196 mmol), and the mixture stirred at reflux 
for 16 h. The solvent was removed under reduced pressure, and the residue suspended 
in water (3 ml). The product was extracted with ethyl acetate (2x10 ml), washed with 
water (5 ml), and saturated brine (5 ml), then dried (sodium sulfate), and the solvent 
removed under reduced pressure to give an orange oil. Purification was carried out by 
flash chromatography on silica gel using ethyl acetate:hexane (1:4) as eluting solvent, to 
give the product (23.5 mg, 92%) as a white powder.
Rf 0.32 (ethyl acetate:hexane, 1:4). mp 50-52°C. IR (CH2CI2) 1262, 1269, 1386, 
1727 cm-1.
*H NMR (300 MHz, CDCI3): 6 1.17-2.60 (14H, m), 1.20 (3H, s, H18), 2.61 (1H, d, 
J = 12.5 Hz, H5), 3.62 (3H, s, -C 02CH3), 3.71 (6H, s, 2 x -C 02CH3 overlapped), 
3.88 (1H, d, J = 12.5 Hz, H6), 4.84 (1H, br s, H17), 4.90 (1H, br s, HT7), 5.87 (1H, 
br s, H3), 7.08 (1H, br s, H’5), 7.66 (1H, br s, H’4), 8.40 (1H, br s, H’2).
13C NMR (75 MHz, CDC13): 6 18.5 (C ll) , 22.6 (C18), 25.8 (C l), 31.3 (C2), 31.4 
(C12), 36.3 (C14), 39.3 (C13), 46.1 (C15), 49.2 (C4), 50.2 (C8 , -C 0 2C H 3 
overlapped), 50.3 (C5), 51.2, 51.5 (2x-CO;>CH3), 52.0 (C6), 56.3 (C9), 56.8 (CIO), 
86.3 (C3), 106.3 (C17), 117.4 (C41), 131.0 (C5’), 136.9 (C21), 156.0 (C16), 173.6, 
174.0, 174.9 (C7, C19, C20), 182.7 (-OC(S)N).
MS (El) m/z 530 (M+, 30%), 403 (51), 371 (50), 343 (60), 311 (100), 283 (100), 251 
(48), 223 (70), 181 (34), 129 (52).
HRMS (El) m/z: calc’d for M+ C27H2J4N2O7S: 530.2087; found: 530.2088.
M icroanalysis C27H34N 30 7 S requires: C 61.11, H 6.46, N 5.28; found: C 61.00, H 
6.53, N 4.96.
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Trimethyl e/it-Gibberell-16-ene-7,19,20-trioate (14)
The above imidazolide (631 mg, 1.19 mmol) was taken up in dry benzene (70 ml) 
and heated at reflux under N2 for 10 minutes. Tributyltin hydride (640 Jll, 2.38 mmol) 
was added via syringe followed by AIBN (40 mg, 10% wt). The resulting mixture was 
heated at reflux for a further 30 mins, after which the solvent was removed under reduced 
pressure. The product was purified by flash chromatography on silica gel using ethyl 
acetateihexane (1:10), to give a yellow oil. Residual tin by-products were removed by 
taking the residue up in diethyl ether (30 ml) and washing with ammonia (3x15 ml), and 
chromatographed again to give GA25 trimethyl ester (369 mg, 77%) as a white solid.
Rf 0.28 (ethyl acetateihexane, 1:10). mp 77-79°C. IR (KBr disc) 1729 cm*1.
*H NMR (300 MHz, CDCI3): 6  1.00-2.58 (16H, m), 1.13 (3H, s, H18), 2.13 (1H, d, 
J  = 12.6 Hz, H5), 3.59, 3.85, 3.71 (3x3H, s, -C 0 2C H 3), 3.84 (1H, d, /  = 12.6 Hz, 
H6 ), 4.81 (1H, br s, H17), 4.89 (1H, br s, HT7).
13C NMR (75 MHz, CDC13): 618.5 (C ll) , 21.5 (C2), 28.4 (C18), 31.5 (C12), 36.4 
(C14), 36.5 (C l), 37.7 (C3), 39.5 (C13), 44.9 (C4), 46.0 (C15), 50.0 (C8 ), 50.8 (C5, 
-CO 2CH 3 overlapped), 51.2, 51.3 (2x-C 02CH3), 56.3 (C6 ), 56.6 (C9), 57.0 (CIO), 
105.8 (C17), 156.5 (C6 ), 174.5, 175.6, 176.0 (C7, C19, C20).
MS (El) m/z 404 (M+, 32%), 374 (71), 372 (74), 342 (35), 328 (26), 312 (93), 284 
(100), 255 (26), 225 (73), 183 (38).
HRMS (El) m/z\ calc’d for M+ C23H32O6: 404.2199; found: 404.2190.
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Trimethyl e«f-16ß,17-Dihydroxygibberell-16-ene-7,19,20-trioate (15)
To the above olefin (107 mg, 0.265 mmol) in acetone/water (8/1 ml), was added 
ten small crystals of /?-toluenesulfonic acid, and /V-methyl morpholine-7V-oxide (37 mg, 
0.317 mmol). One crystal of osmium tetroxide was dissolved in t-butyl alcohol (1 ml) 
and added to the above mixture, which was stirred at room temperature for 3 h. The 
reaction mixture was then diluted with water (5 ml) and extracted with ethyl acetate (2x10 
ml). The organic extracts were combined and washed with water (5 ml), and saturated 
brine (5 ml), then dried (sodium sulfate), and the solvent removed under reduced 
pressure to give the crude product as a brown oil (114 mg, 98%). Purification was 
carried out by flash chromatography on silica gel using ethyl acetate:hexane (4:1), giving 
a white crystalline solid which was recrystallised from ether/heptane to give pure 16a, 17- 
dihydroxy-GA25 trimethyl ester, (79% Yield).
R f 0.18 (ethyl acetate:hexane, 2:1). m p 47°C. IR  (KBr disc) 1143, 1169, 1198, 1230, 
1729, 2930, 3437 cm-1.
*H NMR (300 MHz, CDCI3): 6  0.88-2.04 (15H, m), 1.11 (3H, s, H18), 2.07 (1H, d, 
J  = 12.6 Hz, H5), 2.43 (1H, m, H 15a), 3.58-3.76 (2H, m, H17), 3.60, 3.65, 3.74 
(3x3H, s, -CO2CH 3), 3.86 (1H, d, J  = 12.6 Hz, H6 ).
13C NM R (75 MHz, CDC13): 6  18.7 (C ll) ,  21.4 (C2), 21.9 (C12), 28.3 (C18), 34.6 
(C14), 36.3 (C l), 327.6 (C3), 43.1 (C13), 44.8 (C4), 50.4 (C8 ), 50.9 (-CO2C H 3), 
51.3 (-CO2CH3), 51.5 (C15), 51.5 (-CO2CH3), 51.7 (C6 ), 56.5 (C5), 57.0 (CIO), 58.1 
(C9), 6 6 .8  (C17), 82.2 (C16), 174.3, 175.8, 176.0 (C7, C19, C20).
MS (El) m /z  406 (M-32+, 14%), 375 (25), 347 (18), 315 (27), 287 (40), 245 (17), 227 
(18), 185 (24), 129 (28), 105 (42).
M icroanalysis C23H34O8 requires: C 63.00, H 7.81; found: C 62.85, H 8.02.
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Trimethyl ewf-16-0xo-17-norgibberellane-7,19,20-trioate (16)
To the starting diol 15 (136 mg, 0.310 mmol) in dry toluene (15 ml) was added 
lead tetraacetate (417 mg, 0.929 mmol). The mixture was stirred under nitrogen at room 
temp for 2.5 h, after which, tic indicated that no starting material remained. The mixture 
was diluted with water (8 ml) and extracted with ethyl acetate (2x10 ml). The combined 
organic fractions were washed with saturated sodium bicarbonate (2x10 ml), and 
saturated brine (15 ml), then dried (sodium sulfate) and the solvent removed under 
reduced pressure. The crude product was purified by flash chromatography on silica gel 
using ethyl acetateihexane, (1:3) as eluting solvent to give the pure norketone 16 as a 
white solid (117 mg, 93%).
Rf 0.32 (ethyl acetateihexane, 1:3). mp 141°C. IR (KBr disc) 1197, 1169, 1721, 
1739, 2952 cm*1.
*H NMR (300 MHz, CDC13): 5 0.86-2.19 (14H, m), 1.13 (3H, s, H18), 2.12 (1H, d, 
J = 12.8 Hz, H5), 2.36 (1H, m, H13), 2.48 (1H, m, H15a), 3.62, 3.65, 3.72 (3x3H, 
s, -CO2CH3), 3.96 (1H, d, J = 12.7 Hz, H6).
13C NMR (75 MHz, CDC13): 8 19.4 (C ll), 21.4 (C2), 24.9 (C12), 28.2 (C18), 33.2 
(C14), 36.1 (Cl), 37.5 (C3), 44.9 (C13), 45.0 (C4), 48.5 (C8), 51.1, 51.4, 51.6 
(3x-C 02CH3), 52.0 (C5), 52.3 (C15), 56.5 (C6), 56.6 (C9), 57.3 (CIO), 174.3, 174.0, 
174.8 (C7, C19, C20), 220.9 (C16).
MS (El) m/z 406 (M+, 6%), 374 (74), 314 (49), 286 (35), 207 (48), 105 (50), 91 (84), 
79 (53), 59 (100), 55 (91).
Microanalysis C22H30O7 requires: C 65.01, H 7.44; found: C 64.76, H 7.76.
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Trimethyl ewf-(17,17-D2)-Gibberell-16-ene-7,19,20-trioate (17)
The Lombardo reagent78 (approximately 4.5 ml in suspension) was added by a 
Pasteur pipette to a solution of the 17-norketone 16 (90 mg, 0.22 mmol) in dry 
dichloromethane (5 ml), with stirring under a nitrogen atmosphere. Tic analysis indicated 
that the reaction was complete after 1 min. The reaction mixture was quenched with 
saturated sodium bicarbonate (5 ml) and extracted with ethyl acetate (2x10 ml). The 
combined organic phases were washed with 2M hydrochloric acid (2x5 ml), water (10 
ml), and saturated brine (10  ml), then dried (sodium sulfate) and the solvent removed 
under reduced pressure to give a clear oil. Chromatography on silica gel using ethyl 
acetate:hexane (1:7) afforded the desired dideuterated compound 17 (62 mg, 70%) as a 
colourless oil.
Rf 0.34 (ethyl acetateihexane, 1:7). IR (film) 1144, 1168, 1197, 1230, 1730, 2948 
cm-1.
*H NMR (300 MHz, CDC13): 8  0.99-2.16 (14H, m), 1.12 (3H, s, H18), 2.09 (1H, d, 
J = 12.3 Hz, H5), 2.45 (1H, m, H15a), 2.55 (1H, m, H13), 3.59, 3.64, 3.70 (3x3H, 
s, -CO2CH3), 3.83 (1H, d, J = 12.6 Hz, H6 ).
13C NMR (75 MHz, CDCI3): 8  18.5 (C ll) ,  21.4 (C2), 28.4 (C18), 31.5 (C12), 36.3 
(C14), 36.5 (C l), 37.6 (C3), 39.4 (C13), 44.9 (C4), 45.9 (C15), 49.9 (C8 ), 50.8 (C5), 
50.9 (-CO2C H 3), 51.2 (-CO2C H 3), 51.3 (-CO2C H 3), 56.2 (C6 ), 56.6 (C9), 56.9 
(CIO), 156.3 (C16), 174.5, 175.5, 176.0 (C7, C19, C20).
MS (El) m/z 406 (M+, 13%), 374 (20), 314 (6 6 ), 286 (100), 227 (72), 143 (14), 129 
(16).
HRMS (El) m/z calc’d for M+ C23H30D2O6: 406.2355, found 406.2336.
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Tri(methoxymethyl) cw/-3a-Hydroxygibberell-16-ene-7,19,20-trioate (18)
To the free acid 10 (50 mg, 0.132 mmol) in dry dichloromethane (5 ml) was 
added triethylamine (92 p.1, 0.66 mmol), followed by chloromethyl methyl ether (104 pi, 
1.32 mmol) and the mixture stirred at room temperature under an atmosphere of nitrogen 
for 10 min. Saturated sodium bicarbonate (1 ml) was added and the mixture was diluted 
with water (5 ml), and extracted with ethyl acetate (2x5 ml). The combined organic 
phases were washed with water (5 ml), 2M hydrochloric acid (5 ml), water (5 ml), and 
saturated brine (5 ml), then dried (sodium sulfate) and the solvent removed under reduced 
pressure to give a clear oil. Purification was carried out by flash chromatography on 
silica gel using ethyl acetate:hexane (1:2), to give 18 as a clear oil (51 mg, 79%). The oil 
was crystallised using ethenheptane to give a white solid.
Rf 0.27 (ethyl acetate:hexane, 1:2). mp 99-101 °C. IR (KBr disc) 923, 941, 1081, 
1136, 1157, 1711, 1743, 3513 cm-1.
NMR (300 MHz, CDC13): 6 1.10-2.37 (13H, m), 1.33 (3H, s, H18), 2.57 (1H, m, 
H13), 2.61 (1H, d, /  = 12.7 Hz, H5), 3.48, 3.51, 3.53 (3x3H, s, -OCH2OCH3), 3.98 
(1H, d, J = 12.6 Hz, H6), 3.40 (1H, s, H3), 4.82 (1H, br s, H17), 4.90 (1H, br s, 
HT7), 5.02, 5.41 (2xlH , ABd, J = 6.0 Hz, -OCH2O C H 2O, 5.10, 5.33 (2xlH , ABd, 
J = 6.0 Hz, -OCH2OCH3), 5.23, 5.25 (2xlH, ABd, J = 4.9 Hz, -OCEhOCH^, .
13C NMR (75 MHz, CDC13): 8 18.5 (C ll) , 22.8 (C18), 28.9 (C l), 29.8 (C2), 31.4 
(C12), 36.2 (C14), 39.3 (C13), 45.8 (C15), 49.4 (C4), 49.9 (C5), 50.0 (C8), 
50.5(C6), 56.3 (C9), 56.9 (CIO), 57.6, 57.6, 58.0 (3x-OCH2OCH3), 70.6 (C3), 90.2, 
90.9, 91.6 (3x-OCH 2O C H 3), 106.1 (C17), 156.3 (C16), 174.1, 174.3, 174.4 (C7, 
C19, C20).
MS (El) m/z 510 (M+, 9%), 448 (69), 420 (86), 416 (86), 404 (50), 359 (50), 326 
(74), 313 (76), 285 (62), 269 (100), 241 (51), 225 (45).
Microanalysis C26H38 0 io requires: C 61.16, H 7.50; found: C 61.38, H 7.83
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Tri(methoxymethyl) enf-3a-Imidazol-r-yIthiocarbonyloxygibberell-16- 
ene-7,19,20-trioate (19)
m o m o 2c
HO T  
M 0 M 0 2C c o 2m o m
A/,A/'-thiocarbonyldiimidazole
To a solution of the starting alcohol (792 mg, 1.55 mmol) in dry 
1,2-dichloroethane (80 ml) under an atmosphere of N2, was added 
A, A'-thiocarbonyldiimidazole (1.66 g, 9.31 mmol), and the mixture stirred at reflux for 
16 h. The solvent was removed under reduced pressure, and the residue was suspended 
in water (20 ml). The product was extracted with ethyl acetate (2x30 ml), and the 
combined organic phases were washed with water (30 ml), and saturated brine (30 ml), 
then dried (sodium sulfate), and the solvent removed under reduced pressure to give an 
orange oil. Purification was carried out by flash chromatography on silica gel using ethyl 
acetate:hexane (1:2) as eluting solvent, to give 19 (906 mg, 94%) as a clear oil.
Rf 0.35 (ethyl acetate:hexane, 1:2). IR (CDCI3) 1092, 1138, 1164, 1230, 1282, 1384, 
1728, 2944 cm*1.
!H NMR (300 MHz, CDCI3): 6 1.18-2.51 (13H, m), 1.29 (3H, s, H18), 2.60 (1H, m, 
H13), 2.64 (1H, d, J = 12.6 Hz, H5), 3.49 (6H, s, 2x-OCH2OCH3 overlapped), 3.53 
(3H, s, -OCH2OCH3), 3.98 (1H, d, J = 12.6 Hz, H6), 4.85 (1H, br s, H17), 4.92 (1H, 
br s, HT7), 5.06, 5.44 (2xlH, ABd, J = 5.8 Hz, -OCH2OCH3), 5.13, 5.27 (2xlH, 
ABd, J = 6.0 Hz, -0CH20CH3), 5.25, 5.30 (2xlH, ABd, J = 6.1 Hz, -OQfcOCH^, 
5.89 (1H, s, H3), 7.09 (1H br s, H5’), 7.66 (1H br s, H4’), 8.44 (1H, br s, H2’).
13C NMR (75 MHz, CDC13): 6 18.4 (C ll), 22.7 (C18), 285.8 (Cl), 31.1 (C2), 31.3 
(C l2), 36.3 (C14), 39.3 (C13), 45.9 (C15), 49.4 (C8), 50.2 (C5), 51.9 (C6), 56.5 
(C9), 56.8 (CIO), 57.6, 57.8, 58.1 (3x-OCH2OCH3), 77.1 (C4), 83.3 (C3), 90.5, 
91.3, 92.2 (3x-OCH2OCH3), 106.5 (C17), 117.4 (C4’), 131.1 (C51), 137.0 (C2’), 
155.7 (Cl6), 172.8, 173.5, 174.1 (C7, C19, C20), 182.7 (-OC(S)N).
MS (El) m/z 620 (M+, 48%), 559 (35), 493 (6), 431 (31), 386 (57), 342 (82), 269 
(92), 223 (56), 157 (100).
HRMS (El) m/z calc’d for M+ C 3oH 40N 2O ioS: 620.2404, found 620.2407.
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Tri(methoxymethyl) e«f-Gibberell-16-ene-7,19,20-trioate (20)
The above imidazolide (881 mg, 1.42 mmol) was taken up in dry benzene (90 ml) 
and heated to reflux under nitrogen for 10 minutes. Tributyltin hydride (765 pi, 2.84 
mmol) was added via syringe followed by AIBN (47 mg, 10% wt). The resulting 
mixture was heated at reflux for a further 1 h, after which the solvent was removed under 
reduced pressure. The product was purified by flash chromatography on silica gel using 
ethyl acetate:hexane (1:5), to give a clear oil. Residual tin by-products were removed by 
taking the residue up in ethyl acetate (60 ml) and washing with ammonia (3x25 ml), and 
chromatographed again to give GA25 tri(methoxymethyl) ester (507 mg, 72%) as a white 
solid.
Rf 0.30 (ethyl acetate:hexane, 1:5). mp 89-9TC. IR (KBr disc) 1163, 1205, 1729, 
1745, 2939 cm'1.
*H NMR (300 MHz, CDC13): 5 1.03-2.20 (14H, m), 1.22 (3H, s, H18), 2.16 (1H, d, 
J = 12.5 Hz, H5), 2.50 (1H, m, H15a), 2.57 (1H, m, H13), 3.48, 3.50, 3.51 (3x3H, 
s, -OCH2OCH3), 3.95 (1H, d, J = 12.5 Hz, H6 ), 4.81 (1H, br s, H17), 4.89 (1H, br s, 
HT7), 5.05, 5.37 (2xlH, ABd, J = 6.1 Hz, -OCH2OCH3), 5.10, 5.32 (2xlH, ABd, 
/  = 6.1 Hz, -OCH2OCH3), 5.22, 5.25 (2xlH, ABd, J  = 6.0 Hz, -OCH2OCH3) , .
13C NMR (75 MHz, CDC13): 6  18.3 (C ll), 21.4 (C2), 28.4 (C18), 31.4 (C12), 36.1 
(C14), 36.5 (Cl), 37.4 (C3), 39.4 (C13), 45.1 (C4), 45.7 (C15), 49.9 (C8 ), 50.7 (C5), 
56.4 (C6 ), 56.4 (C9), 56.9 (CIO), 57.4, 57.5, 57.9 (3x-OCH2OCH3), 90.0, 90.8, 91.4 
(3x-OCH2OCH3), 106.0 (C17), 156.1 (C16), 173.9, 174.5, 175.0 (C7, C19, C20).
MS (El) m/z 494 (M+, 21%), 465 (20), 432 (79), 417 (28), 404 (32), 315 (57), 269 
(6 8 ), 225 (79), 91 (100).
HRMS (El) m/z calc'd for M+ C26H38O9: 494.2516, found 494.2514.
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Tri(methoxymethyl) e/2f-16ß,17-Dihydroxygibberellane-7 ,19,20-trioate
To the above olefin (49 mg, 0.099 mmol) in acetone/water (10/1 ml), was added 
10 small crystals of p-toluenesulfonic acid and N-methyl morpholine-A-oxide (46 mg, 
0.398 mmol). One crystal of osmium tetroxide was dissolved in /-butyl alcohol (1 ml) 
and added to the above mixture, which was stirred at room temperature for 3 hours. The 
reaction mixture was then diluted with water (5 ml) and extracted with ethyl acetate (2x15 
ml). The organic extracts were combined and washed with water (12 ml), and saturated 
brine (15 ml), then dried (sodium sulfate), and the solvent removed under reduced 
pressure to give the crude product as a brown oil (51 mg, 98%). Purification was carried 
out by flash chromatography on silica gel using ethyl acetate:hexane (4:1), giving the 
expected diol as a white crystalline solid (76% yield).
Rf 0.28 (ethyl acetate:hexane, 4:1). mp 72-74°C. IR (KBr disc) 1739, 2932, 3428 
c m 1.
*H NMR (300 MHz, CDC13): 8 1.01-2.13 (15H, m), 1.20 (3H, s, H18), 2.10 (1H, d, 
J  = 12.6 Hz, H5), 2.50 (1H, m, H15ct), 3.48 (3H, s, -OCH2OCH3), 3.52 (3H, s, 
-OCH2OCH3), 3.54 (3H, s, -OCH2OCH3), 3.57-3.56 (2H, m, H7), 3.97 (1H, d, 
J = 12.7 Hz, H6), 5.05, 5.36 (2xlH , ABd, /  = 6.0 Hz, -OCH2OCH3), 5.10, 5.34 
(2xlH , ABd, J = 6.0 Hz, -OCH2O C H 3), 5.26, 5.28 (2xlH , ABd, J  = 3.3 Hz, 
-OCH2OCH3).
13C NMR (75 MHz, CDC13): 8 18.6 (C ll) , 21.4 (C2), 21.8 (C12), 28.4 (C18), 34.5 
(C14), 36.0 (C l), 37.4 (C3), 42.8 (C13), 45.0 (C4), 50.4 (C8), 51.1 (C15), 51.6 (C5), 
56.3 (C6), 57.0 (CIO), 57.5, 57.9, 58.5 (3x-OCH2OCH3), 58.5 (C9), 66.6 (C17), 82.4 
(C16), 90.0, 90.8, 91.5 (3x-OCH2OCH3), 173.7, 174.9, 175.0 (C7, C19, C20).
MS (El) m/z 528 (M+, 6%), 497 (17), 466 (44), 435 (10), 405 (61), 315 (55), 287 
(86), 269 (43), 241 (67), 185 (30).
HRMS (El) m/z calc’d for M+ C26H40OH: 528.2571, found 528.2590.
M icroanalysis C26H40O11 requires: C 59.08, H 7.63; found: C 59.22, H 7.92.
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Tri(methoxymethyl) e/iM6-Oxo-17-norgibberellane-7,19,20-trioate (21)
To the above diol (326 mg, 0.619 mmol) in dry toluene (70 ml) was added lead 
tetraacetate (824 mg, 1.86 mmol). The mixture was stirred under nitrogen at room temp 
for 5 min, after which, tic indicated that no starting material remained. The mixture was 
diluted with water (50 ml) and extracted with ethyl acetate (2x50 ml). The combined 
organic fractions were washed with saturated sodium bicarbonate (2x50 ml), and 
saturated brine (50 ml), then dried (sodium sulfate) and the solvent was removed under 
reduced pressure. The crude product was purified by flash chromatography on silica gel 
using ethyl acetateihexane, (1:2 ) as eluting solvent to give the pure norketone 21 as a 
clear oil (305 mg, 99%).
Rf 0.30 (ethyl acetateihexane, 1:2). IR (film) 920, 1088, 1144, 1157, 1741 cm-1.
JH NMR (300 MHz, CDC13): 6  1.04-2.22 (14H, m), 1.22 (3H, s, H18), 2.16 (1H, d, 
J = 12.8 Hz, H5), 2.37 (1H, m, H13), 2.52 (1H, m, H15a), 3.49, 3.51, 3.52 (3x3H, 
s, -OCH2OCH3), 4.06 (1H, d, /  = 12.8 Hz, H6 ), 5.05, 5.38 (2xlH, ABd, J = 6.0 Hz, 
-OCH2OCH3), 5.08, 5.31 (2xlH, ABd, J = 6.0 Hz, -OCH2OCH3), 5.23, 5.34 (2xlH, 
ABd, J = 6.1 Hz, -OCH2OCH3) , .
13C NMR (75 MHz, CDC13): 8  19.2 (C ll), 21.4 (C2), 24.9 (C12), 28.2 (C18), 33.3 
(C14), 35.9 (Cl), 37.3 (C3), 44.8 (C13), 45.2 (C4), 48.4 (C8 ), 51.8 (C5), 52.0 (C15), 
56.4 (C6 ), 56.6 (C9), 57.2 (CIO), 57.6, 57.7, 57.9 (3x-OCH2OCH3), 90.4, 91.0, 91.6 
(3x-OCH2OCH3), 173.7, 174.0, 174.8 (Cl, C19, C20) 220.5 (C16).
MS (El) m/z 496 (M+, 23%), 435 (37), 434 (83), 390 (30), 344 (30), 328 (37), 273 
(43), 227 (33), 149 (45).
HRMS (El) m/z calc'd for M+ C25H36Oio: 496.2308, found 496.2309.
Microanalysis C25H3 6 0 io requires: C 60.47, H 7.31; found: C 60.31, H 7.04.
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Tri(methoxymethyl) e/*f-(17,17-D2)-gibberell-16-ene-7,19,20-trioate (22)
The Lombardo reagent78 (approximately 5.7 ml in suspension) was added by a 
Pasteur pipette to a solution of the 17-norketone 21 (265 mg, 0.534 mmol) in dry 
dichloromethane (25 ml), with stirring under a nitrogen atmosphere. Tic analysis 
indicated that the reaction was complete. The reaction mixture was quenched with 
saturated sodium bicarbonate (10 ml) and extracted with ethyl acetate (2x20 ml). The 
combined organic phases were washed with 2M hydrochloric acid (2x15 ml), water (15 
ml), and saturated brine (15 ml), then dried (sodium sulfate) and the solvent was removed 
under reduced pressure to give a clear oil. Chromatography on silica gel using ethyl 
acetate:hexane (1:5) afforded the desired dideuterated compound 22 (165 mg, 62%) as a 
colourless oil.
Rf 0.31 (ethyl acetate:hexane, 1:5). IR (CDCI3) 1723, 2932 cm*1.
!H NMR (300 MHz, CDC13): 5 1.03-2.20 (14H, m), 1.22 (3H, s, H18), 2.16 (1H, d, 
J  = 12.5 Hz, H5), 2.52 (1H, m, H 15a), 2.57 (1H, m, H13), 3.48, 3.50, 3.51 (3x3H, 
s, -OCH2OCH3), 3.95 (1H, d, J  = 12.6 Hz, H6 ), 5.05, 5.37 (2xlH , ABd, J  = 5.9 Hz, 
-OCH2OCH3), 5.11, 5.25 (2xlH , ABd, J  = 6.0 Hz, -OCH2OCH3), 5.22, 5.33 (2xlH, 
ABd, J  = 6.0 Hz, -OCH2OCH3), .
13C NMR (75 MHz, CDC13): 5 18.4 (C ll) , 21.5 (C2), 28.5 (C18), 31.5 (C12), 36.2 
(C14), 36.6 (C l), 37.5 (C3), 39.4 (C13), 45.2 (C4), 45.7 (C15), 50.0 (C8 ), 50.8 (C5), 
56.5 (C6 ), 56.5 (C9), 57.8 (CIO), 57.5, 57.6, 58.0 (3x-OCH2OCH3), 90.1, 90.9, 91.5 
(3x-OCH2OCH3), 156.0 (C16), 174.0, 174.6, 175.1 (C7, C19, C20).
MS (El) m/z 493 (M+, 4%), 434 (47), 406 (82), 390 (40), 361 (41), 344 (44), 317 
(100), 299 (41), 271 (93), 227 (91).
HRMS (El) m/z calc'd for M+ C26H36D20 9: 496.2641, found 496.2646.
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ew/-(17,17-D2)-Gibberell-16-ene-7,19,20-trioic Acid (9)
The 17-dideutero GA25 tri(methoxymethyl) ester (20 mg, 0.040 mmol) was taken 
up in 1M zinc chloride in methanol (5 ml) and the mixture was heated at reflux overnight. 
The mixture was diluted with ethyl acetate (20 ml) and washed with sodium dihydrogen 
phosphate buffer (pH4) (2x10 ml), and saturated brine (10 ml). The aqueous washing's 
were extracted with ethyl acetate (15 ml) and the organic phase was washed with 
saturated brine (10 ml). The combined organic phases were dried (sodium sulfate), and 
the solvent was removed under reduced pressure. The residue was chromatographed on 
silica using ethyl acetate:hexane:methanol:acetic acid, (66:33:1:1) to give the deuterated 
product 9 as a white solid (10.9 mg, 74%), plus a small amount of non-deprotected 
gibberellin.
Rf 0.37 (ethyl acetate:hexane:methanol:acetic acid, 66:33:1:1).
*H NMR (300 MHz, CDC13): 6 1.00-2.19 (14H, m), 1.23 (3H, s, H18), 1.74 (1H, s, 
H3), 2.41 (1H, apparent d, J = 12.2 Hz, H15a), 2.55 (1H, apparent t, H13), 3.94 (1H, 
d, J = 12.5 Hz, H6).
13C NMR (75 MHz, CDC13): 6 18.6 (C ll) , 21.3 (C2), 28.2 (C18), 31.5 (C12), 35.5 
(C3), 36.3 (C15), 37.5 (C l), 30.4 (C13), 45.3 (C4), 46.3 (C14), 49.8 (C8), 51.0 (C6), 
56.0 (C5), 56.6 (C9), 57.0 (CIO), 157.0 (C16), 178.0 (C7), 179.4 (C19), 181.6 (C20).
MS (El) m/z 364 (M+, 3%), 346 (33), 318 (6), 300 (73), 272 (100), 257 (9), 229 (56), 
203 (22), 159 (27).
HRMS (El) m/z calc'd for M+ C20H24D2O6: 364.1855, found 364.1860.
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Tri(methoxymethyl) e/i/-3a, 16ß, 17-Trihydroxy gibbereIlane-7,19,20- 
trioate (23)
To the above olefin (560 mg, 1.10 mmol) in acetone/water (48/6 ml), was added 
10 small crystals of p-toluenesulfonic acid and N-methyl morpholine-/V-oxide (154 mg, 
1.32 mmol). One crystal of osmium tetroxide was dissolved in r-butyl alcohol (1 ml) and 
added to the above mixture, which was stirred at room temperature for 8 hours. The 
reaction mixture was then diluted with water (20 ml) and extracted with ethyl acetate 
(2x40 ml). The organic extracts were combined and washed with water (20 ml), and 
saturated brine (20 ml), then dried (sodium sulfate), and the solvent removed under 
reduced pressure to give the crude product as a white solid (510 mg, 85%). Purification 
was carried out by flash chromatography on silica gel using ethyl acetate:hexane (4:1), 
giving a white crystalline solid (23), (73% yield).
Rf 0.09 (ethyl acetate:hexane, 2:1). IR (film) 1042, 1733, 2928, 3385 cm'1.
*H NMR (300 MHz, CDC13): 5 1.28 (3H, s, H18), 1.48-2.32 (15H, m), 2.52 (1H, d, 
J = 13.1 Hz, H5), 3.47, 3.51, 3.53 (3x3H, s, -OCH2OCH3), 3.64 (2H, m, H7), 3.95 
(1H, s, H3), 3.99 (1H, d, J = 13.0 Hz, H6), 5.01, 5.25 (2xlH, ABd, J = 6.0 Hz, 
-OCH2OCH3), 5.08, 5.33 (2xlH, ABd, J = 6.0 Hz, -OCH2OCH3), 5.24, 5.38 (2xlH, 
ABd, J = 5.9 Hz, -OCH2OCH3), .
13C NMR (75 MHz, CDC13): 6 18.8 (C ll), 21.6 (C12), 22.9 (C18), 29.8 (Cl), 29.7 
(C2), 34.1 (C14), 42.8 (C13), 49.4 (C8), 49.6 (C5), 50.5 (C4), 51.2 (C6), 51.5 (C15), 
57.0 (C9), 57.0, 57.6, 58.0 (3x-OCH2OCH3), 58.4 (CIO), 66.9 (C17), 70.6 (C3), 82.2 
(Cl6), 90.1, 90.9, 91.6 (3x-OCH2OCH3), 173.8, 174.3, 174.7 (C7, C19, C20).
MS (El) m/z 544 (M+, 2%), 513 (6), 482 (33), 451 (96), 420 (72), 375 (71), 358 (66), 
329 (100), 301 (86), 285 (96), 227 (43), 183 (41).
HRMS (El) m/z calc’d for M+ C26H40O12: 544.2520, found 544.2514
105
Tri(methoxymethyl) en/-3a-Hydroxy-16-oxo-17-norgibberellane-7,19, 
20-trioate (24)
To the starting diol 23 (459 mg, 0.843 mmol) in dry toluene (120 ml) was added 
lead tetraacetate (1.12 g, 2.53 mmol). The mixture was stirred under nitrogen at room 
temperature for 5 minutes, after which, tic indicated that no starting material remained. 
The mixture was diluted with water (80 ml) and extracted with ethyl acetate (2x100 ml). 
The combined organic fractions were washed with saturated sodium bicarbonate 
(2x100 ml), and saturated brine (100 ml), then dried (sodium sulfate) and the solvent was 
removed under reduced pressure. The crude product was purified by flash 
chromatography on silica gel using ethyl acetate:hexane (1:1), as eluting solvent to give 
the pure norketone (24) as a clear oil (296 mg, 68%).
Rf 0.32 (ethyl acetate:hexane, 1:1). IR (film) 1161, 1717, 1733, 1744, 2965, 3511 
cm-1.
*H NMR (300 MHz, CDC13): 5 1.30 (3H, s, H18), 1.43-2.38 (13H, m), 2.60 (1H, d, 
J = 13.0 Hz, H5), 3.47, 3.49, 3.51 (3x3H, s, -OCH2OCH3), 3.95 (1H, s, H3), 4.05 
(1H, d, J = 13.0 Hz, H6), 5.00, 5.28 (2xlH, ABd, J = 6.0 Hz, -OCH2OCH3), 5.05, 
5.32 (2xlH, ABd, /  = 6.0 Hz, -OCH2OCH3), 5.21, 5.39 (2xlH, ABd, /  = 6.0 Hz, 
-OCH2OCH3),.
13C NMR (75 MHz, CDC13): 5 19.2 (C ll), 22.7 (C18), 24.8 (C12), 29.0 (Cl), 29.5 
(C2), 33.0 (C14), 44.7 (C13), 48.4 (C8), 49.4 (C4), 49.6 (C5), 51.4 (C6), 52.0 (C15), 
56.4 (C9), 57.1 (CIO), 57.6, 57.7, 58.0 (3x-OCH2OCH3), 70.4 (C3), 90.4, 91.0, 91.7 
(3x-OCH2OCH3), 173.7, 173.8, 174.1 (C7, C19, C20), 220.6 (C16).
MS (El) m/z 512 (M+, 21%), 451 (18), 418 (100), 405 (25), 374 (33), 344 (36), 315 
(48), 271 (55), 227 (21).
HRMS (El) m/z calc'd for M+ Q5H34O11: 512.2258, found 512.2249.
(23) (24)
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Tri(methoxymethyl) ewf-3a-Hydroxy-(17,17-D2)-gibbereIl-16-ene- 
7,19, 20-trioate (25)
The Lombardo reagent78 (approximately 2 ml of suspension) was added by a 
Pasteur pipette to a solution of the 17-norketone 24 (27 mg, 0.052 mmol) in dry 
dichloromethane (2.5 ml), with stirring under a nitrogen atmosphere. Tic analysis 
indicated that the reaction was complete after one min. The reaction mixture was 
quenched with saturated sodium bicarbonate (2 ml) and extracted with ethyl acetate (2x5 
ml). The combined organic phases were washed with 2M hydrochloric acid (2x5 ml), 
water (5 ml), and saturated brine (5 ml), then dried (sodium sulfate) and the solvent was 
removed under reduced pressure to give a clear oil, (26.5 mg). Chromatography on silica 
gel using ethyl acetateihexane (1:2) afforded the desired dideuterated compound 25 (15 
mg, 57%) as a colourless oil and some starting material was recovered (3.9 mg, 15%).
Rf 0.24 (ethyl acetateihexane, 1:2). IR (film) 1718, 1728, 1739, 2936 cm 1.
lH  NMR (300 MHz, CDC13): 6 1.10-2.58 (14H, m), 1.32 (3H, s, H18), 2.61 (1H, d, 
J = 12.8 Hz, H5), 3.48, 3.51, 3.52 (3x3H, s, -OCH2OCH3), 3.97 (1H, d, J = 12.8 Hz, 
H6), 3.99 (1H, s, H3), 5.02, 5.24 (2xlH, ABd, J = 6.0 Hz, -OCH2OCH3), 5.10, 5.33 
(2xlH, ABd, J = 6.0 Hz, -OCH2OCH3), 5.22, 5.41 (2xlH, ABd, J = 5.9 Hz, 
-0CH20CH3) , .
13C NMR (75 MHz, CDC13): 6 18.5 (C ll), 22.8 (C18), 28.9 (Cl), 29.8 (C2), 31.4 
(C l2), 36.2 (C14), 39.2 (C13), 45.7 (C15), 49.4 (C4), 49.9 (C5), 50.0 (C8), 50.6 
(C6), 56.3 (C9), 56.9 (CIO), 57.5, 57.6, 58.0 (3x-OCH2OCH3), 70.6 (C3), 90.2, 
90.9, 91.6 (3x-OCH2OCH3), 156.1 (C16), 174.1, 174.2, 174.4 (C7, C19, C20).
MS (El) m/z 512 (M+, 2%), 466 (3), 450 (19), 422 (58), 388 (15), 359 (28), 333 (28), 
315 (52), 287 (38), 271 (70).
HRMS (El) m/z calc’d for M+-62 C24H30D2O8: 450.2223, found 450.2228.
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ewf-3a-H yd roxy-(17, 17-cl2)gibberell-16-ene-7 ,19,20-trioc A cid (8)
The 17-dideutero GA13 tri(methoxymethyl) ester (15 mg, 0.029 mmol) was taken 
up in 1M zinc chloride in methanol (10 ml) and the mixture was heated at reflux for 16 h. 
The mixture was diluted with ethyl acetate (20 ml) and washed with sodium dihydrogen 
phosphate buffer (pH4) (2x10 ml), and saturated brine (10 ml). The aqueous washing's 
were extracted with ethyl acetate (15 ml) and the organic phase was washed with 
saturated brine (10 ml). The combined organic phases were dried (sodium sulfate) and 
the solvent was removed under reduced pressure to give the crude product as a white 
solid (5 mg, 45%).
Rf 0.13 (ethyl acetate:hexane:methanol:acetic acid, 66:33:1:1).
*H NMR (300 MHz, CDC13): 5 1.00-2.40 (13H, m), 1.21 (3H, s, H18), 2.54 (1H, 
apparent d, J = 12.6 Hz, H5), 2.54 (1H, m, H13), 3.88 (1H, d, J = 12.6 Hz, H6), 3.91 
(1H, s, H3).
MS (El) m/z 380 (M+, 1%), 362 (11), 316 (100), 288 (66), 270 (95), 243 (24), 227 
(38).
HRMS (El) m/z calc'd for M+-18 C20H22D2O6: 362.1698, found 362.1698.__________
108
9.3 Experimental for Chapter 4
e«f-la-Iodo-3a,10ß,13-trihydroxy-20-norgibberell-16-ene-7,19-dioic  
Acid 19,10-Lactone 7-Methyl Ester (29)168
To the diene acid 28 (202 mg, 0.558 mmol) in THF (6 ml), was added potassium 
hydrogen carbonate (559 mg, 5.58 mmol) in water (5 ml), potassium iodide (463 mg, 
2.79 mmol), and iodine (1.14 g, 4.46 mmol) in THF (1 ml). The dark brown mixture 
was stirred at room temp for 30 min. Saturated sodium thiosulfate (13 ml) was added to 
the mixture which became colourless upon addition. The product was extracted with 
diethyl ether (2x15 ml) and the combined organic phases were washed with saturated 
brine (20 ml), then dried (sodium sulfate) and the solvent removed under reduced 
pressure. The iodolactone 29 was recrystallised from dichloromethane:heptane to give 
white crystals (230 mg, 84%).
Rf 0.30 (ethyl acetaterhexane, 1:1). mp 139-141°C. IR (CHC13) 1215, 1428, 1733, 
1779, 3028, 3619 cm-1.
JH NMR (300 MHz, CDC13): 6 1.17 (3H, s, H18), 1.50-2.73 (11H, m), 2.66 (1H, d, 
J = 9.8 Hz, H6), 3.72 (3H, s, 7-C02CH3), 3.82 (1H, d, J = 9.9 Hz, H5), 3.93 (1H, s, 
H3), 4.39 (1H, d, J  = 5.9 Hz, HI), 4.97 (1H, br s, H17), 5.24 (1H, br s, HT7).
13C NMR (75 MHz, CDC13): 6 14.4 (C18), 16.9 (C ll), 20.2 (Cl), 37.8, 37.9 (C2, 
C12), 42.2 (C15), 45.2 (C14), 48.7 (C6), 49.2 (C8), 50.6, 50.9 (C5, C9), 52.1 
(7-C 02CH3), 54.7 (C4), 70.6 (C3), 78.1 (C13), 94.9 (CIO), 107.7 (C17), 156.3 
(C16), 172.2 (Cl), 177.1 (C19).
MS (El) m/z 488 (M+, 11%), 456 (3), 429 (13), 361 (5), 343 (7), 329 (7), 301 (7), 283 
(7), 255 (11), 239 (10), 135 (25).
HRMS (El) m/z calc’d for M+ C20H25O6I: 488.0696, found 488.0698.
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e/if-10ß,13-Dihydroxy-3a-im idazoI-r-ylthiocarbonyloxy-la-iodo-20- 
norgibberell-16-ene-7,19-dioic Acid 19,10-Lactone 7-Methyl Ester (30)
A/,A/'-thiocarbonyldiimidazole
C 0 2Me
To a solution of the starting alcohol (196 mg, 0.402 mmol) in dry 
dichloromethane (10 ml), under an atmosphere of nitrogen was added 
A,A'-thiocarbonyldiimidazole (143 mg, 0.803 mmol), and imidazole (27 mg, 0.40 
mmol), and the mixture was stirred at room temperature for 7 hours. The solvent was 
removed under reduced pressure, and the residue was suspended in water (20 ml). The 
product was extracted with ethyl acetate (2x30 ml), washed with water (20 ml), and 
saturated brine (20 mi), then dried (sodium sulfate) and the solvent removed under 
reduced pressure to give an orange oil. Purification was carried out by flash 
chromatography on silica gel using ethyl acetateihexane (1:2) as eluting solvent, to give 
the product (208 mg, 87%) as a white powder, which was recrystallised from 
ether:hexane.
Rf 0.31 (ethyl acetateihexane, 1:2). mp 104°C. IR (KBr disc) 1093, 1734, 1788, 3393 
cm'1.
*H NMR (300 MHz, CDC13): 8 1.16 (3H, s, H18), 1.52-2.91 (11H, m), 2.71 (1H, d, 
J  = 10.4 Hz, H6), 3.75 (3H, s, 7-C02CH3), 4.01 (1H, d, J  = 10.3 Hz, H5), 4.47 (1H, 
d, J  = 5.0 Hz, HI), 5.01 (1H, br s, H17), 5.30 (1H, br s, HT7), 5.69 (1H, apparent d, 
J  = 2.3 Hz, H3), 7.09 (1H, br s, H’5), 7.79 (1H, br s, H’4), 8.51 (1H, br s, H’2).
13C NMR (75 MHz, CDC13): 5 14.2 (C18), 16.8 (C ll), 19.5 (Cl), 37.7 (C2), 37.9 
(C12), 42.0 (C15), 44.5 (C14), 49.1 (C8), 49.8, 50.3, 50.8 (C5, C6, C9), 52.2 
(7-C02CH3), 53.2 (C4), 77.6 (C13), 79.2 (C3), 94.4 (CIO), 107.8 (C17), 117.8 (C4), 
130.8 (C5), 137.1 (C2’), 156.1 (C16), 171.6 (C7), 174.9 (C19), 182.0 (-OC(S)N).
MS (El) m /z 598 (M+, 32%), 239 (33), 221 (10), 129 (36), 105 (19), 69 (100).
HRMS (El) m/z: calc’d for M+ C24H27N20 6SI: 598.0635; found: 598.0634.
Microanalysis C24H27N2C>6SI requires: C 48.17, H 4.55, N 4.68, I 21.21; found: C 
48.36, H 4.69, N 4.42, I 21.33.
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e/if-10ß,13-Dihydroxy-20-norgibberell-16-ene-7,19-dioic Acid
19,10-Lactone 7-Methyl Ester (31)
The above imidazolide (160 mg, 0.268 mmol) was taken up in dry benzene (15 
ml) and heated at reflux under nitrogen for 10 minutes. «-Tributyltin hydride (144 jul, 
0.536 mmol) was added via syringe followed by AIBN (9 mg, 10% wt). The resulting 
mixture was heated to reflux for a further 10 mins, after which the solvent was removed 
under reduced pressure. The residue was taken up in diethyl ether (10 ml) and DBU (160 
fil, 1.07 mmol) was added. The mixture was stirred while a 0.1M solution of I2 in 
diethyl ether was added until the brown colour persisted. The solution was then passed 
through a plug of silica gel using diethyl ether, and the solvent was removed under 
reduced pressure. The product was purified by flash chromatography on silica gel using 
ethyl acetate:hexane (1:1), to give a white crystalline solid. Residual tin by-products were 
removed by taking the residue up in ethyl acetate (10 ml) and washing with ammonia 
(3x5 ml). The residue was again chromatographed to give the 3-deoxy lactone (31) (65 
mg, 70%) as a white solid, which was recrystallised from ethyl acetate:hexane.
R f 0.17 (ethyl acetate:hexane, 1:2). mp 144-148°C (lit.16^  187°C). IR  (KBr disc) 991, 
1712, 1775, 2932, 3508 cm-1.
NMR (300 MHz, CDCI3): 8 1.01 (3H, s, H18), 1.33-2.07 (15H, m), 2.49 (1H, d, 
J = 10.0 Hz, H5), 2.62 (1H, d, J = 10.0 Hz, H6), 3.65 (3H, s, 7 -C 02CH3), 4.87 (1H, 
br s, H17), 5.18 (1H, br s, HT7).
13C NMR (75 MHz, CDC13): 8 16.8 (C18), 16.9 (C ll) , 19.0 (C2), 30.2 (C l), 34.0 
(C3), 38.1 (C12), 42.7 (C15), 44.8 (C14), 48.7, 49.2 (C4, C8), 51.1 (C6), 51.8 
(7-CO2CH3), 52.7 (C9), 58.2 (C5), 77.7 (C13), 92.6 (CIO), 106.9 (C17), 156.5 
(C16), 172.8 (C7), 179.0 (C19).
MS (El) m/z 346 (M+, 12%), 314 (22), 303 (14), 286 (12), 199 (11), 159 (15), 135 
(26), 129 (16), 115 (16), 105 (29).
HRMS (El) m/z calc’d for M+ C20H26O5: 346.1780, found 346.1779.
I l l
ew/-10ß-Hydroxy-13-trimethylsiIyloxy-20-norgibberell-16-ene-7,19-dioic 
Acid 19,10-Lactone 7-Methyl Ester (32)
To the above methyl ester 31 (127 mg, 0.368 mmol) in dry dichloromethane (10 
ml) was added diisopropylethylamine (320 jil, 1.84 mmol), trimethylsilyl chloride (233 
jl l I ,  1.84 mmol) and DMAP (catalytic), and the mixture stirred under nitrogen at room 
temp for 1 h. The mixture was diluted with ethyl acetate (20 ml), washed with 2 M 
hydrochloric acid (2x10 ml), water (15 ml), and saturated brine (15 ml), then dried 
(sodium sulfate), and the solvent removed under reduced pressure. The crude mixture 
was chromatographed on silica gel using ethyl acetate:hexane (1:5), with a trace amount 
of triethylamine to buffer the silica gel, to give the pure silylated product 32 as a 
colourless oil (94 mg, 61%).
Rf 0.37 (ethyl acetate:hexane, 1:4). IR (film) 840, 1143, 1736, 1776, 2951 cm 1.
!H NMR (300 MHz, CDC13): 6 0.1 (9H, s, 13-OSi(CH3)3), 1.07 (3H, s, H18), 1.37- 
2.10 (15H, m), 2.53 (1H, d, J = 9.9 Hz, H5), 2.67 (1H, d, J = 9.9 Hz, H6), 3.71 (3H, 
s, 7-C02CH3), 4.89 (1H, br s, H17), 5.17 (1H, br s, HT7).
13C NMR (75 MHz, CDC13): 6 2.1 (13-OSi(CH3)3), 17.0 (C18), 17.2 (C ll), 19.2 
(C2), 30.3 (Cl), 34.3 (C3), 40.2 (C12), 42.6 (C15), 44.6 (C14), 48.8, 49.7 (C4, C8), 
51.5 (C6), 51.8 (7-C02CH3), 52.8 (C9), 58.4 (C5), 79.7 (C13), 92.8 (CIO), 107.2 
(C17), 156.5 (C16), 173.0 (C7), 179.1 (C19).
MS (El) m/z 418 (M+, 100%), 403 (19), 375 (58), 359 (18), 301 (16), 207 (28), 73 
(32).
HRMS (El) m/z calc’d for M+ C23H340 5Si: 418.2176, found 418.2162.
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e/if-10ß-Hydroxy-13-trimethylsilyloxy-16-oxo-17,20-dinorgibbereIlane- 
7,19-dioic Acid 19,10-Lactone 7-Methyl Ester (33)
Through a solution of the olefin 32 (80 mg, 0.191 mmol) in 
dichloromethane/pyridine (8/2 ml) at -78°C, was bubbled ozone until no starting material 
was observed by tic (approximately 4 minutes). Dimethylsulfide (56 pi, 0.766 mmol) 
was added dropwise to the stirred solution which was then warmed to room temp over a 
period of 1 h. The solvent was removed under reduced pressure and the residue was 
chromatographed on silica gel using ethyl acetate:hexane (1:3), with a trace amount of 
triethylamine to buffer the silica gel, affording the norketone 33 as a white foam (28 mg, 
35%). The free 13-hydroxy olefin (34) was also recovered (13 mg, 20%) as well as a 
very small amount of free 13-hydroxy norketone.
Rf 0.26 (ethyl acetate:hexane, 1:3). IR (KBr disc) 919, 1114, 1162, 1173, 1738, 1759, 
1784, 2953 cm-1.
!H NMR (300 MHz, CDC13): Ö 0.14 (9H, s, 13-OSi(CH3)3), 1.11 (3H, s, H18), 1.42- 
2.18 (14H, m), 2.41 (1H, dd, H15a), 2.59 (1H, d, /  = 10.2 Hz, H5), 2.73 (1H, d, /  = 
10.2 Hz, H6), 3.74 (3H, s, 7-C02CH3).
13C NMR (75 MHz, CDC13): 6 1.9 (13-OSi(CH3)3), 17.0 (C18), 17.1 (C ll), 19.1 
(C2), 30.2 (Cl), 34.1 (C3), 34.2, 42.4, 48.0 (C12, C14, C15), 46.4 (C8), 49.1 (C4), 
52.2 (7-C02CH3), 52.8, 53.4 (C6, C9), 58.2 (C5), 80.5 (C13), 92.4 (CIO), 172.3 
(C7), 178.9 (C19), 216.4 (C16).
MS (El) m/z 420 (M+, 12%), 392 (56), 364 (100), 305 (21), 158 (13), 143 (29), 130 
(18), 73 (61).
HRMS (El) m/z calc'd for M+ C22H320 6Si: 420.1968, found 420.1956.
Microanalysis C22H32C>6Si requires: C 62.83, H 7.67; found: C 62.60, H 7.93.
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e/ri-10ß-Hydroxy-13-trimethylsilyloxy-20-norgibberell-16-ene-7,19-dioic 
Acid 19,10-Lactone 7-Methyl Ester (35)
Methyltriphenylphosphonium iodide (20 mg, 0.050 mmol) was placed in a flask 
which was then subjected to high vacuum, and heated to 60°C with rapid stirring for 
16 h. The flask was then filled with Argon and dry THF (3 ml) was added with clean 
potassium hydride (10 mg, 0.250 mmol), and the mixture stirred rapidly under nitrogen 
with heating (30°C) for 30 min. The stirrer was turned off and the yellow solution was 
cannulated into a dry flask containing the starting norketone 33 (3.0 mg, 0.007 mmol). 
The mixture was stirred at room temp for 1 h. Tic indicated that the reaction had almost 
gone to completion. The solvent was removed under reduced pressure and the residue 
was chromatographed on silica gel using ethyl acetate:hexane (1:5), as eluting solvent. 
The solvent was removed by blowing a stream of nitrogen over the flask containing the 
product (35) (2.3 mg, 79%).
Rf 0.37 (ethyl acetate:hexane, 1:4).
See 32 for relative data.
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ewf-10ß,13-Dihydroxy-20-norgibberelI-16-ene-7,19-dioic Acid 19,10- 
Lactone (37)
i) 2M NaOH, MeOH, 
110°C, o/n
ii) AcOH, 100°C, 1 hr
.....OH
The alkene 35 was transferred to a 1 ml reacti-vial with a stirrer. Methanol 
(150 j l l I )  and 2M sodium hydroxide (150 pi) were added to the vial, which was then 
capped and placed in an oil bath at 110°C overnight with stirring. The mixture was 
transferred to a separating funnel and a small amount of methyl red indicator was added. 
1M hydrochloric acid (approx. 350 pi) was added to bring the mixture to a pH of 3. The 
solvent was removed under a stream of nitrogen. Acetic acid (1 ml) was added to the 
reacti-vial which was then capped and placed into an oil bath at 100°C for 1 hour. The 
acetic acid was removed under a stream of nitrogen and the residue was passed through a 
plug of silica gel using ethyl acetateihexane (1:2). The solvent was changed to ethyl 
acetate, but the free acid 37 did not elute from the silica gel column until straight methanol 
was used. The free acid was collected and the solvent removed under a stream of 
nitrogen to give a white solid (0.8 mg, 44%).
!H NMR (300 MHz, CDC13): 6 1.12 (3H, s H18), 1.38-2.16 (14H, m), 2.35 (1H, dt, 
J\ = 16 Hz, J2 = 3 Hz, H 15a), 2.51 (1H, d, J = 10 Hz, H5), 2.66 (1H, d, J = 10 Hz, 
H6), 4.94 (1H, br s, H17), 5.24 (1H, br s, HT7).
13C NMR (75 MHz, CDC13): 6 18.3 (C ll  and C18 overlapped), 20.3 (C2), 31.9 (C l), 
35.7 (C3), 39.8 (C12), 44.1 (C15), 46.0 (C14), 50.3, 50.6 (C4, C8), 52.4 (C6), 54.5 
(C9), 59.6 (C5), 79.8 (C13), 94.3 (CIO), 108.0 (C17), 157.4 (C16), 177.2 (C7), 181.0 
(C19).
MS (El) m/z 332 (M+, 35%), 314 (100), 289 (72), 286 (31), 268 (17), 244 (22), 199 
(12), 163 (17), 135 (23).
HRMS (El) m/z calc’d for M+ Q 9H24O5: 332.1624, found 332.1629.
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e/if-[17-14C ]-10ß-H ydroxy-13-trim ethyIsilyloxy-20-norgibberell-16-ene-
7,19-dioic Acid 19,10-Lactone 7-Methyl Ester (38)
To a flask containing [14C]methyltriphenylphosphonium iodide (20 mg, 0.0492 
mmol) in dry THF (3 ml) was added a large spatula load of clean potassium hydride, and 
the mixture stirred rapidly under nitrogen with heating (30°C) for 45 min. The stirrer was 
turned off and the yellow solution was cannulated through a needle, plugged with glass 
wool to act as a filter, into a dry flask containing the starting norketone 33 (7.4 mg, 
0.0176 mmol). The mixture was stirred at room temp overnight. Tic indicated that the 
reaction had almost gone to completion. The solvent was removed under reduced 
pressure and the residue was chromatographed on silica gel using ethyl acetateihexane 
(1:5), as eluting solvent. The solvent was removed by blowing a stream of nitrogen over 
the flask containing the product (38) (5.5 mg, 74%).
Rf 0.37 (ethyl acetate:hexane, 1:4).______________________________________________
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e/if-[17-14C]-10ß,13-Dihydroxy-20-norgibberell-16-ene-7,19-dioic Acid 
19,10-Lactone (26)
C 02Me
i) 2M NaOH, MeOH, 
110°C, o/n
ii) AcOH, 100°C, 1 hr
The labelled alkene 38 was transferred to a 1 ml reacti-vial with a stirrer. 
Methanol (150 j l i I )  and 2M sodium hydroxide (150 p.1) were added to the vial, which was 
then capped and placed in an oil bath at 110°C over night with stirring. The mixture was 
transferred to a separating funnel and a small amount of methyl red indicator was added. 
1M hydrochloric acid (approx. 350 jil) was added to bring the mixture to a pH of 3. The 
mixture was then extracted with 10% butan-2-ol in ethyl acetate (4x1.5 ml) and the 
combined organic phases were placed into a clean separating funnel and washed with 
50% brine (2 ml), and saturated brine (2 ml), then dried (sodium sulfate) and filtered 
through a Pasteur pipette containing a plug of cotton wool, into a 3 ml reacti-vial. The 
solvent was removed under reduced pressure. Acetic acid (1 ml) was added to the reacti- 
vial which was then capped and placed into an oil bath at 100°C for 1 hour. The acetic 
acid was removed under a stream of nitrogen and the residue was passed through a plug 
of silica gel using ethyl acetate:hexane (1:2). The solvent was changed to ethyl acetate, 
but the free acid 26 did not elute from the silica gel column until straight methanol was 
used. The free acid was collected and the solvent removed under a stream of nitrogen to 
give a white solid (4.1 mg). The product was further purified using reverse phase 
HPLC, (2.5 mg, 45% over 3 steps). Radiochemical yield of 266 p,Ci._______________
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9.4 Experimental for Chapter 5
en*-13-Methoxymethoxy-20-norgibberell-l(10),16-diene-7,19-dioic Acid
7-Methoxymethyl Ester (49)
The protected GA3 derivative 48 (8.00 g, 16.7 mmol) was dissolved in dry THF 
(200 ml) containing t-butyl alcohol (11.8 ml, 0.125 mol). After cooling to -78°C, liquid 
ammonia (approximately 800 ml) was distilled into the flask from a sodium amide 
solution. Lithium metal (approximately 990 mg, 0.143 mol) was added in small pieces 
with vigorous stirring until tic showed no remaining starting material. The reaction was 
then quenched with saturated ammonium chloride (200 ml) and the ammonia was 
removed under a gentle stream of nitrogen. The white, solid residue was dissolved in 
phosphoric acid (10%, 100 ml), and ethyl acetate (300 ml), the layers were separated and 
the aqueous layer further extracted with ethyl acetate (2x100 ml). The combined organic 
phases were washed with saturated brine (3x100 ml) to pH4, then dried (sodium sulfate) 
and the solvent removed under reduced pressure to give a mixture of acids 49 and 50, as 
a yellow oil. The mixture was separated by flash chromatography on silica gel using 
ethyl acetate:hexane (1:2), to give both the acid 49 (4.07 g, 58%) and the carbinol 50 
(3.58 g, 42%) as colourless oils.
Rf 0.24 (ethyl acetate:hexane, 1:2). IR (film) 739, 1266, 1733, 2929 cm*1.
*H NMR (300 MHz, CDC13): 6 1.26 (3H, s, H18), 1.46-2.53 (12H, m), 2.61 (1H, d, 
J  = 15.0 Hz, H15a), 2.85 (1H, br s, H6), 3.15 (1H, d, /  = 6.0 Hz, H5), 3.36, 3.50 
(2x3H, s, -OCH2OCH3), 4.59, 4.79 (2xlH, ABd, J = 7.1 Hz, 13-OCH2OCH3), 5.03 
(2H, br s, H17), 5.26 (2xlH, ABd, 7-OCH2OCH3), 5.35 (1H, br s, HI).
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13C NMR (75 MHz, CDC13): 5 18.3 (Cl 1), 23.1 (C2), 26.4 (C18), 34.5 (C3), 36.7 
(C l2), 39.2 (C15), 43.2 (C8), 45.0 (C14), 46.3 (C9), 49.9 (C4), 50.0 (C6), 51.0 (C5), 
55.0 (I3-OCH2OCH3), 57.7 (7-OCH2OCH3), 84.3 (C13), 90.4 (7-OCH2OCH3), 91.5 
(13-OCH2OCH3), 106.8 (C17), 113.7 (Cl), 140.5 (CIO), 151.1 (C16), 175.6 (C7), 
180.9 (C19).
MS (El) m/z 420 (M+, 8%), 390 (18), 375 (24), 358 (68), 344 (34), 330 (94), 314 
(88), 296 (64), 258 (72), 268 (100), 255 (58), 223 (82).
HRMS (El) m/z: calc'd for M+ C23H32O7: 420.2148; found: 420.2149._____________
c/if-13-Methoxymethoxy-7-hydroxy-20-norgibberell-1(10), 16-diene-19- 
oic Acid (50)
Rf 0.51 (ethyl acetate:hexane:acetic acid:methanol, 100:100:1:1). IR (film) 739, 1266, 
1699, 2935 cm-1.
*H NMR (300 MHz, CDC13): 6 0.82-2.58 (14H, m), 1.29 (3H, s, H18), 2.80 (1H, d, 
J = 15.9 Hz, H150C), 3.37 (3H, s, 13-OCH2OCH3), 3.63 (2H, m, H7), 4.58, 4.78 
(2xlH, ABd, J = 7.0 Hz, B-OCH2OCH3), 5.01 (2H, br s, H17), 5.34 (1H, br s, HI).
13C NMR (75 MHz, CDC13): 6 18.5 (C ll), 23.3 (C2), 26.9 (C18), 34.2 (C3), 36.6 
(C l2), 38.3 (C15), 42.9 (C8), 44.5 (C14), 46.2 (C9), 46.8 (C6), 48.6 (C4), 50.1 (C5), 
54.9 (I3-OCH2OCH3), 65.5 (C7), 84.3 (C13), 91.2 (13-OCH2OCH3), 106.0 (C17), 
113.8 (Cl), 140.2 (CIO), 152.1 (C16), 180.6 (C19).
MS (El) m/z 362 (M+, 15%), 344 (69), 330 (31), 316 (38), 299 (100), 282 (100), 267 
(70), 237 (81), 213 (74).
HRMS (El) m/z: calc'd for M+ C21H30O5: 362.2093; found: 362.2081.
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ent- 10ß Hydroxy-la-iodo-13-methoxymethoxy-20-norgibbereII-16-ene- 
7,19-dioic Acid 19,10-Lactone 7-Methoxymethyl Ester (51)
To the diene acid 49 (192 mg, 0.457 mmol) in THF (6 ml), was added potassium 
hydrogen carbonate (460 mg, 4.57 mmol) in water (4 ml), potassium iodide (380 mg, 
2.29 mmol), and iodine (930 mg, 3.66 mmol) dissolved in THF (1 ml). The dark brown 
mixture was stirred at room temp for 30 min. Saturated sodium thiosulfate (10 ml) was 
added to the mixture which became colourless upon addition. The product was extracted 
with diethyl ether (2x15 ml), the combined organic phases were washed with saturated 
brine (20 ml), then dried (sodium sulfate) and the solvent removed under reduced 
pressure. The iodo lactone 51 was chromatographed on silica gel using ethyl 
acetateihexane (1:4), to give a white solid (184 mg, 88%), plus some starting material (35 
mg).
Rf 0.24 (ethyl acetate:hexane, 1:4). mp 91-92°C. IR (KBr disc) 1035, 1083, 1151, 
1165, 1743, 1781, 2954 cm-1.
*H NMR (300 MHz, CDC13): 6 1.11 (3H, s, H18), 1.50-2.46 (13H, m), 2.66 (1H, d, 
J = 10.0 Hz, H6), 3.33, 3.46 (2x3H, s, -OCH2OCH3), 3.43 (1H, d, /  = 10.1 Hz, H5), 
4.53 (1H, br s, HI), 4.51, 4.73 (2xlH, ABd, J = 7.2 Hz, I3-OCH2OCH3), 5.04 (1H, 
br s, H17), 5.14 (1H, br s, HT7), 5.17, 5.35 (2xlH, ABd, J = 6.0 Hz, 
7-OCH2OCH3).
13C NMR (75 MHz, CDC13): 6 16.6 (C ll), 16.8 (C18), 27.3 (Cl), 30.7, 31.6 (C2, 
C3), 37.6 (Cl2), 40.9 (C15), 42.6 (C14), 48.7 (C8), 49.4 (C4), 50.7, 51.2, 54.8 (C5, 
C6 , C9), 55.1 ( I 3-OCH2O C H 3), 57.7 (7-OCH2O C H 3), 83.1 (C13), 90.6 
(7-OCH2OCH3), 91.7 (I3-OCH2OCH3), 93.9 (CIO), 108.5 (C17), 152.6 (C16), 171.4 
(C7), 178.1 (C19).
MS (El) m/z 546 (M+, 78%), 531 (57), 514 (28), 501 (90), 485 (50), 471 (56), 357 
(68), 343 (78), 329 (96), 313 (87), 297 (79), 258 (86), 269 (100), 255 (72), 223 (86). 
HRMS (El) m/z: calc'd for M+ C23H31O7I: 546.1115; found: 546.1109.
Microanalysis C 23H 31O 7I requires: C 50.56, H 5.72; found: C 50.69, H 5.59.
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enf-lO ß-H ydroxy-loc-iodo- 13-m ethoxym ethoxy-16-oxo-17,20- 
dinorgibbereIlane-7,19-dioic Acid 19,10-Lactone 7-MethyI Ester (53)
Ozone was bubbled through a solution of the olefin 51 (200 mg, 0.366 mmol) in 
dichloromethane/pyridine (12/3 ml) at -78°C until no starting material was observed by tic 
(approximately 7 min). Triethylamine (204 p.1, 1.47 mmol) was added drop wise to the 
stirred solution which was then warmed to room temperature over a period of 1 h. The 
solvent was removed under reduced pressure and the residue was chromatographed on 
silica gel using ethyl acetaterhexane (1:4), to afford the norketone 53 as a clear oil (112 
mg, 56%). Some starting material was also recovered (33 mg, 16%).
Rf 0.16 (ethyl acetateihexane, 1:4).
*H NMR (300 MHz, CDC13): 6 1.11 (3H, s, H18), 1.54-2.48 (13H, m), 2.69 (1H, d, 
J = 10.2 Hz, H6), 3.28, 3.44 (2x3H, s, -OCH2OCH3), 3.44 (1H, d, J  = 10.2 Hz, H5), 
4.50 (1H, br s, HI), 4.56, 4.73 (2xlH, ABd, J  = 7.5 Hz, I3-OCH2OCH3), 5.15, 5.37 
(2xlH, ABd, /  = 6.0 Hz, 7-OCH2OCH3).
13C NMR (75 MHz, CDC13): 6 16.5 (C ll) , 16.8 (C18), 26.6 (C l), 30.5, 31.3 (C2, 
C3), 31.4, 47.8 (C14, C15), 37.6 (C12), 46.0 (C8), 49.6 (C4), 51.3, 52.4, 54.6 (C5, 
C6, C9), 55.7 (I3 -O C H 2O C H 3), 57.9 (7-OCH2O C H 3), 82.5 (C13), 90.7 
(7-OCH2OCH3), 92.5 (I3-OCH2OCH3), 93.5 (CIO), 170.7 (Cl), 177.7 (C19), 215.2 
(C16).
MS (El) m/z 548 (M+, 12%), 520 (34), 505 (28), 458 (20), 375 (36), 331 (100), 303 
(57), 285 (61), 271 (72), 259 (66), 213 (69).
HRMS (El) m/z: calc’d for M + C22H2908I: 548.0907; found: 548.0904.
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ent-lOfi-Hydroxy- 13-m ethoxymethoxy- 16-oxo-17,20-d inorg ibberell-1- 
ene-7,19-dioic Acid 19,10-Lactone 7-Methoxymethyl Ester (54)
A solution of the iodide (444 mg, 0.910 mmol) in dry dichloromethane (20 ml) 
was treated with DBU (967 pi, 6.48 mmol) and heated at reflux overnight. The mixture 
was diluted with ethyl acetate (30 ml), washed with 1M hydrochloric acid (2x20 ml), 
water (4x20 ml), and saturated brine (20 ml), then dried (sodium sulfate) and the solvent 
removed under reduced pressure. The residue was chromatographed on silica gel using 
ethyl acetate:hexane, (1:2) to give the alkene 54 as a clear oil (215 mg, 66%).
Rf 0.26 (ethyl acetate:hexane, 1:2).
XH NMR (300 MHz, CDC13): 8  1.23 (3H, s, H18), 1.73-2.39 (11H, m), 2.82 (1H, d, 
J = 10.6 Hz, H6 ), 2.98 (1H, d, J = 10.6 Hz, H5), 3.32, 3.46 (2x3H, s, -OCH2OCH3), 
4.60, 4.80 (2xlH, ABd, J = 7.5 Hz, I3 -OCH2OCH3), 5.17, 5.40 (2xlH, ABd, J = 6.0 
Hz, 7 -OCH2OCH3), 5.90 (1H, br d, J = 9.3 Hz, H2), 6.16 (1H, br d, J = 9.3 Hz, HI).
13C NMR (75 MHz, CDC13): 8 16.8 (C ll), 17.5 (C18), 31.7 (C3), 37.6, 37.7, 48.3 
(C12, C14, C15), 47.5 (C8), 47.9 (C4), 51.6, 52.2, 56.2 (C5, C6, C9), 55.8 
( I 3 - O C H 2O C H 3), 57.9 (7 -OCH2O C H 3), 82.5 (C13), 89.5 (CIO), 90.9 
(7-OCH2OCH3), 92.6 (I3 -OCH2OCH3), 129.0 (C2), 131.3 (Cl), 171.2 (C7), 178.9 
(C19), 215.3 (C16).
MS (El) m/z 420 (M+, 3%), 389 (16), 375 (10), 359 (27), 314 (36), 301 (31), 286 
(44), 270 (47), 257 (100), 242 (51), 225 (48), 211 (60), 197 (61), 169 (60).
HRMS (El) m/z: calc'd for M+ C22H2808: 420.1784; found: 420.1781.
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e/i/-10ß-H ydroxy-la-iodo-13-hydroxy-16-oxo-17,20-dinorgibberellane- 
7,19-dioic A dd 19, 10-Lactone (56)
A solution of the iodo lactone 53 (90 mg, 0.164 mmol) in methanol/water (15/3 
ml) containing Dowex 50W resin (90 mg) was heated at reflux overnight. After filtration 
through celite, the solvent was removed under reduced pressure. The residue was taken 
up in ethyl acetate (30 ml), washed with 20% potassium dihydrogen phosphate (20 ml), 
and saturated brine (20 ml), then dried (sodium sulfate) and the solvent removed under 
reduced pressure to give a mixture of the acid 56, (45 mg, 55%) with the starting material 
and some 13-methoxymethoxy ether.
Rf 0.24 (ethyl acetate:hexane:methanol:acetic acid, 66:33:1:1). mp 105-107°C. 
IR (KBr disc) 1098, 1753, 1785, 2934, 3434 cm*1.
1H NMR (300 MHz, CDCl3y. 8 1.14 (3H, s, H18), 1.16-2.47 (13H, m), 2.69 (1H, d, 
J = 10.0 Hz, H6), 3.38 (1H, d, J = 10.2 Hz, H5), 4.50 (1H, d, J = 4.3 Hz, HI).
13C NMR (75 MHz, CDCI3): 8 16.6 (C ll), 16.8 (C18), 26.8 (Cl), 30.4, 31.3 (C2, 
C3), 32.2, 47.3 (C14, C15), 40.4 (C12), 45.8 (C8), 49.6 (C4), 51.3, 52.1, 54.4 (C5, 
C6, C9), 78.7 (Cl3), 93.6 (CIO), 174.0 (Cl), 178.1 (C19), 218.6 (C16).
MS (El) m/z 460 (M+, 10%), 414 (4), 333 (3), 315 (11), 287 (58), 259 (100), 241 
(53), 213 (56).
HRMS (El) m/z: calc'd for M+ C i8H2i0 6I: 460.0383; found: 460.0393.
M icroanalysis CigH2i06l requires: C 46.97, H 4.60, I 27.57; found: C 46.96, H 
4.76, I 27.47.
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ew/-10ß, 13-Dihydroxy-la -iod o- 16-oxo-17,20-dinorgibberellane-7,19- 
dioic Acid 19,10-Lactone 7-Methoxymethyl Ester (57)
A solution of the acid 56 (100 mg, 0.217 mmol) in dry dichloromethane (4 ml), 
with triethylamine (152 jixl, 1.087 mmol) and chloromethyl methyl ether (8 6  pi, 1.087 
mmol), was stirred at room temp under nitrogen for 15 min. The mixture was then 
quenched with saturated sodium bicarbonate (3 ml) and extracted with ethyl acetate (10 
ml). The organic phase was washed with 2 M hydrochloric acid (5 ml), water (5 ml), 
and saturated brine (5 ml), then dried (sodium sulfate) and the solvent removed under 
reduced pressure to give the ester 57 as a foam (108 ml, 99%).
Rf 0.36 (ethyl acetate:hexane, 1:1). mp 54°C. IR (KBr disc) 1089, 1145, 1752, 1785, 
2935, 3452 cnr1.
m  NMR (300 MHz, CDC13): 8  1.15 (3H, s, H18), 1.56-2.52 (13H, m), 2.72 (1H, d, 
J = 10.1 Hz, H6 ), 3.46 (3H, s, 7 -OCH2OCH3), 3.48 (1H, d, J = 10.2 Hz, H5), 4.53 
(1H, d, J = 5.0 Hz, HI), 5.25, 5.31 (2xlH, ABd, J = 6.0 Hz, 7 -OCH2OCH3).
13C NMR (75 MHz, CDC13): 5 16.7 (C ll), 16.8 (C18), 26.8 (Cl), 30.5, 31.4 (C2, 
C3), 32.6, 47.1 (C14, C15), 40.6 (C12), 46.1 (C8 ), 49.6 (C4), 51.8, 52.4, 54.6 (C5, 
C6 , C9), 58.0 (7-OCH2OCH3), 78.5 (C13), 91.0 (7-OCH2OCH3), 93.5 (CIO), 170.8 
(C7), 177.7 (C19), 217.4 (C16).
MS (El) m/z 504 (M+, 1%), 476 (1), 414 (4), 315 (10), 287 (59), 259 (100), 241 (56), 
213 (63), 157 (25).
HRMS (El) m/z: calc'd for M+ C20H25O7I: 504.0645; found: 504.0657.
Microanalysis C20H25O7I requires: C 47.63, H 5.00; found: C 48.04, H 4.77.
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e/if-10ß,13-Dihydroxy- 16-oxo-17,20-dinorgibberell-l-ene-7,19-dioic 
Acid 19,10-Lactone 7-MethoxymethyI Ester (58)
A solution of the iodide (117 mg, 0.233 mmol) in dry dichloromethane (10 ml) 
was treated with DBU (278 pi, 1.86 mmol) and heated at reflux overnight. The mixture 
was diluted with ethyl acetate (15 ml), washed with 1M hydrochloric acid (2x12 ml), 
water (4x12 ml), and saturated brine (12 ml), then dried (sodium sulfate), and the solvent 
removed under reduced pressure. The residue was chromatographed on silica gel using 
ethyl acetate:hexane (1:1), to give the alkene 58 as a white solid (71 mg, 81%), which 
was recrystallised from ethyl acetate:hexane (1:10).
Rf 0.20 (ethyl acetate:hexane, 1:1). mp 145-146°C. IR (film) 1089, 1144, 1733, 
1750, 1778, 2967, 3400 cnr1.
NMR (300 MHz, CDC13): 6 1.24 (3H, s, H18), 1.72-2.52 (11H, m), 2.83 (1H, d, 
/  = 10.7 Hz, H6), 3.00 (1H, d, J = 10.7 Hz, H5), 3.46 (3H, s, 7-OCH2OCH3), 5.25, 
5.31 (2xlH, ABd, J = 6.0 Hz, 7-OCH2OCH3), 5.91 (1H, br d, J = 9.3 Hz, H2), 6.16 
(1H, br d, /  = 9.3 Hz, HI).
13C NMR (75 MHz, CDC13): 5 16.9 (C ll), 17.5 (C18), 32.8, 47.5 (C14, C15), 37.6 
(C3), 40.6 (C12), 47.5, 47.9 (C4, C8), 52.0, 52.2, 56.2 (C5, C6, C9), 58.0 
(7-OCH2OCH3), 78.5 (C13), 89.4 (CIO), 90.9 (7-OCH2OCH3), 129.0 (C2), 131.3 
(Cl), 171.2 (Cl), 178.9 (C19), 217.5 (C16).
MS (El) m/z 376 (M+, 7%), 358 (4), 344 (8), 332 (20), 315 (46), 287 (63), 270 (41), 
257 (88), 242 (67), 213 (100), 197 (56), 169 (45), 155 (48), 143 (54).
HRMS (El) m/z: calc'd for M+ C20H24O7: 376.1522; found: 376.1522.
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ent- 10ß-Hydroxy- 13-trim ethylsiIyloxy- 16-oxo-17,20-dinorg ibberelI-l- 
ene-7,19-dioic Acid 19,10-Lactone 7-Methoxymethyl Ester (59)
To the above methoxymethyl ester (37 mg, 0.098 mmol) in dry dichloromethane 
(3 ml) was added diisopropylethylamine (86 |ll, 0.492 mmol), trimethylsilyl chloride (38 
j l l I ,  0.295 mmol) and DMAP (cat) and the mixture stirred under nitrogen at room 
temperature for 1 h. The mixture was diluted with ethyl acetate (10 ml), washed with 2M 
hydrochloric acid (2x7 ml), water (8 ml), and saturated brine (8 ml), then dried (sodium 
sulfate) and the solvent removed under reduced pressure. The crude mixture was 
chromatographed on silica gel using ethyl acetate:hexane (1:3), with a trace amount of 
triethylamine to buffer the silica gel, to give the pure silylated product as a colourless oil 
(32 mg, 73%), which was crystallised using ethenhexane.
Rf 0.58 (ethyl acetate:hexane, 1:1). mp 89-91°C. IR (KBr disc) 1137, 1739, 1761, 
1775,2958 cur1.
!H NMR (300 MHz, CDC13): 6 0.13 (9H, s, 13-OSi(CH3)3), 1.23 (3H, s, H18), 1.68- 
2.48 (11H, m), 2.78 (1H, d, /  = 10.7 Hz, H6), 2.97 (1H, d, J = 10.7 Hz, H5), 3.46 
(3H, s, 7-OCH2OCH3), 5.25, 5.31 (2xlH, ABd, J = 6.0 Hz, 7-OCH2OCH2O, 5.89 
(1H, br d, J = 9.3 Hz, H2), 6.15 (1H, br d, J = 9.3 Hz, HI).
13C NMR (75 MHz, CDC13): 5 1.91 (13-OSi(CH3)3, 17.0 (C ll), 17.5 (C18), 34.0, 
47.9 (C14, C15), 37.7 (C3), 42.0 (C12), 47.3, 47.9 (C4, C8), 51.6, 52.4, 56.1 (C5, 
C6, C9), 58.0 (7-OCH2OCH3), 80.4 (C13), 89.5 (CIO), 91.0 (7-OCH2OCH3), 129.0 
(C2), 131.2 (Cl), 171.2 (Cl), 179.0 (C19), 216.0 (C16).
MS (El) m/z 448 (M+, 3%), 434 (27), 420 (81), 392 (78), 375 (84), 304 (74), 285 
(28), 241 (30), 157 (47), 143 (58).
HRMS (El) m/z: calc'd for M+ C23H320 7Si: 448.1917; found: 448.1930. 
Microanalysis C23H320 7Si requires: C 61.58, H 7.19; found: C 61.23, H 7.55.
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ent- 10ß-Hydroxy- 13-trimethy lsilyloxy-20-norgibberell-1,16-diene-7,19- 
dioic Acid 19,10-lactone 7-Methoxymethyl Ester (60)
To a flask containing methyltriphenylphosphonium iodide (35 mg, 0.087 mmol) 
in dry THF (3 ml) was added a large spatula load of clean potassium hydride, and the 
mixture was stirred rapidly under nitrogen with heating (30°C) for 45 minutes. The 
stirrer was turned off and the yellow solution was cannulated through a needle, plugged 
with glass wool to act as a filter, into a dry flask containing the starting norketone 59 (13 
mg, 0.029 mmol). The mixture was stirred at room temperature overnight. Tic indicated 
that the reaction had gone to completion. The solvent was removed under reduced 
pressure and the residue was chromatographed on silica gel using ethyl acetate:hexane 
(1:5), as eluting solvent. The solvent was removed under reduced pressure to give the 
product (10.3 mg, 80%).
Rf 0.22 (ethyl acetate-.hexane, 1:5).
!H NMR (300 MHz, CDC13): 5 0.18 (9H, s, 13-OSi(CH3)3), 1.22 (3H, s, H I8), 1.58- 
2.38 (11H, m), 2.77 (1H, d, J  = 10.6 Hz, H6), 2.96 (1H, d, J = 10.6 Hz, H5), 3.48 
(3H, s, 7-OCH2OCH3), 4.91 (1H, br s, H17), 5.22 (1H, br s, HT7), 5.27, 5.30 
(2xlH, ABd, J = 6.0 Hz, 7-0CH20CH3), 5.87 (1H, br d, J = 9.3 Hz, H2), 6.16 (1H, 
br d, 7 = 9.3 Hz, HI)._____________________________________________________
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ent-10 ß, 13-D ihydroxy-la-iodo- 13-hydroxy- 16-oxo-17,20- 
dinorgibberellane-7,19-dioic Acid 19,10-Lactone 7-Methyl Ester (62)
To the acid 56 (132 mg, 0.396 mmol) in methanol (5 ml), was added dropwise, 
an ethereal solution of diazomethane until the yellow colour persisted. The solvent was 
removed under reduced pressure to give the methyl ester 62 as a white foam (136 mg, 
quantitative), which was recrystallised from ethenheptane (1:10).
Rf 0.51 (ethyl acetate:hexane, 1:1). mp 54-55°C. IR (KBr disc) 1278, 1735, 1753, 
1789, 2953 cm-1.
!H NMR (300 MHz, CDC13): 6 1.13 (3H, s, H18), 1.57-2.53 (13H, m), 2.70 (1H, d, 
J = 10.2 Hz, H6), 3.73 (1H, d, J = 10.5 Hz, H5), 3.75 (3H, s, 7-C02CH3), 4.52 (1H, 
d, J=  5.0 Hz, HI).
13C NMR (75 MHz, CDCI3): 6 16.7 (C18), 16.8 (C ll), 26.8 (Cl), 30.6. 31.5 (C2, 
C3), 32.8, 47.3 (C14, C15), 40.6 (C12), 46.2 (C8), 49.7 (C4), 51.7, 52.4, 52.5 (C5, 
C6, C9), 54.7 (7-C02CH3), 78.7 (C13), 93.5 (CIO), 171.6 (C7), 177.8 (C19), 217.6 
(C16).
MS (El) m/z 474 (M+, 15%), 446 (9), 431 (11), 347 (12), 301 (90), 287 (100), 273 
(76), 259 (72), 241 (93), 213 (91).
HRMS (El) m/z: calc'd for M+ C19H23O6I: 474.0539; found: 474.0539.____________
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c/ri-10ß,13-D ihydroxy-16-oxo-17,20-dinorgibberelI-l-ene-7,19-dioic Acid 
19,10-Lactone 7-Methyl Ester (63)
A solution of the iodide (150 mg, 0.316 mmol) in dry dichloromethane (10 ml), 
was treated with DBU (378 pi, 2.53 mmol) and heated at reflux overnight. The mixture 
was diluted with ethyl acetate (15 ml), washed with cold 1M hydrochloric acid (2x12 ml), 
water (4x12 ml), and saturated brine (12 ml), then dried (sodium sulfate), and the solvent 
removed under reduced pressure. The residue was chromatographed on silica gel using 
ethyl acetate:hexane, (1:1) to give a mixture of the alkene 63 as a white solid (39 mg, 
36%), and the iodide (71 mg, 47%). 63 was recrystailised from ethyl acetate:hexane 
( 1: 10).
R f 0.26 (ethyl acetate:hexane, 1:1). mp 118-119°C. IR  (solution cell, CHCI3) 1734, 
1752, 1772 cm-1.
NMR (300 MHz, CDCI3): 6 1.21 (3H, s, H18), 1.72-2.48 (11H, m), 2.80 (1H, d, 
J  = 10.9 Hz, H6), 2.98 (1H, d, /  = 10.9 Hz, H5), 3.74 (3H, s, 7 -C 02CH3), 5.90 (1H, 
br d, J  = 9.3 Hz, H2), 6.15 (1H, br d, J  = 9.2 Hz, H I).
« C  NM R (75 MHz, CDC13): 5 16.9 (C18), 17.5 (C ll) ,  32.9, 47.7 (C14, C15), 37.7 
(C3), 40.5 (C12), 47.8, 47.9 (C4, C8), 51.9, 52.3, 56.4 (C5, C6, C9), 54.6 
(7 -C 0 2C H 3), 78.6 (C13), 89.5 (CIO), 129.0 (C2), 131.3 (C l), 172.0 (C7), 178.9 
(C l9), 217.5 (C16).
M S (El) m/z 346 (M+, 7%), 328 (23), 314 (31), 302 (52), 287 (18), 271 (100), 259 
(44), 242 (50), 213 (83), 197 (93), 157 (74).
HRMS (El) m/z: calc’d for M+ Q9H22O6: 346.1416; found: 346.1422.
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e/if-10ß-Hydroxy-16-oxo-13-trimethylsilyloxy-17,20-dinorgibberell-l- 
ene-7,19-dioic Acid 19,10-Lactone 7-Methyl Ester (64)
To the above methyl ester (32 mg, 0.093 mmol) in dry dichloromethane (3 ml) 
was added diisopropylethylamine (81 |il, 0.462 mmol), trimethylsilyl chloride (35 pi, 
0.277 mmol) and DMAP (catalytic), and the mixture stirred under nitrogen at room temp 
for 1 h. The mixture was diluted with ethyl acetate (10 ml), washed with 2M 
hydrochloric acid (2x7 ml), water (8 ml), and saturated brine (8 ml), then dried (sodium 
sulfate) and the solvent removed under reduced pressure. The crude mixture was 
chromatographed on silica gel using ethyl acetateihexane (1:3), with a trace amount of 
triethylamine to buffer the silica gel, to give the pure silylated product 64 as a colourless 
oil (32 mg, 73%) which was crystallised using etherihexane.
Rf 0.27 (ethyl acetateihexane, 1:3). mp 107-108°C. IR (CHC13) 1737, 1756, 1774, 
2951 cm-1.
lH  NMR (300 MHz, CDC13): 5 0.15 (9H, s, 13-OSi(CH3)3, 1.22 (3H, s, H18), 1.58- 
2.45 (11H, m), 2.77 (1H, d, J = 10.7 Hz, H6), 2.97 (1H, d, /  = 10.6 Hz, H5), 3.75 
(3H, s, 7-CO2CH3), 5.89 (1H, br d, J = 9.3 Hz, H2), 6.15 (1H, br d, /  = 9.3 Hz, HI).
13C NMR (75 MHz, CDC13): 5 1.9 (13-OSi(CH3)3, 17.0 (C18), 17.5 (C ll), 34.0, 
48.1 (C14, C15), 37.8 (C3), 42.0 (C12), 47.3, 47.9 (C4, C8), 51.4, 52.2, 56.2 (C5, 
C6, C9), 52.4 (7-C02CH3), 80.4 (C13), 89.6 (CIO), 129.1 (C2), 131.2 (Cl), 172.0 
(C7), 179.0 (C19), 216.2 (C16).
MS (El) m/z 418 (M+, 4%), 390 (85), 362 (100), 345 (10), 330 (20), 285 (16), 255 
(12), 216 (18), 195 (28).
HRMS (El) m/z: calc'd for M+ C22H3o06Si: 418.1812; found: 418.1809.
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e/zf-[17-14C ]-lO ß-H ydroxy-13-trim ethylsily loxy-20-n org ib b erell-l,16- 
diene-?,19-dioic Acid 19,10-Lactone 7-Methyl Ester (65)
To a flask containing [14C]methyltriphenylphosphonium iodide (24 mg, 0.059 
mmol) in dry THF (3 ml) was added a large spatula load of clean potassium hydride, and 
the mixture was stirred rapidly under nitrogen with heating (30°C) for 45 min. The stirrer 
was turned off and the yellow solution was cannulated through a needle, plugged with 
glass wool to act as a filter, into a dry flask containing the starting norketone 64 (8 mg, 
0.019 mmol). The mixture was stirred at room temp overnight. Tic indicated that the 
reaction had almost gone to completion. The solvent was removed under reduced 
pressure and the residue was chromatographed on silica gel using ethyl acetateihexane 
(1:5), as eluting solvent. The solvent was removed by blowing a stream of nitrogen over 
the flask containing the product 65 (4.9 mg, 74%). Radiochemical yield 180 jiCi.
Rf 0,37 (ethyl acetate:hexane, 1:4).______________________________________________
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9.5 Experimental for Chapter 7
e/2f-7-Chloro-3a,13-diacetoxy-7-oxo-20-norgibberell-l,16-dien-19-oic  
Acid 19,10-Lactone (81)
A solution of the acid 80 (100 mg, 0.232 mmol) in dry THF (2 ml) containing 
pyridine (282 jxl, 3.48 mmol) was added via cannula to oxalyl chloride (203 jllI ,  2.32 
mmol) in dry THF (5 ml) at -40°C under nitrogen. The solution was allowed to warm to 
room temp, and stirred for 4 h. The reaction mixture was filtered through a sintered 
funnel and washed into a dry flask with dry benzene. Residual oxalyl chloride was 
removed by azeotroping with benzene (4x10 ml), and the residue was filtered through a 
plug of celite into a dry flask. The solvent was removed under reduced pressure to give 
the acid chloride (81) (-100%) as a yellow oil.
Rf0.81 (ethyl acetate:hexane, 1:1).
NMR (300 MHz, CDC13): 8 1.22 (3H, s, H18), 1.67-2.65 (9H, m), 2.05, 2.13 
(2x3H, s, -OCOCH3), 3.25 (1H, d, J = 10.8 Hz, H6), 3.32 (1H, d, 7=  10.8 Hz, H5), 
5.06 (1H, br s, H17), 5.24 (1H, br s, HT7), 5.35 (1H, d, J = 3.6 Hz, H3), 5.89 (1H, 
dd, J2,1 = 9.2 Hz, J2,3 = 3.7 Hz, H2), 6.36 (1H, d, J = 9.2 Hz, HI).
13C NMR (75 MHz, CDC13): 8 15.3 (C18), 17.3 (C ll), 21.3, 22.5 (2x-OCOCH3), 
36.4 (C12), 40.2 (C14), 42.4 (C15), 51.9 (C9), 52.0 (C6), 52.6 (C8), 54.9 (C4), 62.3 
(C5), 70.4 (C3), 84.1 (C13), 89.9 (CIO), 109.7 (C17), 141.8 (Cl), 146.6 (C2), 153.0 
(C16), 170.4, 170.5 (2x-OCOCH3), 173.9 (C7), 176.8 (C19).
MS (El) m/z 448 (M+, 24%), 406 (50), 352 (24), 301 (19), 281 (53), 255 (33), 238 
(71), 221 (100), 196 (65), 155 (64).
HRMS (El) m/z calc'd for M+ C23U250 ^ 5C\: 448.1289; found: 448.1287.
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c/if-3oc,13-Diacetoxy-7-hydroxy-20-norgibberell-l,16-dien-19-oic Acid 
19,10-Lactone (82)
To the starting acid chloride (81) (225 mg, 0.502 mmol) in dry, distilled 
dimethoxyethane (10 ml) at 0°C under nitrogen, was added sodium borohydride (25 mg, 
0.661 mmol). The mixture was stirred at 0°C and allowed to warm slowly to room temp 
over 4 h. Acetic acid (2 ml) was added and the mixture was stirred for a further 20 min, 
then diluted with ethyl acetate (20 ml). The mixture was washed with saturated sodium 
bicarbonate (4x10 ml), and saturated brine (1x10 ml), then dried over sodium sulfate. 
The solvent was removed under reduced pressure to give the crude alcohol. Purification 
was carried out by silica gel chromatography using ethyl acetate:hexane (1:1), as eluting 
solvent to give pure alcohol (82) as a white crystalline compound (187 mg, 90%), which 
was recrystallised from ethyl acetate:hexane (1:10).
Rf 0.28 (ethyl acetate:hexane:methanol:acetic acid, 100:100:1:1). mp 62°C. IR (KBr 
disc) 1734, 1776, 2934, 3482 cm'1.
*H NMR (300 MHz, CDC13): 5 1.26 (3H, s, H18), 1.65-2.36 (9H, m), 2.00, 2.09 
(2x3H, s, -OCOCH3), 2.66 (1H, d, 7 = 10.6 Hz, H5), 2.83 (1H, dt, Jx = 18 Hz, 
H15a), 3.69-3.85 (2H, m, H7), 4.98 (1H, br s, H17), 5.11 (1H, br s, HT7), 5.30 
(1H, d, 7 = 3.5 Hz, H3), 5.81 (1H, dd, J2,1 = 9.3 Hz, J2,3 = 3.8 Hz, H2), 6.37 (1H, d, 
7 = 9.5 Hz, HI).
13C NMR (75 MHz, CDC13): 6 14.9 (C18), 16.7 (C ll), 20.7, 22.0 (2x-OCOCH3), 
36.3 (C12), 41.1 (C14), 46.3 (C15), 50.2 (C9), 50.8 (C5, C6 overlapped), 51.8 (C8), 
52.2 (C4), 61.9 (C7), 70.9 (C3), 84.2 (C13), 90.4 (CIO), 106.9 (C17), 128.6 (Cl), 
134.7 (C2), 153.7 (C16), 169.9 (-OCOCH3, -OCOCH3 overlapped), 177.4 (C19).
MS (El) m/z 416 (M+, 10%), 374 (46), 281 (56), 239 (57), 223 (58), 221 (100), 209 
(75), 195 (50), 155 (63).
HRMS (El) mJz calc’d for M+ C23H28O7: 416.1835; found: 416.1837.
Microanalysis C23H28O7 requires: C 66.33, H 6.78; found: C 66.27, H 7.01.
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e/if-3a,13-D iacetoxy-16ß,17-epoxy-7-hydroxy-20-norgibbereIl-l-en-19- 
oic Add 19,10 Lactone (83)
To the starting alcohol 82 (343 mg, 0.822 mmol) in dichloromethane (4 ml) at 
-15°C (ice/salt bath), was added 50% m-chloroperbenzoic acid (312 mg, 1.81 mmol), 
(pre-dried over sodium sulfate) in dichloromethane (6 ml). The mixture was stirred at 
-15°C and allowed to warm to room temp overnight. Tic showed no remaining starting 
material, and the mixture was diluted with ethyl acetate (20 ml), washed with saturated 
sodium bicarbonate (2x10 ml), and saturated brine (1x10 ml), then dried (sodium 
sulfate). The solvent was removed under reduced pressure to give the crude epoxide 83, 
which was purified by silica gel chromatography using ethyl acetaterhexane (1:1), as 
eluting solvent to give the pure epoxide as a white crystalline solid (275 mg, 77%), which 
was recrystallised from ethyl acetateihexane (1:10).
Rf 0.26 (ethyl acetate:hexane, 3:1). mp 91.5-93.5°C. IR (CHCI3) 1250, 1728, 1755, 
2880, 2940, 2970, 3040, 3500 cm '1.
*H NMR (300 MHz, CDC13): 8 1.25 (3H, s, H18), 1.72-2.40 (10H, m), 1.97, 2.08 
(2x3H, s, -OCOCH3), 2.66 (1H, d, J  = 10.7 Hz, H5), 2.76 (1H, d, J  = 5.3 Hz, H17), 
3.07 (1H, d, J  = 5.3 Hz, HT7), 3.62-3.84 (2H, m, H7), 5.29 (1H, d, J  = 3.7 Hz, H3), 
5.82 (1H, dd, J2,1 = 9.3 Hz, J2,3 = 3.7 Hz, H2), 6.38 (1H, d, J = 9.3 Hz, HI).
13C NMR (75 MHz, CDC13): 8 14.6 (C18), 16.9 (C ll) ,  20.5, 21.4 (2x-OCOCH3), 
32.6 (C12), 40.6 (C14), 41.1 (C15), 46.8 (C9), 88.7 (C8), 50.1 (C17), 51.3 (C6), 51.4 
(C5), 52.1 (C4), 61.4 (Cl), 66.6 (C16), 70.6 (C3), 80.0 (C13), 90.2 (CIO), 128.5 
(C l), 134.3 (C2), 169.8, 169.9 (2x-OCOCH3), 177.4 (C19).
MS (El) m/z 432 (M+, 26%), 390 (37), 297 (50), 237 (37), 209 (58), 195 (35), 169 
(36), 155 (61).
HRMS (El) m/z calc'd for M+ C23H2808: 432.1784; found: 432.1780.
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cnf-3oc,13-Diacetoxy-7-16ß,17-epoxy-hydroxy-20-norgibbereIlan-19-oic 
Acid 19,10 Lactone (84)
To a solution of the above epoxide (230 mg, 0.531 mmol) in ethyl acetate (15 
ml), was added 10% palladium on charcoal (27.6 mg, 12% wt). The resulting mixture 
was stirred under a hydrogen atmosphere at room temp for 3 h. The mixture was then 
filtered through a plug of celite and the solvent removed under reduced pressure to give 
the saturated epoxide (84) as a white solid (231 mg, 100%), which was recrystallised 
from ethenhexane.
Rf 0.26 (ethyl acetate:hexane, 3:1). mp 164.5-166.5°C. IR (CHC13) 1733, 1774, 
2933, 3620 cm'1.
*H NMR (300 MHz, CDC13): 6 1.19 (3H, s, H18), 1.50-2.17 (12H, m), 1.99, 2.11 
(2x3H, s, -OCOCH3), 2.36 (1H, d, J = 13.7 Hz, H5), 2.39 (1H, d, J = 10.9 Hz, H15), 
2.56 (1H, apparent dd, Jx = 13.2 Hz, J2 = 6.6 Hz, H6), 2.78 (1H, d, J = 5.3 Hz, H17), 
3.10 (1H, d, J = 5.3 Hz, HT7), 3.60-3.83 (2H, m, H7), 4.95 (1H, apparent t, J = 2.7 
Hz, H3).
13C NMR (75 MHz, CDC13): 6 14.7 (C18), 17.2 (C ll), 21.0, 21.5 (2x-OCOCH3),
25.2 (C2), 27.2 (Cl), 32.7 (C12), 40.9 (C14), 41.7 (C15), 47.2 (C9), 48.0 (C8), 50.2 
(C5, C17 overlapped), 53.2 (C6, C4 overlapped), 61.7 (C7), 66.2 (C16), 71.9 (C3),
80.3 (C13), 93.1 (CIO), 169.9, 170.0 (2x-OCOCH3), 177.0 (C19).
MS (El) m/z 434 (M+, 7%), 392 (100), 374 (37), 335 (32), 257 (68), 239 (33), 211 
(60), 157 (51).
Microanalysis C23H30O8 requires: C 63.58, H 6.96; found: C 63.28, H 7.25.
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e /i^ -3 a ,1 3 -D iace to x y -1 6 ß ,1 7 -ep o x y -7 -(2 ’-n itro b en z e n ese len e n y I)-2 0 - 
n o rg ib b e re llan  19-oic Acid 19,10-Lactone (85)
To the alcohol 84 (230 mg, 0.528 mmol) in THF (10 ml), was added 
o-nitrophenyl selenocyanate (264 mg, 1.16 mmol), followed by the drop wise addition of 
n-tributylphosphine (290 jllI, 1.16 mmol) under an atmosphere of nitrogen at room 
temperature. The resulting mixture was stirred for 1 hour, after which, the solvent was 
removed under reduced pressure and the residue was chromatographed on silica gel (ethyl 
acetate:hexane, 1:1) to give the o-nitrophenyl selenide 85 (290 mg, 89%) as a yellow 
powder, which was recrystallised from ethyl acetate:hexane (1:10).
R f 0.28 (ethyl acetate:hexane, 1:1). m p 103-105°C. IR  (KBr disc) 1239, 1740, 1773 
cm*1.
1H N M R (300 MHz, CDC13): 5 1.16 (3H, s, H18), 1.53-2.25 (12H, m), 2.00, 2.10 
(2x3H, s, -OCOCH3), 2.31 (1H, d, J = 13.4 Hz, H 15a), 2.40 (1H, d, J = 11.1 Hz, 
H 14ß), 2.67 (1H, d, J = 9.2 Hz, H5), 2.78 (1H, d, J = 5.4 Hz, H17), 2.90 (1H, dd, 
/ gem = 10.8 Hz, 7vic = 4.8 Hz, H7), 3.05 (1H, dd, 7gem = 10.8 Hz, Jyic = 7.5 Hz, 
H'7), 3.13 (1H, d, J = 5.4 Hz, HT7), 4.98 (1H, apparent t, H3), 7.36 (1H, apparent t, 
J = 7.0 Hz, H'4), 7.43 (1H, d, J = 8.2 Hz, H'6), 7.55 (1H, apparent t, J = 7.0 Hz, 
H'5), 8.28 (1H, d, J = 8.3 Hz, H’3).
13C NM R (75 MHz, CDC13): 8 14.8 (C18), 17.4 (C ll) ,  20.9, 21.5 (2x-OCOCH3), 
25.1 (C2), 27.5 (C l), 27.7 (C7), 32.7 (C12), 41.2 (C14), 42.2 (C15), 43.3 (C9), 49.2 
(C8), 50.4 (C17), 52.6 (C5), 53.2 (C4), 55.3 (C6), 65.4 (C16), 71.8 (C3), 80.4 (C13), 
92.4 (CIO), 125.7 (C 3), 126.3 (C 4), 128.7 (C 6), 132.3 (CT), 133.7 (C 5), 146.5 
(C2), 169.8 (-OCOCH3, -OCOCH3 overlapped), 176.4 (C19).
M S (El) mfz 619 (M+, 70%), 589 (15), 376 (26), 357 (27), 315 (37), 297 (58), 211 
(62), 186 (100), 155 (56).
HRM S (El) m/z calc'd for M + C29H330 9NSe: 619.1321; found: 619.1311. 
M icroanalysis C29H 3309NSe requires: C 56.31, H 5.38; found: C 56.38, H 5.66.
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e«f-3a,13-Diacetoxy-16ß,17-epoxy-20-norgibberell-6-en-19-oic Acid
19,10-Lactone (86)
A solution of the selenide (85) (53 mg, 0.086 mmol) in a mixture of THF (2 ml) 
and 30% hydrogen peroxide (97 pi, 0.860 mmol) was stirred at 0°C for 1.5 h and then 
allowed to warm to room temp over 10.5 h. The solvent was removed under reduced 
pressure and the residue was chromatographed on silica gel using ethyl acetate:hexane 
(1:2), to give the olefin as a clear oil (33 mg, 90%). The olefin was recrystallised from 
dichloromethane:hexane to give a white crystalline solid.
Rf 0.33 (ethyl acetate:hexane, 1:1). mp 160-163°C. IR (KBr disc) 1221, 1739, 1753, 
1768, 2936 cm'1.
*H NMR (300 MHz, CDC13): 5 1.31(3H, s, H18), 1.53-2.20 (12H, m), 1.97, 2.10 
(2x3H, s, -OCOCH3), 2.51 (1H, dd, J x = 2.4 Hz, J2 = 11.3 Hz, H15oc), 2.80 (1H, d, 
J = 5.2 Hz, H17), 3.06 (1H, d, J = 5.1 Hz, HT7), 3.20 (1H, apparent t, J = 2.7 Hz, 
H5), 4.98 (1H, dd, Jx = 2.6 Hz, J2 = 2.9 Hz, H3), 5.17 (1H, d, J = 2.7 Hz, H7), 5.31 
(1H, d, J = 3.0 Hz, H'7).
13C NMR (75 MHz, CDC13): 5 15.3 (C18), 17.1 (C ll), 21.0, 21.6 (2x-OCOCH3), 
25.2 (C2), 26.6 (Cl), 32.3 (C12), 42.1 (C14), 46.8 (C15), 49.4 (C17), 50.4 (C8), 51.5 
(C9), 53.0 (C4), 53.4 (C5), 65.4 (C16), 72.9 (C3), 81.0 (C13), 92.2 (CIO), 113.0 
(C7), 151.5 (C6), 169.7, 169.8 (2x-OCOCH3), 176.3 (C19).
MS (El) m/z 416 (M+, 100%), 374 (51), 356 (42), 312 (76), 270 (37), 252 (46), 211 
(61), 149 (49).
HRMS (El) m/z calc’d for M+ C23H280 7: 416.1835; found: 416.1825.
Microanalysis C23H280 7 requires: C 66.33, H 6.78; found: C 65.99, H 7.10.
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ent-3a, 13-Diacetoxy-6oc, 7-dihydroxy-16 ß,17-epoxy-20-norgibberellan-19- 
oic Acid 19,10-Lactone (87)
0 s 0 4, NMMO, t-BuOH
COl h
H CH2
To a solution of the olefin (86) (65 mg, 0.153 mmol) in acetone/water (5/1 ml) 
was added A-methylmorpholine-A-oxide (89 mg, 0.763 mmol), and osmium tetroxide 
(catalytic) dissolved in r-butyl alcohol (100 pi), and the mixture stirred at 30°C for 9 
days. Sodium bisulfite (10 mg) was added to the mixture, which was then diluted with 
water (4 ml) and stirred for another 30 min. The mixture was extracted with ethyl acetate 
(2x10 ml), and the combined organic phases were washed with water (12 ml), and 
saturated brine (12 ml), then dried (sodium sulfate) and the solvent removed under 
reduced pressure. The residue was chromatographed on silica gel using ethyl 
acetateihexane (2:1), to give the diol 87, (55 mg, 66%) as a white solid, plus some 
starting olefin (11.3 mg, 17%). The diol was recrystallised from etherihexane.
Rf 0.10 (ethyl acetate:hexane, 2:1). mp 169-171°C. IR (KBr disc) 1233, 1262, 1719, 
1740, 1776, 2955, 3422, 3513 cm'1.
*H NMR (300 MHz, CDC13): 6 1.31(3H, s, H18), 1.57-2.17 (11H, m), 1.97, 2.12 
(2x3H, s, -OCOCH3), 2.55 (1H, d, J  =  13.5 Hz, H15a), 2.61 (1H, d, /  = 10.8 Hz, 
H14), 2.80 (1H, d, J  =  5.5 Hz, H17), 2.90 (1H, s, H5), 3.06 (1H, d, J  = 5.5 Hz, 
HT7), 3.38 (1H, br s, 6-OH), 3.74 (2H, d, J  = 2.8 Hz, H7), 4.91 (1H, br s, H3).
13C NMR (75 MHz, CDC13): 6 16.5 (C18), 17.3 (C ll), 21.1, 21.8 (2x-OCOCH3), 
25.2 (C2), 27.3 (Cl), 32.8 (C12), 38.2 (C14), 41.2 (C15), 47.0 (C9), 50.3 (C17), 52.0 
(C8), 54.5 (C4), 61.8 (C5), 62.5 (C16), 64.7 (C7), 75.0 (C3), 82.6 (C13), 82.7 (CIO), 
92.9 (C6), 170.0, 170.3 (2x-OCOCH3), 177.1 (C19).
MS (El) m /z 450 (M+, 11%), 419 (82), 408 (100), 390 (28), 377 (31), 359 (44), 331 
(33), 315 (74), 289 (50), 271 (68), 255 (65), 227 (66), 197 (51), 171 (44).
HRMS (El) m /z calc’d for M+ C23H30O9: 450.1890; found: 450.1894.
Microanalysis C23H30O9 requires: C 61.32, H 6.71; found: C 61.12, H 6.96.
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e/if-3a,13-Diacetoxy-6a,7-dihydroxy-20-norgibberell-16-en-19-oic Acid
19,10-Lactone (89)
3-methylbenzothiazole-
2-selone
CF3COOH, CH2CI2
A solution of the diol (87) (176 mg, 0.391 mmol) in dichloromethane (8 ml), 
with 3-methylbenzothiazole-2-selone (98 mg, 0.430 mmol) and trifluoroacetic acid (33 
pi, 0.430 mmol), was stirred under nitrogen at room temp. The solution turned a dark 
yellow colour. After 6 h the now brown solution, was diluted with ethyl acetate (15 ml), 
washed with water (2x10 ml), and saturated brine (10 ml), then dried (sodium sulfate) 
and the solvent removed under reduced pressure. The residue was chromatographed on 
silica gel using ethyl acetateihexane, (1:1 changing to 2:1), to give the alkene (89) as a 
clear oil (81 mg, 48%).
R f0 .ll  (ethyl acetate:hexane, 1:1). IR (CDC13) 1044, 1241, 1372, 1454, 1733, 1766, 
2944, 3535, 3622 cnr1.
*H NMR (300 MHz, CDC13): 8 1.29 (3H, s, H18), 1.54-1.70 (2xlH, m, Hl, H12), 
1.85-1.90 (4xlH, m, H2, H ll) , 1.97-2.10 (3xlH, m, HI, H9, H14), 2.00, 2.11 
(2x3H, s, -OCOCH3), 2.13-2.20 (1H, m, H12), 2.25 (1H, d, J  = 17.3 Hz, H15ß), 
2.53 (1H, d, J  = 12.4 Hz, H14), 2.86 (1H, s, H5), 2.90-2.96 (1H, m, H15), 3.67 (2H, 
br s, H7), 4.90 (1H, dd, J x = 2.9 Hz, J 2 = 2.6 Hz, H3), 4.94 (1H, br s, H17), 5.00 
(1H, br s, HT7).
13C NMR (75 MHz, CDC13): 8 16.5 (C18), 17.64 (C ll), 21.1, 22.1 (2x-OCOCH3), 
25.3 (C2), 27.4 (Cl), 36.7 (C12), 37.2 (C14), 41.2 (C15), 47.1 (C9), 52.0 (C8), 55.8 
(C4), 61.6 (C5), 64.8 (C7), 75.1 (C3), 82.7 (C13), 86.2 (C6), 93.1 (CIO), 105.7 
(C17), 149.7 (C16), 170.0, 170.1 (2x-OCOCH3), 177.2 (C19).
MS (El) m/z 434 (M+, 58%), 392 (84), 356 (38), 344 (100), 314 (36), 299 (72), 257 
(58), 239 (91), 209 (59), 197 (72).
HRMS (El) m /z  calc'd for M+ C23H30O8: 434.1941; found: 434.1944.
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e/i*-3a,13-Diacetoxy-6a-hydroxy-7-methanesulfonyIoxy-20-norgibbereIl- 
16-ene-19-oic Acid 19, 10-Lactone (96)
To the starting diol (89) (61 mg, 0.142 mmol) in dry dichloromethane (10 ml) at 
-10°C, was added triethylamine (197 pi, 1.42 mmol), and methanesulfonyl chloride 
(44 pi, 0.566 mmol), and the resulting mixture was stirred under nitrogen for 3 h. Ice 
was added to the mixture which was then extracted with ethyl acetate (2x15 ml). The 
combined organic phases were washed with water (12 ml), and saturated brine (12 ml), 
then dried (sodium sulfate) and the solvent removed under reduced pressure. The residue 
w'as chromatographed on silica gel using ethyl acetate:hexane (1:1), to give a white solid 
(54 mg, 74%), which was recrystallised from ethyl acetate:hexane (1:10).
Rf 0.18 (ethyl acetate:hexane, 1:1). mp 169-171°C. IR (KBr disc) 1233, 1262, 1719, 
1740, 1776, 2955, 3422, 3513 cm-1.
m  NMR (300 MHz, CDC13): 6 1.30 (3H, s, H18), 1.58-2.16 (10H, m), 2.00, 2.14 
(2x3H, s, -OCOCH3), 2.30 (1H, br d, J = 15.1 Hz, H15ß), 2.67 (1H, dd, Jl = 10.0 
Hz, J2 = 2.2 Hz, H14), 2.91 (1H, br d, J = 15.5 Hz, H15a), 2.95 (1H, s, H5), 3.15 
(3H, s, 7-OSO2CH3), 4.10 (1H, d, J = 10.1 Hz, H7), 4.44 (1H, d, /  = 10.1 Hz, H'7), 
4.94 (1H, dd, J\ = 3.0 Hz, J2 = 2.7 Hz, H3), 4.97 (1H, br s, H17), 5.01 (1H, br s, 
H'17).
13C NMR (75 MHz, CDC13): 5 16.9 (C18), 17.5 (C ll), 21.1 (-OCOCH3), 22.0 
(-OCOCH3), 25.2 (C2), 27.2 (Cl), 36.7 (C12), 37.3 (C14), 37.7 (7-OS02CH3), 40.9 
(C15), 47.0 (C9), 51.8 (C8), 56.4 (C4), 62.3 (C5), 72.0 (C7), 75.1 (C3), 81.8 (C13), 
85.5 (C6), 93.0 (CIO), 106.0 (C17), 148.5 (C16), 169.5 (-OCOCH3), 170.0 
(-OCOCH3), 176.3 (C19).
MS (El) m/z 512 (M+, 16%), 470 (61), 417 (25), 374 (25), 356 (45), 343 (73), 279 
(31), 239 (41), 149 (100).
HRMS (El) m/z calc'd for M+ C24H32O10S: 512.1716; found: 512.1717. 
Microanalysis C24H32O10S requires: C 56.24, H 6.29; found: C 56.08, H 6.72.
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e/if-3a,13-Diacetoxy-6a,7-epoxy-20-norgibberell-16-en-19-oic Acid 
19,10-Lactone (97)
THF, 50°C, 5 days
The mesylate (96) (54 mg, 0.105 mmol) was dissolved in dry THF (2 ml), and 
added to a stirred suspension of lithium perchlorate (112 mg, 1.05 mmol) and calcium 
carbonate (105 mg, 1.05 mmol), (oven-dried) in THF (5 ml). The mixture was stirred 
under an atmosphere of nitrogen at 60°C for 5 days. The mixture was diluted with ethyl 
acetate (15 ml), and washed with water (5x10 ml), saturated brine (10 ml), dried (sodium 
sulfate) and the solvent removed under reduced pressure. The residue was 
chromatographed on silica gel using ethyl acetateihexane, (1:3) to give a high Rf spot by 
tic, which corresponded to the epoxide (97) (1 mg, 2.3%) and a lower Rf spot, the 
starting mesylate (35.5 mg, 66%).
Rf 0.64 (ethyl acetateihexane, 1:1). mp 76-78°C. IR (KBr disc) 1237, 1741, 1781, 
2933 cm-1.
!H NMR (300 MHz, CDC13): 5 1.18-2.42 (13H, m), 1.19 (3H, s, H18), 2.00, 2.09 
(2x3H, s, -OCOCH3), 2.73 (1H, d, J = 3.8 Hz, H7), 2.93 (1H, s, H5), 3.16 (1H, d, 
J = 3.7 Hz, H'7), 4.92 (1H, br s, H17), 5.02 (1H, br s, H3), 5.05 (1H, br s, HT7).
13C NMR (75 MHz, CDC13): 6 14.9 (C18), 17.3 (C ll), 21.0, 21.9 (2x-OCOCH3), 
25.2 (C2), 27.2 (Cl), 36.8 (C12), 38.9 (C14), 39.9 (C15), 47.4 (C7), 49.2 (C9), 48.5 
(C4), 51.9 (C8), 53.6 (C5), 65.5 (C6), 73.4 (C3), 84.8 (C13), 91.4 (CIO), 106.9 
(C17), 150.3 (C16), 169.9, 169.8 (2x-OCOCH3), 176.4 (C19).
MS (El) m/z 416 (M+, 59%), 374 (100), 356 (78), 314 (35), 238 (48), 252 (72), 239 
(57), 223 (66), 197 (51), 135 (55).
HRMS (El) m/z calc’d for M+ C23H280 7: 512.1716; found: 512.1717.
Microanalysis C23H280 7 requires: C 66.33, H 6.78; found: C 66.30, H 6.69.
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c/2f-3a,13-Diacetoxy-6a-hydroxy-7-oxo-20-norgibberelI-16-en-19-oic 
Acid 19,10-Lactone (102)
A solution of the diol (89), (56 mg, 0.129) in dichloromethane (5 ml) containing 
Dess-Martin reagent (71 mg, 0.168 mmol), was stirred at room temp overnight under an 
atmosphere of nitrogen. The solution was diluted with ethyl acetate (10 ml) and sodium 
thiosulfate (1 g) dissolved in saturated sodium bicarbonate (5 ml) was added to the 
mixture, which was stirred for a further 30 min. The organic phase was separated and 
washed with saturated sodium bicarbonate (8 ml), water (8 ml), and saturated brine 
(10 ml), then dried (sodium sulfate) and the solvent removed under reduced pressure. 
The residue was chromatographed on silica gel using ethyl acetate:hexane, (1:2) to give 
the aldehyde 102 as a white crystalline solid (51 mg, 91%), which was recrystallised 
from ether:hexane (1:10).
Rf 0.30 (ethyl acetate:hexane, 1:2). mp 145-147°C. IR (KBr disc) 1704, 1739, 1774, 
2959 cm*1.
!H NMR (300 MHz, CDC13): 8 1.07 (3H, s, H18), 1.61-2.38 (12H, m), 2.00, 2.12 
(2x3H, s, -OCOCH3), 2.63 (1H, m, H15a), 3.05 (1H, s, H5), 4.12 (1H, br s, 6-OH), 
4.94 (1H, br s, H17), 5.03 (1H, br s, H3), 5.14 (1H, br s, HT7), 9.67 (1H, s, 
7-CHO).
13C NMR (75 MHz, CDC13): 8 14.4 (C18), 17.1 (C ll), 20.9, 21.7 (2x-OCOCH3), 
24.9 (C2), 27.9 (Cl), 35.1 (C14), 36.1 (C12), 42.3 (C15), 50.7 (C4), 51.5 (C9), 54.4 
(C8), 61.3 (C5), 72.2 (C3), 84.8 (C13), 86.6 (C6), 91.4 (CIO), 107.6 (C17), 150.5 
(Cl6), 169.6, 169.8 (2x-OCOCH3), 176.9 (C19), 200.6 (C7).
MS (El) m/z 432 (M+, 6%), 390 (10), 360 (26), 272 (7), 255 (10), 231 (25), 172 
(100), 149 (53).
HRMS (El) m/z calc’d for M+ C23H280 8: 432.1784; found: 432.1776.
Microanalysis C23H280 8 requires: C 63.88, H 6.53; found: C 63.59, H 6.64.
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cnf-3a,13-D iacetoxy-6a-hydroxy-7-oxo-20-norkaur-16-en-19-oic Acid 
19,10-Lactone (103)
CHoCI.
(104) (<5%)
To the hydroxy aldehyde (102), (5 mg, 0.0116 mmol) in dry dichloromethane 
(1 ml), was added boron trifluoride etherate (1.9 (J.1, 0.0154 mmol), and the mixture was 
stirred at room temp for 30 min under an atmosphere of nitrogen. The mixture was 
diluted with ethyl acetate (5 ml) and washed with water (2 ml), and saturated brine 
(2 ml), then dried (sodium sulfate), and the solvent removed under reduced pressure to 
give the ketol 103 as a white solid (4.4 mg, 88%), with the 6,7-isomer 104 (<5%). 
Treatment of 102 (10 mg, 0.023 mmol) as above, but increasing the reaction time to 16 
h, yielded the norbeyerane derivative 105 (3.9 mg, 43%), 103 (4.8 mmol, 48%), and 
104 (<5%). Ketol 103 was recrystallised from dichloromethanerhexane (1:10)
Rf 0.20 (ethyl acetate:hexane, 1:2). mp 205-206.5°C. IR (KBr disc) 1209, 1246, 
1717, 1740, 1770, 3503 cm-1.
*H NMR (300 MHz, CDC13): 6 1.34 (3H, s, H18), 1.34-1.52 (1H, m, HI), 1.62-1.68 
(1H, m, H12), 1.78 (1H, d, /  = 8.5 Hz, H9), 1.89-2.22 (6H, m), 2.03, 2.10 (2x3H, s, 
-O CO CH 3), 2.44 (1H, m, H12ß), 2.48 (1H, m, H14), 2.56 (1H, dd, J { = 2 Hz, 
J2 = 10.0 Hz, H14), 2.61 (1H, d, /  = 10.0 Hz, H5), 2.30 (1H, dt, J l = 3.0 Hz, 
J2 = 17.0 Hz, H 15a), 3.62 (1H, d, J = 3.5 Hz, 6-OH), 4.19 (1H, dd, J\ = 3.5 Hz, 
J2 = 10.0 Hz, H6), 4.95 (1H, br s, H17), 4.98 (1H, br s, H3), 5.00 (1H, br s, HT7).
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13C NMR (75 MHz, CDC13): 8 15.8 (C18), 21.1 (Cl 1), 21.9 (2x-OCOCH3), 25.1 
(C2), 29.8 (Cl), 36.2 (C12), 37.3 (C15), 38.7 (C14), 46.4 (C9), 52.3 (C8), 53.4 (C4), 
57.1 (C5), 69.9 (C6), 71.4 (C3), 84.7 (C13), 85.3 (CIO), 105.1 (C17), 147.5 (C16), 
169.2 (-OCOCH3), 169.9 (-OCOCH3), 176.5 (C19), 209.3 (C7).
MS (El) m/z 432 (M+, 33%), 390 (63), 372 (45), 355 (33), 330 (25), 312 (29), 284 
(30), 268 (24), 239 (24), 167 (29), 149 (83).
HRMS (El) m/z calc'd for M+ C23H280 8: 432.1784; found: 432.1786.
Microanalysis C23H280 8 requires: C 63.88, H 6.53; found: C 63.58, H 6.39.
e/it-3a,13-Diacetoxy-7a-hydroxy-6-oxo-20-norkaur-16-ene-19-oic Acid 
19,10-Lactone (104)
Rf 0.10 (ethyl acetate:hexane, 1:2).
!H NMR (300 MHz, CDC13): 5 1.44 (3H, s, H18), 1.50-2.43 (12H, m), 1.95 (3H, s, 
-OCOCH3), 2.06 (3H, s, -OCOCH3), 2.16 (1H, s, H5), 2.43 (1H, m, H12ß), 3.59 
(1H, s, 7-OH), 3.86 (1H, s, H7), 4.79 (1H, br s, H3), 4.81 (1H, br s, H17), 4.89 (1H, 
br s, H'17).
13C NMR (75 MHz, CDC13): 8 15.2 (C18), 20.9, 21.9 (2x-OCOCH3), 24.9 (C ll), 
29.5 (C2), 30.2 (Cl), 37.2 (C12), 37.6 (C15), 38.8 (C14), 42.3 (C9), 49.2, 49.4 (C4, 
C8), 53.8 (C5), 73.1 (C3), 82.2, 85.9 (CIO, C13), 90.2 (C7), 104.2 (C17), 149.5 
(Cl6), 169.6 (-OCOCH3), 170.0 (-OCOCH3), 176.2 (C19), 208.8 (C6).
MS (El) m/z 432 (M+, 50%), 414 (6), 390 (100), 372 (76), 344 (16), 330 (43), 312 
(48), 284 (56), 239 (42), 211 (35), 178 (39), 149 (93).
HRMS (El) m/z calc’d for M+ C23H280 8: 432.1784; found: 432.1780.
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ewf-3a-Acetoxy-7,16-dioxo-6a-hydroxy-20-norbeyeran-19-oic Acid 
19,10-Lactone (105)
Rf 0.11 (ethyl acetate:hexane, 1:2). mp 91-92°C. IR (film) 1210, 1238, 1739, 1778, 
2933, 3467 cm-1.
!H NMR (300 MHz, CDC13): 5 1.10 (3H, s, H18), 1.35 (3H, s, H17), 1.20-2.21 
(11H, m), 2.11 (3H, s, 3-OCOCH3), 2.30 (1H, dd, J x = 2.8 Hz, J2 = 12.7 Hz, H14), 
2.67 (1H, d, J = 10.0 Hz, H5), 3.03 (1H, dd, J x = 3.6 Hz, J2 = 18.0 Hz, H15), 3.66 
(1H, d, J = 3.7 Hz, 6-OH), 4.06 (1H, dd, Jx = 3.6 Hz, J2 = 10.0 Hz, H6), 4.98 (1H, 
br s, H3).
13C NMR (75 MHz, CDC13): 6 16.0 (C18), 19.5 (C17), 20.4 (C ll), 21.0 
(3-OCOCH3), 24.9 (C2), 29.6 (Cl), 35.6, 43.4, 44.0 (C12, C14, C15), 48.2, 49.0 
(C8, C16), 48.2 (C9), 53.8 (C4), 57.1 (C5), 70.4 (C6), 71.4 (C3), 83.9 (CIO), 169.9 
(3-OCOCH3), 176.0 (C19), 210.4 (C7), 215.4 (C13).
MS (El) m/z 390 (M+, 100%), 372 (21), 348 (18), 330 (49), 284 (43), 256 (47), 199 
(29).
HRMS (El) m/z calc'd for M+ C21H26Q7: 390.1679; found: 390.1687._____________
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c/if-3a,13-diacetoxy-7-oxo-20-norgibberell-l,16-dien-19-oic Acid 19,10- 
Lactone (106)
To the starting alcohol (82) (44 mg, 0.105 mmol), in dry dichloromethane (3 ml) 
was added the Dess-Martin reagent (54 mg, 0.127 mmol) at room temp, and the mixture 
was stirred for 4 hrs under an atmosphere of nitrogen. The solution was diluted with 
ethyl acetate (10 ml) and sodium thiosulfate (1 g) dissolved in saturated sodium 
bicarbonate (5 ml) was added to the mixture, which was stirred for a further 30 min. The 
organic phase was separated and washed with saturated sodium bicarbonate (8 ml), water 
(8 ml), and saturated brine (10 ml), then dried (sodium sulfate) and the solvent removed 
under reduced pressure. The residue was chromatographed on silica gel using ethyl 
acetate:hexane, (1:2) to give the aldehyde 106 as a white crystalline solid (40 mg, 91%), 
which was recrystallised from ethenhexane (1:10).
Rf 0.33 (ethyl acetate:hexane, 1:2). mp 158-159°C. IR (film) 1239, 1259, 1727, 
1743, 1775 cm-1.
JH NMR (300 MHz, CDC13): 6 1.09 (3H, s, H18), 1.17-2.40 (8H, m), 2.01, 2.12 
(2x3H, s, 3-OCOCH3, I3-OCOCH3), 2.53 (1H, m, H15a), 2.81(1H, dd, / 5,6 = 11.0 
Hz, J6J = 2.0 Hz, H6), 3.29 (1H, d, J = 11.0 Hz, H5), 5.00 (1H, br s, H17), 5.15 
(1H, br s, HT7), 5.32 (1H, d, J = 4.0 Hz, H3), 5.87 (1H, dd, J2,3 = 4Hz, J2,1 = 9.0 
Hz, H2), 6.36 (1H, d, J = 9.0 Hz, HI), 9.84 (1H, d, J = 2.0 Hz, H7).
13C NMR (75 MHz, CDC13): 6 14.7 (C18), 16.4 (C ll), 20.7, 21.9 (3-OCOCH3, 
I3-OCOCH3), 36.2 (C12), 40.4, 41.6 (C14, C15), 50.6, 50.9, 51.1 (C5, C6, C9),
51.9 (C8), 55.9 (C4), 70.0 (C3), 83.3 (C13), 89.7 (CIO), 108.3 (C17), 129.1 (Cl),
133.9 (C2), 152.6 (C16), 169.7, 169.8 (3-OCOCH3, 13-OCOCH3), 176.7 (C19), 
199.6 (C7).
MS (El) m/z 414 (M+, 11%), 372 (32), 354 (12), 312 (12), 281 (48), 267 (24), 250 
(28), 239 (47), 221 (100), 192 (35), 132 (37).
HRMS (El) m/z calc’d for M+ C23H260 7: 414.1679; found: 414.1680.
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e«f-3a-Acetoxy-10ß,16ß,17-trihydroxy-20-norgibberellan-19-oic Acid
19,10-Lactone Methyl Ester (109)
To a solution of the olefin (108) (100 mg, 0.257 mmol) in acetone/water (8/1 
ml), was added N-methyl morpholine-/V-oxide (151 mg, 1.29 mmol), and osmium 
tetroxide (catalytic) dissolved in r-butyl alcohol (100 pi), and the mixture was stirred at 
room temperature over night. Sodium bisulfite (15 mg) was added to the mixture which 
was diluted with water (6 ml) and stirred for a further 30 min. The mixture was extracted 
with ethyl acetate (2x15 ml), and the combined organic phases were washed with water 
(20 ml), and saturated brine (20 ml), then dried (sodium sulfate) and the solvent removed 
under reduced pressure. The residue was chromatographed on silica gel using ethyl 
acetate:hexane (2:1), to give the diol (109), (108 mg, quant) as a white solid, which was 
recrystallised from ether.hexane.
RfO.10 (ethyl acetate-.hexane, 2:1). mp 188-189°C. IR (KBr disc) 1053, 1232, 1734, 
1742, 2957, 3438, 2955, 3527 cm-1.
*H NMR (300 MHz, CDC13): 5 1.04 (3H, s, H18), 1.36-2.15 (14H, m), 2.13 (3H, s, 
3-OCOCH3), 2.71 (1H, d, J = 10.6 Hz, H5), 3.00 (1H, d, J = 10.7 Hz, H6), 3.57-3.79 
(2H, m, H17), 3.74 (3H, s, 7-C02CH3), 4.95 (1H, t, Jx = 3.4 Hz, J2 = 2.1 Hz, H3).
13C NMR (75 MHz, CDC13): 6 14.2 (C18), 15.9 (C ll), 20.9 (3-OCOCH3), 21.3, 
35.2 (C12, C14), 25.2 (C2), 27.2 (Cl), 42.9 (C13), 49.7 (C15), 51.6 (C6), 51.7 (C8), 
51.9 (7-CO2CH3), 52.2 (C5), 52.9 (C4), 54.8 (C9), 66.7 (C17), 71.2 (C3), 82.8 
(Cl6), 93.5 (CIO), 170.0 (3-OCOCH3), 172.9 (C7), 176.8 (C19).
MS (El) mJz 422 (M+, 1%), 404 (3), 391 (100), 362 (17), 331 (42), 300 (97), 287 
(82), 258 (18), 244 (63), 227 (51), 199 (28), 183 (38).
HRMS (El) m/z calc'd for M+ C22H3o08: 422.1941; found: 422.1935.
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e/f*-3a-Acetoxy-10ß,16ß-dihydroxy-17-oxo-20-norgibberellan-19-oic acid 
19,10-Lactone Methyl Ester (110)
+
A solution of the diol (109), (108 mg, 0..256) in dichloromethane (8 ml) 
containing Dess-Martin reagent (142 mg, 0.335 mmol), was stirred at room temp 
overnight under an atmosphere of nitrogen. The solution was diluted with ethyl acetate 
(20 ml), and sodium thiosulfate (2 g) dissolved in saturated sodium bicarbonate (10 ml) 
was added to the mixture, which was stirred for a further 30 min. The organic phase was 
separated and washed with saturated sodium bicarbonate (20 ml), water (20 ml), and 
saturated brine (20 ml), then dried (sodium sulfate), and the solvent removed under 
reduced pressure. The residue was chromatographed on silica gel using ethyl 
acetate:hexane, (1:3, 1:2, 1:1) to give the aldehyde (110) as a white crystalline solid 
(32.9 mg, 30%), and the 16-norketone (21 mg, 22 %).
Rf 0.33 (ethyl acetate:hexane, 1:1). mp 180-183°C. IR (KBr disc) 1226, 1739, 1755, 
2952, 3468 cm*1.
*H NMR (300 MHz, CDC13): 5 1.07 (3H, s, H18), 1.37-2.33 (14H, m), 2.15 (3H, s, 
3-OCOCH3), 2.77 (1H, d, J = 10.5 Hz, H5), 3.08 (1H, br s, 16-OH), 3.16 (1H, d, 
J = 10.5 Hz, H6), 3.75 (3H, s, 7-C02CH3), 4.98 (1H, br s, H3), 9.80 (1H, s, H17).
13C NMR (75 MHz, CDC13): 6 14.3 (C18), 15.9 (C ll) , 20.9 (C12), 21.0 
(3-OCOCH3), 25.2 (C2), 27.2 (Cl), 36.2 (C14), 46.0 (C13), 47.9 (C15), 51.8 (C6), 
52.1 (C5), 52.1 (7-C02CH3), 52.8, (C4, C8), 54.4 (C9), 71.3 (C3), 86.2 (C16), 93.4 
(CIO), 170.1 (3-OCOCH3), 172.9 (Cl), 176.7 (C19), 203.3 (C17).
MS (El) m/z 420 (M+, 24%), 391 (93), 360 (32), 331 (44), 316 (72), 287 (100), 256 
(43), 244 (90), 199 (45), 183 (66).
HRMS (El) m/z calc’d for M+ C22H280 8: 420.1784; found: 420.1788.
Microanalysis C22H280 8 requires: C 62.85, H 6.71; found: C 62.47, H 6.84.
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e/if-3oc-Acetoxy- 10ß, 16a-dihydroxy-16a-oxo-D-homo-17,20- 
dinorgibbereIlan-19-oic acid 19,10-Lactone Methyl Ester (112)
To the hydroxy aldehyde (110), (10 mg, 0.0238 mmol) in dry dichloromethane 
(1 ml), was added boron trifluoride etherate (3.9 pi, 0.0316 mmol), and the mixture was 
stirred at room temp for 30 min under an atmosphere of nitrogen. The mixture was 
diluted with ethyl acetate (5 ml) and washed with water (2x2 ml), and saturated brine 
(2 ml), then dried (sodium sulfate), and the solvent removed under reduced pressure to 
give a 1:1 mixture of ketols, 112 and 113 (10.5 mg crude), which would not separate 
cleanly by chromatography.
Rf 0.23 (ethyl acetate‘.hexane, 1:1).
(112) *H NMR (300 MHz, CDC13): 6 1.04 (3H, s, H18), 1.60-2.11 (13H, m), 2.12 
(3H, s, 3-OCOCH3), 2.42 (1H, d, /  = 10.1 Hz, H5), 2.56 (1H, m, H15), 3.10 (1H, d, 
J = 10.0 Hz, H6), 3.72 (3H, s, 7-C02CH3), 4.10 (1H, dd, Jx = 9.7 Hz, J2 = 2.7 Hz, 
H17), 4.96 (1H, br d, J = 1.7 Hz, H3).
c/if-3a-Acetoxy-10ß,16ß-dihydroxy-16a-oxo-Z)-homo-17,20- 
dinorgibberellan-19-oic acid 19,10-Lactone Methyl Ester (113)
(113) !H NMR (300 MHz, CDC13): 5 1.03 (3H, s, H18), 1.38-2.35 (13H, m), 2.16 
(3H, s, 3-OCOCH3), 2.52 (1H, d, J = 11.4 Hz, H5), 2.92 (1H, m, H15), 3.20 (1H, d, 
J = 11.2 Hz, H6), 3.70 (3H, s, 7-C02CH3), 4.47 (1H, = 11.3 Hz, J2 = 3.8 Hz,
H17), 4.99 (1H, br s, H3).
MS (El) m/z 420 (M+, 8%), 418 (10), 402 (29), 360 (24), 332 (26), 314 (32), 288 
(61), 270 (34), 244 (100), 228 (40), 183 (41).
HRMS (El) m/z calc'd for M+ C22H280 8: 420.1784; found: 420.1787.
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9.6 Experimental for Chapter 8
e/i/-20-Hydroxy-13-methoxymethoxy-gibberell-16-ene-7,19-dioic Acid 
19,20-Lactone Methyl Ester (126)
NaBH4, DME 
0° C - h 1
C 0 2Me
To the starting aldehyde (125) (250 mg, 0.595 mmol) in dry, distilled dimethoxy 
ethane (25 ml) at 0°C under nitrogen, was added sodium borohydride (68 mg, 1.78 
mmol). The mixture was stirred at 0°C and allowed to warm slowly to room temp over 4 
h. Acetic acid (5 ml) was added and the mixture was stirred for a further 20 min, then 
diluted with ethyl acetate (35 ml). The mixture was washed with saturated sodium 
bicarbonate (4x30 ml), and saturated brine (1x30 ml), then dried (sodium sulfate). The 
solvent was removed under reduced pressure to give the crude lactone. Purification was 
carried out by silica gel chromatography using ethyl acetateihexane (1:3), as eluting 
solvent to give pure lactone 126, as a white crystalline compound (211 mg, 88%), which 
was recrystallised from ethyl acetate:hexane.
Rf0.39 (ethyl acetateihexane, 1:2). mp 153-154°C. IR (KBr disc) 1039, 1149, 1731 
cm_1.
NMR (300 MHz, CDC13): 6 1.12 (3H, s, H18), 1.19-2.25 (16H, m), 2.77 (1H, d, 
J = 12.6 Hz, H6), 3.37 (3H, s, 13-OCH2OCH3), 3.70 (3H, s, 7-C02CH3), 4.09 (1H, 
dd, 7gem = 12.3 Hz, 47 = 2.3 Hz, 20-pro-S-H), 4.40 (1H, d, Jgtm = 12.3 Hz, 20-pro-R- 
H), 4.54, 4.73 (2xlH, ABd, J = 7.1 Hz, B-OCHhOCH^, 4.97 (1H, d, J = 3.0 Hz, 
H17), 5.10 (1H, d, J = 3.0 Hz, HT7).
13C NMR (75 MHz, CDC13): 8 16.3 (C ll), 20.4 (C2), 22.9 (C18), 37.7 (Cl), 38.0 
(C3), 39.5 (C14), 40.3 (C12), 41.2 (CIO), 42.3 (C4), 45.1 (C15), 47.1 (C8), 51.6 
(C6), 51.7 (7-C02CH3), 52.8 (C5), 55.0 (C9), 55.1 (13-OCH2OCH3), 74.0 (C20), 
93.4 (C13), 91.7 (13-OCH2OCH3), 107.2 (C17), 153.1 (C16), 173.0, 174.9 (C7, 
C19).
MS (El) m/z 404 (M+, 100%), 389 (80), 373 (34), 359 (22), 344 (54), 331 (80), 313 
(34), 299 (62), 285 (80), 271 (72), 255 (42), 243 (44), 225 (50), 211 (72), 179 (76). 
HRMS (El) m/z calc'd for M+ C23H320 6: 404.2199; found: 404.2211.
Microanalysis C23H32C>6 requires: C 68.29, H 7.97; found: C 68.31, H 8.25.
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cnf-13,20-Dihydroxy-gibbereIl-16-ene-7,19-dioic Acid 19,20-Lactone 
Methyl Ester (127)
Dowex
MeOH/H20
reflux, 3 hrs
.....OH
To MOM ether 126 (73 mg, 0.180 mmol) in methanol (30 ml) and water (6 ml) 
was added Dowex 50W resin (75 mg) and the mixture was stirred at reflux for 3 h. The 
mixture was filtered to remove the resin and the solvent was removed under reduced 
pressure. The residue was taken up in ethyl acetate (15 ml) and washed with saturated 
brine (10 ml), then dried (sodium sulfate) and the solvent removed under reduced 
pressure to give the free alcohol (127), which was purified by silica gel chromatography 
using ethyl acetateihexane (1:1) as the eluting solvent to give pure 127 (48 mg, 74%).
Data previously reported168.
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e/if-20-Hydroxy-13-methyloxalyloxy-gibberell-16-ene-7,19-dioic Acid 
19,20-Lactone Methyl Ester (128)
o
methyl oxalyl chloride 
i-Pr2NEt, DMAP
.....OH
CHoCI-
To the alcohol (127), (154 mg, 0.427 mmol) in dry dichloromethane (15 ml), 
was added diisopropylethylamine (447 pi, 2.56 mmol), dimethylaminopyridine 
(catalytic), and methyloxalyl chloride (236 jil, 2.56 mmol). The mixture was stirred at 
room temp under an atmosphere of nitrogen overnight. The mixture was diluted with 
ethyl acetate (30 ml), and washed with saturated sodium bicarbonate (25 ml) and 
saturated brine (25 ml). The aqueous washings were then extracted with ethyl acetate (15 
ml), the combined organic phases were dried (sodium sulfate), and the solvent removed 
under reduced pressure. The residue was chromatographed on silica gel using ethyl 
acetate:hexane (1:2), to give 128 as a white crystalline solid, (171 mg, 90%), which was 
recrystallised from dichloromethane:hexane.
Rf 0.27 (ethyl acetate:hexane, 1:2). mp 195-197°C. IR (KBr disc) 1162, 1206, 
1724, 1747, 2938 cm-1.
*H NMR (300 MHz, CDCI3): 8 1.12 (3H, s, H18), 1.22-2.47 (16H, m), 2.78 (1H, d, 
J = 12.6 Hz, H6), 3.69 (3H, s, 7-C02CH3), 3.87 (3H, s, 13-0(C0)20CH3), 4.10 (1H, 
d, 7gem = 12.5 Hz, AJ = 2.4 Hz, 20-pro-S-H), 4.39 (1H, d, 7gem = 12.2 Hz, 20-pro-R- 
H), 5.02 (1H, br s, H17), 5.23 (1H, br s, HT7).
13C NMR (75 MHz, CDC13): 8 16.6 (C ll), 20.5 (C2), 23.1 (C18), 35.8 (Cl), 38.2 
(C3), 39.4 (C14), 39.6 (C12), 41.4 (CIO), 42.5 (C4), 43.8 (C15), 48.3 (C8), 51.4 
(C6), 51.9 (7-C02CH3), 52.8 (C5), 53.4 (13-0(C0)20C H 3), 54.9 (C9), 73.9 (C20), 
87.4 (C13), 108.6 (C17), 151.5 (C16), 156.2, 158.1 (2x-0(C0)20CH3), 172.8, (C7), 
174.8 (C19).
MS (El) m/z 446 (M+, 100%), 415 (17), 400 (10), 386 (36), 341 (50), 310 (31), 282 
(74), 237 (81).
HRMS (El) m/z calc'd for M+ C24H30O8: 446.1941; found: 446.1944.
Microanalysis C24H3oOg requires: C 64.56, H 6.77; found: C 64.67, H 7.05.
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enf-20-Hydroxy-gibberelI-16-ene-7,19-dioic Acid 19,20-Lactone Methyl 
Ester (129)
To the oxalate (128), (170 mg, 0.381 mmol), at reflux in dry, degassed toluene 
(20 ml), was added tri-n-butyltin hydride (154 jil, 0.571 mmol) followed by AIBN 
(catalytic), and the mixture stirred at reflux under nitrogen for 3 h. The solvent was 
removed under reduced pressure and the residue was chromatographed on silica using 
hexane at first, and then ethyl acetate:hexane, (1:4) to give the 13-deoxy product as a 
white solid (115 mg, 88%), and some recovered starting oxalate (21 mg, 12%). 129 
was recrystallised from ethyl acetate:hexane (1:10).
Rf 0.74 (ethyl acetate:hexane, 1:1). mp 198°C (lit.171 198-200°C). IR (KBr disc) 
1727, 2935 cm’1.
lR NMR (300 MHz, CDC13): 5 0.97-2.12 (15H, m), 1.12 (3H, s, H18), 2.15 (1H, d, 
J = 12.9 Hz, H5), 2.62 (1H, m, H13), 2.75 (1H, d, J = 12.6 Hz, H6), 3.67 (3H, s, 7- 
C 02CH3), 4.07 (1H, d, Jgem = 12.2 Hz, 47 = 2.4 Hz, 20-pro-S-H), 4.39 (1H, d, 7gem 
= 12.2 Hz, 20-pro-R-H), 4.79 (1H, br s, H17), 4.92 (1H, br s, HT7).
13C NMR (75 MHz, CDC13): 5 15.8 (C ll), 20.6 (C2), 23.2 (C18), 31.3 (C12), 36.3 
(Cl), 38.2 (C3), 39.2 (C13), 39.8 (C14), 41.7 (CIO), 42.5 (C4), 46.0 (C15), 49.6 
(C8), 51.7 (7-CO2CH3), 51.9 (C6), 52.4 (C5), 55.6 (C9), 74.3 (C20), 106.5 (C17), 
156.6 (Cl6), 173.5, (C7), 175.2 (C19).
MS (El) m/z 344 (M+, 4%), 312 (28), 298 (20), 284 (71), 239 (100), 195 (29), 155 
(15), 129 (15).
HRMS (El) m/z calc'd for M+ C21H28O4: 344.1988; found: 344.1986.
Microanalysis C21H28O4 requires: C 73.23, H 8.19; found: C 72.91, H 8.50.
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cw/-20-Hydroxy-16-oxo-17-norgibberellane-7,19-dioic Acid 19,20- 
Lactone Methyl Ester (131)
C 02Me
i) 0 3, CH2CI2/MeOH
ii) Et3N, CH2CI2
(131)
Ozone was bubbled through a solution of the alkene (129), (70 mg, 0.203 mmol) 
in dichloromethane/methanol (9/3 ml) at -78°C for 40 sec. Tic indicated that no starting 
material remained and so the solvent was removed by bubbling nitrogen through the 
solution. The residue was taken up in dichloromethane (12 ml), and triethylamine (113 
ml, 0.813) was added. The mixture was stirred for 20 h at room temp. The solvent was 
removed under reduced pressure and the residue was chromatographed on silica gel using 
ethyl acetate:hexane (1:2, 1:1), to give the norketone (131) as a white solid (55 mg, 
78%), which was recrystallised from ethyl acetate:hexane (1:10).
Rf 0.35 (ethyl acetate:hexane, 1:1). mp 175-176°C (lit.171 238-240°C). IR (KBr 
disc) 1727, 2933 cm '1.
JH NMR (300 MHz, CDCI3): 8 1.12 (3H, s, H18), 1.20-2.20 (15H, m), 2.14 (1H, d, 
J = 12.7 Hz, H5), 2.42 (1H, m, H13), 2.79 (1H, d, J = 12.8 Hz, H6), 3.69 (3H, s, 7- 
CO2CH3), 4.12 (1H, d, 7gem = 11.9 Hz, 47 = 2.1 Hz, 20-pro-S-H), 4.43 (1H, d, 7gem = 
12.2 Hz, 20-pro-R-H).
13C NMR (75 MHz, CDC13): 8 16.6 (C ll) , 20.4 (C2), 23.0 (C18), 24.3 (C12), 34.0 
(C l), 38.1 (C3), 39.6 (C14), 41.8 (CIO), 42.4 (C4), 44.6 (C13), 48.2 (C8), 51.9 (C15, 
7-CO2CH3 overlapped), 52.5 (C5), 52.8 (C6), 55.9 (C9), 73.8 (C20), 172.9, (C7), 
174.7 (C l9), 219.6 (C16).
MS (El) m/z 346 (M+, 100%), 318 (78), 300 (13), 286 (58), 273 (37), 258 (41), 241 
(52), 227 (33), 213 (43), 201 (52), 187 (54), 145 (49).
HRMS (El) m/z calc'd for M+ C20H26O5: 346.1780; found: 346.1787.
M icroanalysis C20H26O5 requires: C 69.34, H 7.56; found: C 68.90, H 7.50.
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cnf-20-Hydroxy-16-oxo-17-norgibberellane-7,19-dioic Acid 19,20- 
Lactone (132)
(131) (132)
A solution of the methyl ester (131), (102 mg, 0.294 mmol) in methanol (450 pi) 
was treated with 2M sodium hydroxide (5.6 ml) and heated at reflux for 7 h. The solvent 
was removed under reduced pressure and the residue was taken up in methanol (80 ml). 
The mixture was then acidified with Dowex 50 W H+ resin to pH 3-4, with cooling. The 
resin was filtered off and the solvent was removed under reduced pressure to give acid 
132 as a white solid, (92 mg, 94 %), which was recrystallised from ethanol-ether- 
heptane.
Rf 0.13 (ethyl acetate:hexane:methanol:acetic acid, 100:100:1:1). mp 264°C. IR (KBr 
disc) 1158, 1704, 1739 cn r1.
*H NMR (300 MHz, CDC13): 6 1.20 (3H, s, H18), 1.21-2.27 (15H, m), 2.12 (1H, d, 
J = 12.8 Hz, H5), 2.48 (1H, m, H13), 2.83 (1H, d, J = 12.8 Hz, H6), 4.15 (1H, d, 
Jgem = 12.2 Hz, 4J  = 2.1 Hz, 20-pro-S-H), 4.45 (1H, d, ygem = 12.2 Hz, 20-pro-R-H).
13C NMR (75 MHz, CDC13): 6 16.6 (C ll), 20.4 (C2), 23.0 (C18), 24.3 (C12), 34.0 
(Cl), 38.1 (C3), 39.7 (C14), 41.9 (CIO), 42.5 (C4), 44.7 (C13), 48.2 (C8), 51.9 
(C15), 52.4 (C5), 52.6 (C6), 55.9 (C9), 73.9 (C20), 175.1 (C19), 176.5 (C7), 220.4 
(C16).
MS (El) m/z 332 (M+, 100%), 314 (6), 304 (43), 286 (87), 273 (26), 258 (43), 245 
(38), 229 (17), 215 (18), 201 (35), 187 (25), 159 (22), 145 (29).
HRMS (El) m/z calc’d for M+ Q9H24O5: 332.1624; found: 332.1628.
155
ewf-7-ChIoro-20-hydroxy-7,16-dioxo-17-norgibberelIane-7,19-dioic Acid 
19,20-Lactone (133)
The starting acid 132 (100 mg, 0.301 mmol) was dissolved in dry THF (2 ml) 
and pyridine (365 jj.1, 4.51 mmol) was added. To a two-necked flask containing oxalyl 
chloride (262 jllI ,  3.01 mmol) in dry THF (5 ml) at -40°C under nitrogen, was added via 
cannular the above mixture. The solution was allowed to warm to room temperature, and 
after 5 h no starting material remained. The reaction mixture was filtered through a 
sintered funnel and washed into a dry flask with dry benzene. Residual oxalyl chloride 
was removed by azeotroping with benzene (4x10 ml) and the residue was filtered through 
a plug of celite into a dry flask. The solvent was removed under reduced pressure to give 
the acid chloride (133) (-100%) as a yellow oil.
JH NMR (300 MHz, CDC13): 8 1.21 (3H, s, H18), 1.28-2.31 (15H, m), 2.04 (1H, d, 
J  = 12.1 Hz, H5), 2.51 (1H, m, H13), 3.32 (1H, d, J = 12.1 Hz, H6), 4.16 (1H, d, 
/gem = 11.8 Hz, 47 = 2.1 Hz, 20-pro-S-H), 4.42 (1H, d, 7gem = 12.1 Hz, 20-pro-R-H).
13C NMR (75 MHz, CDC13): 8 16.7 (C ll) , 20.3 (C2), 24.0 (C18), 24.3 (C12), 33.9 
(C l), 38.0 (C3), 39.5 (C14), 41.6 (CIO), 42.5 (C4), 44.6 (C13), 48.9 (C8), 51.1 
(C15), 53.6 (C5), 56.4 (C9), 64.4 (C6), 73.4 (C20), 174.0 (C7), 174.2 (C19), 217.9 
(C16).
MS (El) m/z 350 (M+, 100%), 332 (3), 315 (69), 286 (79), 273 (48), 259 (53), 243 
(53), 229 (47), 213 (23), 199 (38), 187 (40), 159 (27).
HRMS (El) m/z calc'd for M+ C19H23O4CI: 350.1285; found: 350.1287.
156
cnf-7,16a,20-Trihydroxy-17-norgibberellan-19-oic Acid 19,20-Lactone 
(134)
(133) (134)
To the above acid chloride (133) (0.301 mmol) in dry, distilled dimethoxyethane 
(6 ml) at 0°C under nitrogen, was added sodium borohydride (57 mg, 1.51 mmol). The 
mixture was stirred at 0°C and allowed to warm slowly to room temp overnight. Acetic 
acid (20 drops) was added and the mixture was stirred for a further 20 minutes, then 
diluted with ethyl acetate (15 ml). The mixture was washed with saturated sodium 
bicarbonate (4x8 ml), and saturated brine (10 ml), then dried over sodium sulfate. The 
solvent was removed under reduced pressure to give the crude alcohol. Purification was 
carried out by silica gel chromatography using ethyl acetate:hexane, 1:1 as eluting solvent 
to give pure alcohol 134, as a white crystalline compound (80 mg, 82%), which was 
recrystallised from ethyl acetate:hexane (1:10).
Rf0.21 (ethyl acetate:hexane:methanol:acetic acid, 66:33:1:1). mp 249°C. IR (KBr 
disc) 1159, 1724, 1738, 2937, 3412, 3521 cm-1.
*H NMR (300 MHz, CDC13): 8 0.88-1.81 (15H, m), 1.26 (3H, s, H18), 1.94 (1H, d, 
J = 11.6 Hz, H5), 2.18 (1H, m, H13), 2.37 (1H, dd, Jx = 11.6 Hz, J2 = 12.3 Hz, H6), 
3.16 (1H, br s, 7-OH), 3.69 (1H, m, H7), 3.84 (1H, m, H7), 3.98 (1H, d, / gem = 12.0 
Hz, 47 = 2.2 Hz, 20-pro-S-H), 4.17 (1H, td, / 15_16 = 6.5 Hz, 6.8 Hz, Jl3. l6 = 4.0 Hz, 
H16), 4.40 (1H, d, 7gem = 12.0 Hz, 20-pro-R-H).
13C NMR (75 MHz, CDC13): 8 14.9 (C ll), 17.4 (2), 20.4 (C12), 23.8 (C18), 35.7 
(Cl), 36.6 (C13), 38.4 (C3), 40.9 (C14), 41.4 (CIO), 42.6 (C4), 44.5 (C15), 48.7 
(C8), 49.1 (C5), 50.9 (C6), 58.9 (C9), 61.0 (C7), 72.0 (C16), 74.9 (C20), 177.1 
(C19).
MS (El) m/z 320 (M+, 4%), 32 (16), 284 (100), 272 (8), 257 (19), 244 (36), 225 (37), 
213 (37), 199 (24), 185 (16), 143 (22).
HRMS (El) m/z calc'd for M+ Q9H28O4: 320.1988; found: 320.1986.
Microanalysis Q9H28O4 requires: C 71.22, H 8.81; found: C 70.84, H 8.66.
157
^w/-16a,20-Dihydroxy-7-(2’-nitrobenzeneselenenyl)-17-norgibberellan- 
19-oic Acid 19,20-Lactone (135)
o-N02C6H4SeCN 
n-Bu3P
THF, rt
(134)
To the diol (134) (150 mg, 0.462 mmol) in THF (20 ml), was added 
o-nitrophenyl seleno-cyanate (1.05 g, 4.62 mmol), followed by the dropwise addition of 
/i-tributylphosphine (1.15* ml, 4.62 mmol) under an atmosphere of nitrogen at room 
temp. The resulting mixture was stirred for 1 h, after which, the solvent was removed 
under reduced pressure and the residue was chromatographed on silica gel (ethyl 
acetate:hexane:methanol:acetic acid, 100:100:1:1) to give the o-nitrophenyl selenide (135) 
(210 mg, 90%) as dark orange crystals.
Rf 0.43 (ethyl acetate:hexane:methanol:acetic acid, 66:33:1:1). mp 197-199°C. IR 
(KBr disc) 1019, 1037, 1090, 1717, 2872, 2914, 2928, 2961 cm*1.
NMR (300 MHz, CDC13): 6 0.87-2.03 (15H, m), 1.42 (3H, s, H18), 2.23 (2xlH, 
m, H5, H6 overlapped), 2.47 (1H, dd, Jgem = 13.5 Hz, 7VIC = 7.7 Hz, H15ß), 2.83 
(1H, m, H7), 3.50 (1H, m, H'7), 4.02 (1H, d, 7gem = 12.1 Hz, 20-pro-S-H), 4.30 (1H, 
m, H16), 4.42 (1H, d, 7gem = 12.1 Hz, 20-pro-R-H), 7.31 (1H, dd, J x = 7.0 Hz, J2 = 
8.3 Hz, H'4), 7.42 (1H, d, J = 7.0 Hz, H’6), 7.54 (1H, dd, Jx = 6.8 Hz, J2 = 8.3 Hz, 
H'5), 8.26 (1H, d, J = 6.9 Hz, H’3).
13C NMR (75 MHz, CDC13): 5 15.1 (C ll), 17.3 (2), 20.4 (C12), 25.3 (C18), 28.8 
(C7), 36.8 (Cl), 37.1 (C13), 38.8 (C3), 41.5 (C14), 41.9 (CIO), 43.0 (C4), 44.4 
(C15), 46.3 (C5), 49.5 (C8), 56.4 (C9), 59.5 (C6), 72.0 (C16), 74.4 (C20), 125.5 
(C'4), 126.3 (C3), 128.9 (C6), 133.1 (C l), 133.8 (C5), 146.7 (C2), 175.6 (C19).
MS (El) m/z 505 (M+, 80Se, 91%), 503 (M+, 78Se, 54%), 488 (43), 486 (22), 429 (8), 
382 (2), 303 (13), 285 (28), 257 (51), 227 (37).
HRMS (El) m/z calc’d for M+ C25H3iO580SeN: 505.1367; found: 505.1386.
Microanalysis C25H3i0 5 SeN requires: C 59.52, H 6.19, N 2.78; found: C 59.32, H 
6.11, N 2.70.
(135) Se
158
ent-16a,20-Dihydroxy-17-norgibberelI-6-en-19-oic Acid 19,20-Lactone 
(136)
A solution of the selenide (135) (210 mg, 0.417 mmol) in THF (40 ml) 
containing 30% hydrogen peroxide (473 p.1, 4.17 mmol), was stirred at 0°C for 1.5 h, 
and then allowed to warm to room temp over 10.5 h. The solvent was removed under 
reduced pressure and the residue was chromatographed on silica gel using ethyl 
acetate:hexane (1:2), to give the olefin as a clear oil (98 mg, 78%). The olefin was 
recrystallised from dichloromethane/hexane to give a white crystalline solid.
Rf 0.31 (ethyl acetate:hexane, 1:1). mp 161°C. IR (KBr disc) 1158, 1166, 1702, 
2920, 2939, 3480 cm'1.
1H NMR (300 MHz, CDC13): Ö 0.87 (1H, m, HI), 1.21-2.04 (14H, m), 1.41 (3H, s, 
H18), 2.18 (1H, s, H5), 2.37 (1H, m, H13), 3.92 (1H, d, 7gem = 11.7 Hz, 20-pro-S- 
H), 4.19 (1H, d, Jgem = 11.5 Hz, 20-pro-R-H), 4.35 (1H, m, H16), 4.91 (1H, d, J = 
2.7 Hz, H7), 5.03 (1H, d, J = 2.7 Hz, H7).
13C NMR (75 MHz, CDC13): 5 15.2 (C ll), 17.8 (2), 20.3 (C12), 23.0 (C18), 33.5 
(Cl), 37.2 (C3), 37.4 (C13), 40.5 (C14), 53.3 (C15), 41.5, 41.8 (C4, CIO), 49.3 (C8), 
55.2 (C9), 57.0 (C5), 72.3 (C16), 74.6 (C20), 104.4 (7), 156.0 (C6), 175.9 (C19).
MS (El) m/z 302 (M+, 55%), 284 (36), 260 (16), 244 (100), 226 (30), 212 (23), 199 
(34), 186 (35), 152 (34).
HRMS (El) m/z calc'd for M+ C i9H2603: 302.1882; found: 302.1883.
159
cwf-20-Hydroxy- 16-oxo- 17-norgibberell-6-en-19-oic Acid 19,20-Lactone 
(137)
Dess-Martin
periodinane
CH2CI2, rt
(136) (137)
A solution of the alcohol (136), (68 mg, 0.225) in dichloromethane (10 ml) with 
Dess-Martin reagent (143 mg, 0.338 mmol), was stirred for 3 h under an atmosphere of 
nitrogen. The solution was diluted with ethyl acetate (20 ml), and sodium thiosulfate (1 
g) dissolved in saturated sodium bicarbonate (5 ml) was added to the mixture, which was 
stirred for another 30 min. The organic phase was separated and washed with saturated 
sodium bicarbonate (15 ml), water (15 ml), and saturated brine (15 ml), then dried 
(sodium sulfate) and the solvent removed under reduced pressure. The residue was 
chromatographed on silica gel using ethyl acetate:hexane (1:1), to give the norketone 
(137) as a white crystalline solid (60 mg, 89%), which was recrystallised from ethyl 
acetate:hexane (1:10).
Rf 0.27 (ethyl acetate:hexane, 1:1). mp at 165°C reformed very fine needles which then 
melted at 192-194°C. IR (KBr disc) 1148, 1725, 1737, 2939 cm'1.
*H NMR (300 MHz, CDC13): 5l.07-2.30 (13H, m), 1.44 (3H, s, H18), 2.10 (1H, d, 
J = 17.5 Hz, H15), 2.20 (1H, s, H5), 2.27 (1H, dd, Jx = 17.5 Hz, J2 = 3.4 Hz, HT5), 
2.48 (1H, dd, J = 10.5 Hz, H13), 3.98 (1H, d, / gem = 11.5 Hz, 20-pro-S-H), 4.25 
(1H, d, /gem = 11.6 Hz, 20-pro-R-H), 5.05 (1H, s, H7), 5.15 (1H, s, H’7).
13C NMR (75 MHz, CDC13): 5 16.6 (C ll), 20.2 (C2), 22.9 (C18), 24.9 (C12), 31.9 
(Cl), 37.0 (C3), 40.4 (C14), 41.4, 41.9 (CIO, C4), 44.7 (C13), 47.6 (C8), 54.6, 54.9 
(C9, C5), 56.1 (C15), 74.3 (C20), 105.8 (7), 154.0 (C6), 175.2 (C19), 220.7 (C16).
MS (El) m/z 300 (M+, 100%), 282 (6), 272 (21), 258 (28), 242 (84), 227 (25), 213 
(22), 199 (43), 185 (27), 151 (55).
HRMS (El) m/z calc'd for M+ Q9H24O3: 300.1725; found: 300.1725.
160
ew/-6a,7,20-Trihydroxy-16-oxo-17-norgibberellan-19-oic Acid 19,20- 
Lactone (138)
To a solution of the olefin (137) (60 mg, 0.200 mmol) in acetone/water (5/1 ml), 
was added A-methyl morpholine-iV-oxide (117 mg, 1.00 mmol), and osmium tetroxide 
(catalytic) dissolved in f-butylalcohol (100 jil), and the mixture was stirred at 40°C for 4 
weeks. Sodium bisulfite (10 mg) was added to the mixture, which was diluted with 
water (4 ml) and stirred for another 30 min. The mixture was extracted with ethyl acetate 
(2x10 ml), then the combined organic fractions were washed with water (12 ml), and 
saturated brine (12 ml), then dried (sodium sulfate), and the solvent removed under 
reduced pressure. The residue was chromatographed on silica using ethyl acetate:hexane 
(2:1), to give the diol (138), (51 mg, 76%) as a white solid, plus some starting olefin (5 
mg, 8%). 138 was recrystallised from dichloromethane:hexane (1:5).
Rf 0.36 (ethyl acetate:hexane, 2:1). mp 197-198°C. IR (KBr disc) 1144, 1708, 
1727, 1743, 2948 cm-1.
!H NMR (300 MHz, CDC13): 6l.22-2.51 (14H, m), 1.39 (3H, s, H18), 1.92 (1H, s, 
H5), 2.45 (1H, m, H13), 2.48 (1H, d, J = 16.8 Hz, H15), 3.65 (2H, br s, 6-OH, 7- 
OH), 3.76, 3.85 (2xlH, ABd, J = 10.1 Hz, H7, H7), 4.11 (1H, d, 7gem = 11.9 Hz, 
20-pro-S-H), 4.43 (1H, d, / gem = 12.5 Hz, 20-pro-R-H).
13C NMR (75 MHz, CDC13): 6 16.7 (C ll), 20.3 (C2), 22.5 (C18), 24.7 (C12), 29.7 
(Cl), 38.1 (C3), 40.9, 41.46 (C4, CIO), 41.0 (C14), 45.1 (C13), 52.5 (C8), 53.1 
(C15), 56.0 (C9), 58.6 (C5), 63.7 (Cl), 75.6 (C20), 80.9 (C6), 176.9 (C19), 222.4 
(C16).
MS (El) m/z 334 (M+, 1%), 316 (1), 303 (100), 286 (8), 257 (47), 239 (24).
HRMS (El) m/z calc'd for M+ Q9H26O5: 334.1780; found: 334.1781.
Microanalysis Q9H26O5 requires: C 68.24, H 7.84; found: C 67.83, H 8.03.
161
e/if-6a,20-Dihydroxy-7,16-dioxo-17-norgibberellan-19-oic Acid 19,20-
Lactone (139)
(138)
Dess-Martin
periodinane
CH2CI21 ft
(139)
A solution of the diol (138), (40 mg, 0.120) in dichloromethane (8 ml) with 
Dess-Martin reagent (76 mg, 0.180 mmol), was stirred overnight under an atmosphere of 
nitrogen. The solution was diluted with ethyl acetate (15 ml), and sodium thiosulfate 
(1.0 g) dissolved in saturated sodium bicarbonate (5 ml) was added to the mixture, 
which was stirred for a further 30 min. The organic phase was separated and washed 
with saturated sodium bicarbonate (8 ml), water (8 ml), and saturated brine (8 ml), then 
dried (sodium sulfate), and the solvent removed under reduced pressure. The residue 
was chromatographed on silica using ethyl acetate:hexane ( 1:1), to give the hydroxy 
aldehyde (139) as a white crystalline solid (60 mg, 89%).
Rf 0.36 (ethyl acetateihexane, 1:2). IR (film) 1038, 1155, 1705, 1727, 3403 cm*1.
!H NMR (300 MHz, CDCI3): 81.15 (3H, s, H18), 1.34-2.57 (14H, m), 2.07 (1H, s, 
H5), 2.46 (1H, m, H13), 2.53 (1H, d, J = 18.1 Hz, H15), 4.20 (1H, br s, 6-OH), 4.33 
(1H, d, /gem = 12.9 Hz, 20-pro-S-H), 4.66 (1H, d, 7gem = 12.9 Hz, 20-pro-R-H), 9.83 
(1H, s, H7).
13C NMR (75 MHz, CDCI3): 8 16.7 (C ll) , 20.4 (C2), 21.7 (C18), 24.0 (C12), 29.6 
(C l), 39.1, 40.8 (C4, CIO), 40.4 (C3), 41.2 (C14), 44.7 (C13), 51.3 (C15), 53.0 (C8), 
55.5 (C9), 60.4 (C5), 74.9 (C20), 87.2 (C6), 174.1 (C19), 201.9 (C7), 219.1 (C16).
MS (El) m/z 332 (M+, 19%), 314 (17), 303 (100), 286 (10), 275 (40), 257 (65), 245 
(48), 229 (22).
HRMS (El) mJz calc'd for M+ Q 9H24O5: 332.1624; found: 332.1639.
162
c«f-7a,20-Dihydroxy-6,16-dioxo-17-norkaiiran-19-oic Acid 19,20- 
Lactone (140)
To the hydroxy aldehyde (139), (5 mg, 0.0151 mmol) in dry dichloromethane 
(1 ml), was added boron trifluoride etherate (2.5 jil, 0.0200 mmol), and the mixture was 
stirred at room temp for 30 min under an atmosphere of nitrogen. The mixture was 
diluted with ethyl acetate (5 ml) and washed with water (2 ml), and saturated brine (2 ml), 
then dried (sodium sulfate), and the solvent removed under reduced pressure to give the 
ketol (140) as a white solid (5 mg, 100%), which was recrystallised from ethyl 
acetate:hexane (1:10).
Rf 0.23 (ethyl acetate:hexane, 1:2). mp 186-187°C.
!H NMR (300 MHz, CDC13): 81.27 (3H, s, H18), 1.37-2.54 (15H, m), 2.26 (1H, s, 
H5), 3.49 (1H, s, 7-OH), 3.86 (1H, br s, H7), 4.14 (1H, d, Jgtm = 12.1 Hz, 20-pro-S- 
H), 4.83 (1H, d, /gem = 12.1 Hz, 20-pro-R-H).
13C NMR (75 MHz, CDC13): 8 17.6 (C ll) , 20.4 (C2), 22.4 (C18), 28.4 (C12), 29.6 
(C l), 35.1 (C3), 39.0 (C14), 40.0 (CIO), 43.6 (C13), 46.1 (C9), 45.0 (C4), 51.4 
(C15), 51.6 (C8), 55.3 (C5), 73.4 (C20), 82.5 (C7), 174.7 (C19), 210.5 (C6), 218.5 
(C16).
MS (El) m/z 332 (M+, 36%), 314 (16), 304 (25), 286 (22), 275 (100), 258 (29), 243 
(24), 231 (22), 149 (56).
HRMS (El) m/z calc’d for M+ C19H24O5: 332.1624; found: 332.1636.
163
ew /-3a,13-D iacetoxy-10ß-hydroxy-7-oxo-6-/-butyldim ethyIsilyloxy-20- 
norkaur-16-en-19-oic Acid 19,10-Lactone (144)
To the ketol (103), (7.7 mg, 0.0178 mmol) in 1,2-dichloroethane (2 ml) was 
added diisopropylethylamine (186 j l l I ,  1.07 mmol), t -butyldimethylsilyl triflate (164 pi, 
0.712 mmol) and 4-dimethylamino pyridine (1 mg, 0.009 mmol), and the mixture stirred 
at room temp for 24 h under an atmosphere of nitrogen. The mixture was diluted with 
ethyl acetate (10 ml), washed with saturated sodium bicarbonate (2x5 ml), and saturated 
brine (6 ml), then dried (sodium sulfate), and the solvent removed under reduced 
pressure. The residue was chromatographed twice on silica gel using ethyl acetate:hexane 
(1:3), to give the TBDMS ether (144) as a clear oil (6 mg, 63%) plus some starting ketol.
Rf0.61 (ethyl acetate:hexane, 1:2).
*H NMR (300 MHz, CDC13): 6 -0.02, 0.07 (2x3H, s, 6-OSi(CH3)2C(CH3)3), 0.89 
(9H, s, 6-OSi(CH3)2C(CH3)3), 1.29 (3H, s, H18), 1.43-2.62 (12H, m), 2.05, 2.08 
(2x3H, s, -OCOCH3), 2.78 (1H, d, J = 10.0 Hz, H5), 3.15 (1H, m, H15a), 4.43 (1H, 
d, J = 10.0 Hz, H6), 4.95, 4.97, 5.01 (3H, br s, H3, H17, HT7).
13C NMR (75 MHz, CDC13): 6 -4.3, -3.4 (2x6-OSi(CH3)2C(CH3)3), 16.8 (C18), 18.3 
(6 -O S i(C H 3)2C (C H 3)3), 20.4 (C ll) ,  21.2, 21.9 (2x-OCOCH3), 25.1 (C2), 25.9 
(6-O Si(C H 3)2C (C H 3)3), 30.4 (C l), 36.1 (C12), 37.8, 38.1 (C14, C15), 47.0 (C9), 
53.0, 53.3 (C4, C8), 57.4 (C5), 71.9 (C3), 76.9 (C6), 85.5, 85.6 (CIO, C13), 104.9 
(C17), 147.8 (C16), 169.3 (-OCOCH3), 169.9 (-OCOCH3), 176.7 (C19), 208.3 (Cl).
MS (El) mJz 531 (M+-15, 3%), 503 (54), 489 (100), 429 (53), 385 (17), 325 (48), 149 
(26).
HRMS (El) m/z calc'd for M+(-15) C28H390 8Si: 531.2414; found: 531.2418
164
c/2f-3a,13-Diacetoxy-10ß,15ß-dihydroxy-7-oxo-6-f-butyldimethyl- 
silyloxy-20-norkaur-16-en-19-oic Acid 19,10-Lactone (145)
(144) (145)
To the silyl ether (144), (6 mg, 0.0112 mmol) in dry dichloromethane (500 p,l), 
was added selenium dioxide (3.7 mg, 0.0337 mmol), followed by r-butyl hydroperoxide 
(1 drop) and the mixture sonicated for 3 h. The mixture was diluted with ethyl acetate (5 
ml) and washed with 1M hydrochloric acid (2 ml) and water (2 ml). The aqueous 
washings were extracted with ethyl acetate (5 ml), and the combined organic fractions 
were washed with saturated sodium bicarbonate (5 ml), saturated brine (5 ml), dried 
(sodium sulfate) and the solvent removed under reduced pressure. The residue was 
chromatographed on silica gel using ethyl acetateihexane (1:2), to give the 15a-hydroxy 
kaurene (145) as a clear oil (3.6 mg, 58%).
Rf 0.24 (ethyl acetateihexane, 1:2). IR (film) 1211, 1239, 1739, 1783, 2933, 3111 
cm_1.
NMR (300 MHz, CDC13): 5 -0.00, 0.03 (2x3H, s, 6-OSi(CÜ3)2C(CH3)3), 0.93 
(9H, s, 6-OSi(CH3)2C(CH3)3), 1.27 (3H, s, H18), 1.42-2.90 (11H, m), 2.06, 2.08 
(2x3H, s, -OCOCH3), 2.82 (1H, d, J = 9.5 Hz, H5), 4.40 (1H, br s, H15ß), 4.43 (1H, 
d, J = 9.5 Hz, H6), 4.97 (1H, br s, H3), 5.33 (1H, br s, H17), 5.47 (1H, br s, HT7).
13C NMR (75 MHz, CDC13): Ö -4.3, -3.7 (2x6-OSi(CH3)2C(CH3)3), 16.5 (C18), 18.1 
(6-OSi(CH3)2C(CH3)3), 20.9 (C ll), 21.4, 21.8 (2x-OCOCH3), 25.1 (C2), 25.7 
(6-OSi(CH3)2C(CH3)3), 30.3 (Cl), 34.6 (C14), 34.8 (C12), 46.4 (C9), 53.1 (C4), 
57.4 (C5), 58.6 (C8), 71.7 (C3), 76.4 (C15), 77.1 (C6), 84.2 (C13), 85.4 (CIO), 111.1 
(C17), 150.9 (C l6), 169.5, 169.8 (2x-OCOCH3), 176.1 (C19), 212.8 {Cl).
MS (El) m/z 505 (M+-57, 19%), 461 (6), 445 (100), 385 (15), 357 (6), 341 (19), 285
( 12).
HRMS (El) m/z calc'd for M+(-57) C25H330 9Si: 505.1894; found: 505.1885.
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Appendix I
Complete set of gibberellin structures in order of discovery.
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Appendix II
X-ray Structure Data for c«t-3a,13-Diacetoxy-6a-hydroxy-7-oxo-20- 
norkaur-16-en-19-oic Acid 19,10-Lactone (103)
Experimental
Data Collection
A fragment having approximate dimensions of 0.17 x0.19 x 0.29 mm was 
cleaved from a colourless needle of C23H2808 and was mounted on a quartz fibre. All 
measurements were made on a Rigaku AFC6R diffractometer with graphite 
monochromated Cu-Ka radiation and a 12kW rotating anode generator.
Cell constants and an orientation matrix for data collection, obtained from a least- 
squares refinement using the setting angles of 23 carefully centered reflections in the 
range 100.72 < 20 < 109.71° corresponded to a primitive orthorhombic cell with 
dimensions:
a = 6.552(1) Ä 
b = 13.705(2) Ä 
c=  23.789(1) Ä 
V = 2136.1(5) Ä3
For Z = 4 and F.W. = 432.47, the calculated density is 1.35 g/cm3. The systematic 
absences of:
hOO: h ^  2n 
OkO: k*2n  
001: l *2n
uniquely determine the space group to be:
P212121 (#19)
The data were collected at a temperature of 23 ± 1°C using the co-20 scan 
technique to a maximum 20 value of 120.1°. Omega scans of several intense reflections, 
made prior to data collection, had an average width at half-height of 0.29° with a take-off 
angle of 6.0°. Scans of (1.00 + 0.30 tan 0)° were made at a speed of 8.0°/min (in 
omega). The weak reflections (I < 10.0a(I)) were rescanned (maximum of 4 scans) and 
the counts were accumulated to ensure good counting statistics. Stationary background 
counts were recorded on each side of the reflection. The ratio of peak counting time to 
background counting time was 2:1. The diameter of the incident beam collimator was 0.5 
mm, the crystal to detector distance was 400 mm, and the detector aperture was 7.0 x 7.0 
mm (horizontal x vertical).
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Data Reduction
A total of 1886 reflections was collected. The intensities of three representative 
reflection were measured after every 150 reflections. No decay correction was required.
The linear absorption coefficient, p , for C u-K a radiation is 8.1 cm '1. An 
analytical absorption correction was applied which resulted in transmission factors 
ranging from 0.83 to 0.89. The data were corrected for Lorentz and polarization effects. 
A correction for secondary extinction was applied (coefficient = 9.5 x 10-6).
Structure Solution and Refinement
The structure was solved by direct methods1 and the remaining atoms were 
located in subsequent difference electron-density maps. The non-hydrogen atoms were 
refined with anisotropic displacement factors. Most hydrogen atoms were observed in a 
difference map but were included at calculated positions (those of the acetate groups 
oriented to best fit the difference map peaks) and not refined though they were 
periodically recalculated. The exception was the hydrogen atom on 0(2) which was 
refined positionally in the least-squares, starting with the coordinates from the difference 
map. The final cycle of full-matrix least-squares refinement2 was based on 1777 observed 
reflections (I > 3.0g (I)) and 284 variable parameters and converged (largest parameter 
shift was 0.07 times its esd) with unweighted and weighted agreement factors of:
R = X ||F0| - |FC|| / X |F0| = 0.030 
Rw = [( X w (|F0| - |FC|)2 / X w F02)]1/2 = 0.042
The standard deviation of an observation of unit weight3 was 2.67. The weighting 
scheme was based on counting statistics and included a factor (p = 0.020) to downweight 
the intense reflections. Plots of X w (|F0| - |FC|)2 versus |F0|, reflection order in data 
collection, sin 0 /^  and various classes of indices showed no unusual trends. The 
maximum and minimum peaks on the final difference Fourier map corresponded to 0.12 
and -0.15 eVÄ3, respectively.
Neutral atom scattering factors were taken from Cromer and Waber4. Anomalous 
dispersion effects were included in Fcalc5; the values for A f and A f' were those of 
Creagh and McAuley6. The values for the mass attenuation coefficients are those of 
Creagh and Hubbel7. All calculations were performed using the teXsan8 crystallographic 
software package of Molecular Stmcture Corporation.
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EXPERIMENTAL DETAILS
A. Crystal Data
Empirical Formula ^23^28^8
Formula Weight 432.47
Crystal Color, Habit colourless, needle
Crystal Dimensions 0.17 x 0.19 x 0.29 mm
Crystal System orthorhombic
Lattice Type Primitive
No. of Reflections Used for Unit 
Cell Determination (20 range) 23 ( 100.7 - 109.7° )
Omega Scan Peak Width 
at Half-height 0.29°
Lattice Parameters a = 6.552(1)Ä 
b = 13.705(2) Ä 
c = 23.789(1) Ä 
V  = 2136.1(5) Ä3
Space Group P212121 (#19)
Z value 4
loca le 1.345 g/cm3
F ood 920.00
jj-(Cu-Ka) 8.05 cm-1
B. Intensity Measurements
Diffractometer Rigaku AFC6R
Radiation CuKa (A. = 1.54178 Ä) 
graphite monochromated
Take-off Angle 6.0°
Detector Aperture 7.0 mm horizontal
7.0 mm vertical
Crystal to Detector Distance 400 mm
Temperature 23.0°C
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Scan Type co-20
Scan Rate 8.0°/min (in co) (up to 4 scans)
Scan Width (1.00 + 0.30 tan 0)°
2emax 120.1°
No. of Reflections Measured Total: 1886
Corrections Lorentz-polarization
Absorption (trans. factors: 0.8349
0.8879)
Secondary Extinction (coefficient: 
9.5 x 10-6)
C. Structure Solution and Refinement
Structure Solution Direct Methods (SIR92)
Refinement Full-matrix least-squares
Function Minimized x  W (|F„| - |FC|)2
Least Squares Weights l / a 2(F0) = 4F02/a 2(F02)
p-factor 0.02
Anomalous Dispersion All non-hydrogen atoms
No. Observations (I > 3.0g(I)) 1777
No. Variables 284
Reflection/Parameter Ratio 6.26
Residuals: R; Rw 0.030 ; 0.042
Goodness of Fit Indicator 2.67
Max Shift/Error in Final Cycle 0.07
Maximum peak in Final Diff. Map 
Minimum peak in Final Diff. Map -0.15 eVÄ3
0.12 eVÄ3
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Figure 18. Thermal ellipsoid diagram of C23H280 8 with labelling of selected atoms. 
Ellipsoids show 50% probability levels except for hydrogen atoms which are drawn as 
spheres of arbitrary radius.
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Figure 19. Unit cell packing diagram for C23H2g08, projected down the a axis. 
Ellipsoids show 50% probability levels except for hydrogen atoms which are drawn as 
spheres of arbitrary radius.
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Table 1. Atomic Coordinates and Isotropic Displacement Parameters for C23H280g
atom X y z Beq
0(1) 0.7081(3) 0.1875(1) 0.73891(7) 3.47(4)
0(2) 0.7954(4) 0.3093(1) 0.89920(9) 4.55(5)
0(3) 1.0373(4) 0.2063(2) 0.96637(9) 5.07(6)
0(4) 0.4674(3) 0.0307(1) 0.87809(7) 2.76(4)
0(5) 0.5144(3) -0.0681(1) 1.07250(7) 3.49(4)
0(6) 0.1823(3) 0.1059(2) 0.85134(10) 5.27(6)
0(7) 0.4950(4) 0.2738(2) 0.68458(10) 5.50(7)
0(8) 0.6709(4) 0.0385(2) 1.13015(8) 5.09(6)
C (l) 0.7335(4) -0.0064(2) 0.80952(10) 2.78(5)
C(2) 0.5865(5) 0.0270(2) 0.76346(10) 3.14(6)
C(3) 0.5398(4) 0.1356(2) 0.7648(1) 3.02(6)
C(4) 0.5130(4) 0.1748(2) 0.8254(1) 2.77(5)
C(5) 0.7105(4) 0.1535(2) 0.85785(10) 2.33(5)
C(6) 0.7342(5) 0.2124(2) 0.9123(1) 2.99(6)
C(7) 0.8874(5) 0.1633(2) 0.9507(1) 3.07(6)
C(8) 0.8354(4) 0.0600(2) 0.9674(1) 2.58(5)
C(9) 0.8107(4) -0.0039(2) 0.91379(10) 2.44(5)
C(10) 0.6893(4) 0.0423(2) 0.86654(10) 2.24(5)
C (ll) 0.7407(4) -0.1086(2) 0.9292(1) 2.96(5)
C(12) 0.5899(5) -0.1151(2) 0.9787(1) 3.13(6)
0(13) 0.6542(4) -0.0473(2) 1.0262(1) 2.79(6)
C(14) 0.6431(4) 0.0570(2) 1.00445(10) 2.78(6)
C(15) 0.9937(5) 0.0150(2) 1.0077(1) 3.23(6)
C(16) 0.8776(5) -0.0636(2) 1.0388(1) 2.97(6)
C(17) 0.9546(5) -0.1378(2) 1.0670(1) 4.37(7)
C(18) 0.4323(5) 0.2789(2) 0.8258(1) 4.00(7)
0(19) 0.3648(4) 0.1038(2) 0.8525(1) 3.26(6)
C(20) 0.6622(6) 0.2567(2) 0.7006(1) 4.09(7)
0(21) 0.8538(8) 0.3058(3) 0.6808(2) 7 .1(1)
C(22) 0.5365(5) -0.0193(2) 1.1210(1) 3.82(7)
C(23) 0.3713(6) -0.0437(3) 1.1618(1) 5.70(9)
H (l) 0.7216 -0.0751 0.8138 3.3338
H(2) 0.8688 0.0095 0.7984 3.3338
H(3) 0.4619 -0.0077 0.7677 3.7597
H(4) 0.6453 0.0118 0.7280 3.7597
H(5) 0.4186 0.1478 0.7440 3.6218
H(6) 0.8241 0.1660 0.8341 2.7893
H(7) 0.6060 0.2147 0.9309 3.5891
H(8) 0.9449 -0.0113 0.8993 2.9284
H(9) 0.6770 -0.1363 0.8971 3.5430
H(10) 0.8585 -0.1456 0.9386 3.5430
H (ll) 0.4577 -0.0971 0.9661 3.7466
H(12) 0.5869 -0.1803 0.9923 3.7466
H(13) 0.5227 0.0680 0.9831 3.3272
H(14) 0.6502 0.1032 1.0342 3.3272
H(15) 1.1044 -0.0124 0.9873 3.8711
H(16) 1.0440 0.0627 1.0331 3.8711
H(17) 1.0983 -0.1461 1.0692 5.2340
H(18) 0.8663 -0.1831 1.0850 5.2340
H(19) 0.4069 0.2986 0.8634 4.7932
H(20) 0.5306 0.3211 0.8094 4.7932
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Table 1. Atomic Coordinates and Isotropic Displacement Parameters for C23H280 8 
(cont...)
atom X y z Beq
H(21) 0.3091 0.2819 0.8048 4.7932
H(22) 0.9253 0.2634 0.6561 8.5007
H(23) 0.8197 0.3642 0.6615 8.5007
H(24) 0.9375 0.3208 0.7122 8.5007
H(25) 0.4226 -0.0386 1.1990 6.8276
H(26) 0.3255 -0.1085 1.1553 6.8276
H(27) 0.2608 0.0003 1.1570 6.8276
H(28) 0.905(6) 0.317(3) 0.920(1) 5.5000
Beq = 8/3 7t2(U n(aa*)2 + U22(bb*)2 + U33(cc*)2 + 2U 12(aa*bb*)cos y + 
2Ui3(aa*cc*)cos ß + 2U23(bb*cc*)cos a)
Table 2. Anisotropic Displacement Parameters for C23H280 8
atom U ll U22 U33 U12 U 13 U23
0(1) 0.043(1) 0.046(1) 0.0419(10) -0.0059(10) 0.0002(9) 0.0094(8)
0(2) 0.085(2) 0.0284(9) 0.059(1) -0.012(1) -0.015(1) 0.0014(9)
0(3) 0.073(2) 0.053(1) 0.066(1) -0.032(1) -0.028(1) 0.009(1)
0(4) 0.0279(9) 0.0391(9) 0.0380(9) -0.0058(9) 0.0007(8) 0.0043(8)
0(5) 0.049(1) 0.047(1) 0.0358(10) -0.0095(10) 0.0056(10) 0.0022(8)
0(6) 0.022(1) 0.092(2) 0.086(2) -0.001(1) 0.002(1) 0.025(1)
0(7) 0.088(2) 0.062(1) 0.058(1) 0.022(2) -0.007(1) 0.019(1)
0(8) 0.080(2) 0.070(1) 0.044(1) -0.023(2) 0.003(1) -0.008(1)
C(l) 0.041(1) 0.032(1) 0.033(1) -0.003(1) 0.002(1) -0.001(1)
C(2) 0.046(2) 0.040(1) 0.033(1) -0.008(1) -0.002(1) -0.003(1)
C(3) 0.030(1) 0.046(1) 0.039(1) -0.006(1) -0.005(1) 0.008(1)
C(4) 0.027(1) 0.037(1) 0.041(1) 0.004(1) 0.000(1) 0.004(1)
C(5) 0.025(1) 0.031(1) 0.032(1) -0.002(1) 0.002(1) 0.002(1)
C(6) 0.052(2) 0.025(1) 0.037(1) -0.004(1) 0.001(1) -0.001(1)
C(7) 0.046(2) 0.036(1) 0.035(1) -0.008(1) -0.002(1) -0.007(1)
C(8) 0.033(1) 0.032(1) 0.033(1) -0.004(1) -0.001(1) 0.000(1)
C(9) 0.026(1) 0.030(1) 0.036(1) -0.001(1) 0.003(1) -0.003(1)
C(10) 0.023(1) 0.029(1) 0.034(1) -0.003(1) 0.001(1) -0.001(1)
C(ll) 0.046(2) 0.029(1) 0.037(1) 0.001(1) -0.004(1) -0.001(1)
C(12) 0.046(2) 0.035(1) 0.038(1) -0.006(1) -0.002(1) 0.001(1)
C(13) 0.036(2) 0.039(1) 0.031(1) -0.003(1) 0.003(1) 0.003(1)
C(14) 0.040(2) 0.033(1) 0.033(1) 0.000(1) 0.000(1) -0.004(1)
C(15) 0.040(2) 0.044(2) 0.040(1) -0.003(1) -0.009(1) 0.002(1)
C(16) 0.043(2) 0.038(1) 0.032(1) -0.001(1) -0.004(1) -0.001(1)
C(17) 0.059(2) 0.051(2) 0.055(2) 0.003(2) -0.009(2) 0.011(1)
C(18) 0.047(2) 0.046(2) 0.059(2) 0.015(2) -0.004(2) 0.004(1)
C(19) 0.029(2) 0.053(2) 0.042(1) 0.001(1) 0.001(1) 0.004(1)
C(20) 0.081(3) 0.035(1) 0.039(1) 0.002(2) 0.004(2) 0.003(1)
C(21) 0.118(4) 0.066(2) 0.085(3) -0.030(3) 0.023(3) 0.019(2)
C(22) 0.062(2) 0.049(2) 0.035(1) -0.002(2) 0.003(1) 0.002(1)
C(23) 0.078(3) 0.091(3) 0.048(2) -0.011(2) 0.022(2) -0.002(2)
The general temperature factor expression:
exp(-27t2(a*2Ui ih2 + b*2U22k^ + c*2U33l2 + 2a*b*Ui2hk + 2a*c*Ui3hl + 2b*c*U23kl))
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Table 3. Interatomic Distances (Ä) Involving Non-Hydrogen Atoms for C23H2808
atom atom distance atom atom distance
0(1) 0(3) 1.450(3) 0(1) C(20) 1.349(3)
0(2) 0(6) 1.422(3) 0(3) 0(7) 1.205(3)
0(4) 0(10) 1.488(3) 0(4) 0(19) 1.351(3)
0(5) 0(13) 1.461(3) 0(5) 0(22) 1.341(3)
0(6) 0(19) 1.196(3) 0(7) C(20) 1.183(4)
0(8) 0(22) 1.205(4) 0(1) 0(2) 1.529(4)
C (l) 0(10) 1.539(3) 0(2) 0(3) 1.520(4)
C(3) 0(4) 1.549(4) 0(4) 0(5) 1.534(3)
C(4) 0(18) 1.521(4) 0(4) 0(19) 1.518(4)
C(5) 0(6) 1.535(3) 0(5) 0(10) 1.544(3)
0(6) 0(7) 1.514(4) 0(7) 0(8) 1.509(4)
0(8) 0(9) 1.555(3) 0(8) 0(14) 1.538(4)
0(8) 0(15) 1.542(4) 0(9) 0(10) 1.516(3)
0(9) 0(11) 1.549(3) 0(11) 0(12) 1.540(4)
0(12) 0(13) 1.522(4) 0(13) 0(14) 1.522(4)
0(13) 0(16) 1.511(4) 0(15) 0(16) 1.511(4)
0(16) 0(17) 1.319(4) C(20) 0(21) 1.500(6)
C(22) C(23) 1.491(4)
Table 4. Interatomic Distances (Ä) Involving Hydrogen Atoms for C23H280 8
atom atom distance atom atom distance
0(2) H(28) 0.88(4) 0(1) H (l) 0.95
0(1) H(2) 0.95 0(2) H(3) 0.95
0(2) H(4) 0.95 0(3) H(5) 0.95
0(5) H(6) 0.95 0(6) H(7) 0.95
0(9) H(8) 0.95 0(11) H(9) 0.95
0(11) H(10) 0.95 0(12) H (ll) 0.95
0(12) H(12) 0.95 0(14) H(13) 0.95
0(14) H(14) 0.95 0(15) H(15) 0.95
0(15) H(16) 0.95 0(17) H(17) 0.95
0(17) H(18) 0.95 0(18) H(19) 0.95
0(18) H(20) 0.95 0(18) H(21) 0.95
0(21) H(22) 0.95 0(21) H(23) 0.95
0(21) H(24) 0.95 C(23) H(25) 0.95
C(23) H(26) 0.95 C(23) H(27) 0.95
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Table 5. Interatomic Angles (°) Involving Non-Hydrogen Atoms for C23H28O8
atom atom atom angle atom atom atom angle
C(3) 0(1) C(20) 117.5(2) 0(10) 0(4) 0(19) 108.9(2)
C(13) 0(5) C(22) 118.9(2) 0(2) 0(1) C(10 112.5(2)
C( 1) 0(2) 0(3) 113.9(2) 0(1) 0(3) 0(2) 108.6(2)
0(1) 0(3) 0(4) 108.2(2) 0(2) 0(3) 0(4) 112.5(2)
C(3) 0(4) 0(5) 107.8(2) 0(3) 0(4) 0(18) 111.7(2)
C(3) 0(4) 0(19) 104.2(2) 0(5) 0(4) 0(18) 117.9(2)
C(5) 0(4) 0(19) 101.8(2) 0(18) 0(4) 0(19) 112.1(2)
0(4) 0(5) 0(6) 114.2(2) 0(4) 0(5) 0(10) 100.3(2)
C(6) 0(5) 0(10) 114.5(2) 0(2) 0(6) 0(5) 109.5(2)
0(2) 0(6) 0(7) 111.1(2) 0(5) 0(6) 0(7) 110.0(2)
0(3) 0(7) 0(6) 120.6(2) 0(3) 0(7) 0(8) 124.2(3)
C(6) 0(7) 0(8) 115.2(2) 0(7) 0(8) 0(9) 109.7(2)
C(7) 0(8) 0(14) 111.2(2) 0(7) 0(8) 0(15) 112.8(2)
C(9) 0(8) 0(14) 111.7(2) 0(9) 0(8) 0(15) 110.7(2)
C(14) 0(8) 0(15) 100.6(2) 0(8) 0(9) 0(10) 115.3(2)
C(8) 0(9) 0(11) 111.0(2) 0(10) 0(9) 0(11) 114.1(2)
0(4) 0(10) 0(1) 107.5(2) 0(4) 0(10) 0(5) 102.6(2)
0(4) 0(10) 0(9) 109.3(2) 0(1) 0(10) 0(5) 107.1(2)
C (l) 0(10) 0(9) 111.9(2) 0(5) 0(10) 0(9) 117.7(2)
C(9) 0(11) 0(12) 115.1(2) 0(11) 0(12) 0(13) 110.8(2)
0(5) 0(13) 0(12) 105.5(2) 0(5) 0(13) 0(14) 114.2(2)
0(5) 0(13) 0(16) 115.4(2) 0(12) 0(13) 0(14) 107.9(2)
C(12) 0(13) 0(16) 109.0(2) 0(14) 0(13) 0(16) 104.6(2)
C(8) 0(14) 0(13) 100.4(2) 0(8) 0(15) 0(16) 104.5(2)
0(13) 0(16) 0(15) 106.6(2) 0(13) 0(16) 0(17) 125.8(3)
0(15) 0(16) 0(17) 127.3(3) 0(4) 0(19) 0(6) 121.7(3)
0(4) 0(19) 0(4) 110.4(2) 0(6) 0(19) 0(4) 127.9(3)
0(1) C(20) 0(7) 124.3(3) 0(1) C(20) 0(21) 109.9(3)
0(7) C(20) 0(21) 125.8(3) 0(5) C(22) 0(8) 124.2(3)
0(5) C(22) C(23) 111.7(3) 0(8) C(22) C(23) 124.1(3)
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Table 6. Interatomic Angles (°) Involving Hydrogen Atoms for C23H2g08
atom atom atom angle atom atom atom angle
C(6) 0(2) H(28) 102(2) C(2) C (l) H (l) 108.7
C(2) C (l) H(2) 108.7 C(10) C (l) H (l) 108.7
C(10) C (l) H(2) 108.7 H (l) C (l) H(2) 109.5
C(1) C(2) H(3) 108.4 C (l) C(2) H(4) 108.4
C(3) C(2) H(3) 108.4 C(3) C(2) H(4) 108.4
H(3) C(2) H(4) 109.5 0(1) C(3) H(5) 109.2
C(2) C(3) H(5) 109.2 C(4) C(3) H(5) 109.2
C(4) C(5) H(6) 109.1 C(6) C(5) H(6) 109.1
C(10) C(5) H(6) 109.1 0(2) C(6) H(7) 108.7
C(5) C(6) H(7) 108.7 C(7) C(6) H(7) 108.7
C(8) C(9) H(8) 105.1 C(10) C(9) H(8) 105.1
C (ll) C(9) H(8) 105.1 C(9) C ( ll) H(9) 108.0
C(9) C ( ll) H(10) 108.0 0(12) C ( ll) H(9) 108.0
C(12) C ( ll) H(10) 108.1 H(9) C ( ll) H(10) 109.5
C (ll) C(12) H (11) 109.2 C ( ll) C(12) H(12) 109.1
C(13) C(12) H( l l ) 109.2 C(13) C(12) H(12) 109.1
H(11) C(12) H(12) 109.5 C(8) C(14) H(13) 111.7
C(8) C(14) H(14) 111.7 C(13) C(14) H(13) 111.7
C(13) C(14) H(14) 111.7 H(13) C(14) H(14) 109.5
C(8) C(15) H(15) 110.7 C(8) C(15) H(16) 110.7
C(16) 0(15) H(15) 110.7 0(16) C(15) H(16) 110.7
H(15) C(15) H(16) 109.5 C(16) C(17) H(17) 120.0
C(16) C(17) H(18) 120.0 H(17) C(17) H(18) 120.0
C(4) C(18) H(19) 109.4 C(4) C(18) H(20) 109.5
C(4) 0(18) H(21) 109.5 H(19) C(18) H(20) 109.5
H(19) 0(18) H(21) 109.5 H(20) C(18) H(21) 109.5
C(20) 0(21) H(22) 109.5 C(20) C(21) H(23) 109.4
C(20) 0(21) Hf24) 109.4 H(22) C(21) H(23) 109.5
H(22) 0(21) H(24) 109.5 H(23) C(21) H(24) 109.5
C(22) C(23) H(25) 109.5 C(22) C(23) H(26) 109.5
C(22) C(23) H(27) 109.5 H(25) C(23) H(26) 109.5
H(25) C(23) H(27) 109.5 H(26) C(23) H(27) 109.5
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Table 7. Torsion Angles (°) Involving Non-Hydrogen Atoms for C23H2808
atom atom atom atom angle atom atom atom atom angle
0(1) 0(3) 0(2) 0(1) 79 .6 (3 ) 0(1) C(3) 0(4) 0(5) -61.6(2)
0(1) 0(3) 0(4) 0(18) 69 .5(3) 0(1) C(3) 0(4) 0(19) 169.2(2)
0(2) 0(6) 0(5) 0(4) -77.4(3) 0(2) C(6) 0(5) 0(10) 167.7(2)
0(2) 0(6) 0(7) 0(3) 0 .4 (4 ) 0(2) C(6) 0(7) 0(8) 179.7(2)
0(3) 0(7) 0(6) 0(5) 121.9(3) 0(3) C(7) 0(8) 0(9) ■-123.1(3)
0(3) 0(7) 0(8) 0(14) 112.9(3) 0(3) C(7) 0(8) 0(15) 0.8(4)
0(4) 0(10) 0(1) 0(2) 50 .0(3) 0(4) C(10) 0(5) 0(4) -38.7(2)
0(4) C(10) C(5) 0(6) 84 .1(3) 0(4) C(10) 0(9) 0(8) -81.2(3)
0(4) C(10) C(9) 0(11) 4 8 .9 (3 ) 0(4) C(19) 0(4) 0(3) 91.3(2)
0(4) 0(19) 0(4) 0(5) -20.7(3) 0(4) C(19) 0(4) 0(18) 147.7(2)
0(5) 0(13) 0(12) 0(11) -173.8(2) 0(5) C(13) 0(14) 0(8) 167.8(2)
0(5) 0(13) C(16) 0(15) -144.1(2) 0(5) C(13) 0(16) 0(17) 41.8(4)
0(6) 0(19) 0(4) 0(10) 173.4(3) 0(6) C(19) 0(4) 0(3) -86.3(4)
0(6) 0(19) 0(4) 0(5) 161.7(3) 0(6) C(19) 0(4) 0(18) 34.7(4)
0(7) 0(20) 0(1) 0(3) -4.4(4) 0(8) C(22) 0(5) 0(13) 3.3(4)
C (l) 0(2) 0(3) 0(4) -40.1(3) C (l) C(10) 0(4) 0(19) 85.0(2)
C (l) C(10) C(5) 0(4) 74 .3 (2 ) C (l) C(10) 0(5) 0(6) ■-162.9(2)
C (l) C(10) C(9) 0(8) 159.9(2) C (l) C(10) 0(9) 0(11) -70.0(3)
C(2) 0(1) 0(10) 0(5) -59.6(3) C(2) C(1) 0(10) 0(9) 170.0(2)
C(2) 0(3) 0(1) C(20) 132.8(2) C(2) C(3) 0(4) 0(5) 58.3(3)
C(2) 0(3) 0(4) 0(18) -170.6(2) C(2) 0(3) 0(4) 0(19) -49.3(3)
C(3) 0(1) C(20) 0(21) 177.0(2) C(3) 0(2) 0(1) 0(10) 41.1(3)
C(3) 0(4) 0(5) 0(6) 163.3(2) C(3) 0(4) 0(5) 0(10) -73.7(2)
C(4) 0(3) 0(1) C(20) -104.8(2) C(4) 0(5) 0(6) 0(7) 160.2(2)
C(4) 0(5) 0(10) 0(9) -158.6(2) C(4) 0(19) 0(4) 0(10) -4.4(3)
C(5) 0(6) 0(7) 0(8) -58.9(3) C(5) 0(10) 0(4) 0(19) 27.7(2)
C(5) C(10) C(9) 0(8) 35.2(3) C(5) 0(10) 0(9) 0(11) 165.3(2)
C(6) 0(5) 0(4) 0 0 8 ) 35.7(3) C(6) 0(5) 0(4) 0(19) -87.4(3)
C(6) 0(5) 0(10) 0(9) -35.9(3) C(6) 0(7) 0(8) 0(9) 57.7(3)
C(6) 0(7) 0(8) 0(14) -66.3(3) C(6) 0(7) 0(8) 0(15) -178.4(2)
C(7) 0(6) 0(5) 0(10) 45.2(3) C(7) 0(8) 0(9) 0(10) -44.0(3)
C(7) 0(8) 0(9) 0(11) -175.6(2) C(7) 0(8) 0(14) 0(13) -167.2(2)
C(7) 0(8) 0(15) 0(16) 155.7(2) C(8) 0(9) 0(11) 0(12) 36.5(3)
0(8) C(14) C(13) 0(12) -75.2(3) C(8) 0(14) 0(13) 0(16) 40.7(2)
0(8) 0(15) C(16) 0(13) -12.4(3) C(8) 0(15) 0(16) 0(17) 161.5(3)
0(9) 0(8) 0(14) 0(13) 70.0(2) C(9) 0(8) 0(15) 0(16) -81.0(2)
0(9) C(10) 0(4) 0(19) 153.4(2) C(9) 0(11) 0(12) 0(13) -42.7(3)
0(10) 0(5) 0(4) 0(18) 158.7(2) C(10) C(5) 0(4) 0(19) 35.5(2)
C(10) 0(9) 0(8) 0(14) 79.7(2) C(10) C(9) 0(8) 0(15) -169.1(2)
C(10) 0(9) 0(11) 0(12) -95.7(3) C ( l l )  C(9) 0(8) 0(14) -51.9(3)
0(11) 0(9) 0(8) 0(15) 59.3(3) C ( l l )  C(12) 0(13) 0(14) 63.8(3)
C ( l l )  0(12) C(13) 0(16) -49.3(3) C(12) C(13) 0(5) C(22) 179.2(2)
C(12) C(13) C(16) 0(15) 97.5(2) C(12) C(13) 0(16) 0(17) -76.5(3)
C(13) 0(5) C(22) 0(23) 175.4(3) C(13) C(14) 0(8) 0(15) -47.5(2)
0(14) C(8) 0(15) 0(16) 37.2(2) C(14) C(13) 0(5) C(22) -62.5(3)
0(14) C(13) C(16) 0(15) -17.7(3) C(14) C(13) 0(16) 0(17) 168.2(3)
C(16) C(13) 0(5) C(22) 58.8(3)
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Table 8. Non-bonded Contacts out to 3.60 Ä for C23H280 8
atom atom distance ADC atom atom distance ADC
0(2) 0(8) 3.300(4) 55703 0(2) C(22) 3.318(4) 55703
0(2) C(23) 3.560(4) 55703 0(3) 0(6) 3.207(4) 65501
0(3) C(6) 3.351(3) 55703 0(3) C(14) 3.388(3) 55703
0(3) C(7) 3.514(4) 55703 0(6) C(7) 3.152(4) 45501
0(6) C(5) 3.164(3) 45501 0(6) 0(9) 3.225(3) 45501
0(6) C(10) 3.365(3) 45501 0(6) C (l) 3.465(4) 45501
0(6) C(6) 3.585(4) 45501 0(7) C(1) 3.367(4) 65604
0(7) C(17) 3.377(4) 65402 0(7) 0(11) 3.509(3) 65604
0(8) C(18) 3.209(4) 55703
Potential Hydrogen Bond
Donor—H Acceptor ADC D...A D—H H...A D-]
0(2)—H(28) 0(3) 55501 2.657(3) 0.88(4) 2.07(4) 124(3)
The ADC (atom designator code) specifies the position of an atom in a crystal. The 5-digit 
number shown in the table is a composite of three one-digit numbers and one two-digit 
number: TA (first digit) + TB (second digit) + TC (third digit) + SN (last two digits). TA, 
TB and TC are the crystal lattice translation digits along cell edges a, b and c. A 
translation digit of 5 indicates the origin unit cell. If TA = 4, this indicates a translation of 
one unit cell length along the a-axis in the negative direction. Each translation digit can 
range in value from 1 to 9 and thus ±4 lattice translations from the origin (TA=5, TB=5, 
TC=5) can be represented.
The SN, or symmetry operator number, refers to the number of the symmetry operator 
used to generate the coordinates of the target atom. A list of symmetry operators relevant 
to this structure are given below.
For a given intermolecular contact, the first atom (origin atom) is located in the origin unit 
cell and its position can be generated using the identity operator (SN=1). Thus, the ADC 
for an origin atom is always 55501. The position of the second atom (target atom) can be 
generated using the ADC and the coordinates of the atom in the parameter table. For 
example, an ADC of 47502 refers to the target atom moved through symmetry operator 
two, then translated -1 cell translations along the a axis, +2 cell translations along the b 
axis, and 0 cell translations along the c axis.
An ADC of 1 indicates an intermolecular contact between two fragments (eg. cation and 
anion) that reside in the same asymmetric unit.
Symmetry Operators:
(1) X, Y, Z (2) 1/2-X, -Y, 1/2+Z
(3) 1/2+X, 1/2-Y, -Z (4) -X, 1/2+Y, 1/2-Z
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Table 9. Selected Least Squares Planes for C23H2808
Plane number 1
Atoms defining plane Distance
0(1) 0.001(2)
0(7) 0.003(2)
C(20) -0.007(3)
C(21) 0.005(4)
Additional Atoms Distance
C(3) -0.075
Plane number 2
Atoms defining plane Distance
0(5) -0.001(2)
0(8) -0.002(3)
C(22) 0.007(3)
C(23) -0.004(4)
Additional Atoms Distance
C(13) -0.096
Plane number 3
Atoms defining plane Distance
0(4) -0.001(2)
0(6) -0.006(3)
C(4) -0.003(3)
C(19) 0.012(3)
Additional Atoms Distance
C(3) -1.507
C(5) 0.505
C(10) -0.135
C(18) 0.761
Plane number 4
Atoms defining plane Distance
0(3) -0.002(3)
C(6) -0.001(3)
C(7) 0.004(3)
C(8) -0.001(3)
Additional Atoms Distance
0(2) -0.004
C(5) 1.227
C(9) 1.230
C(14) -1.320
C(15) -0.035
Plane number 5
Atoms defining plane Distance
C(13) 0.013(3)
C(15) 0.010(3)
C(16) -0.031(3)
C(17) 0.019(3)
Additional Atoms Distance
0(5) -0.780
C(8) 0.397
C(12) 1.446
C(14) -0.372
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Plane number 6
Atoms defining plane Distance
C(13) -0.106(3)
C(14) 0.051(2)
C(15) -0.065(3)
C(16) 0.108(3)
Additional Atoms Distance
C(8) -0.688
Plane number 7
Atoms defining plane Distance
C(8) 0 .0
C(14) 0 .0
C(15) 0 .0
Additional Atoms Distance
C(13) 1.104
C(16) 0.885
Summary
plane mean deviation X2
1 0.0040 8.5
2 0.0034 6.8
3 0.0056 22.2
4 0.0021 3.5
5 0.0182 195.9
6 0.0824 4285.2
7 0.0000 0.0
Dihedral angles between planes (°)
plane 1 2 3 4 5 6
2 7 3 .0 4
3 167.67 94 .67
4 30 .67 7 5 .8 4 148.20
5 8 .8 6 81 .53 175.84 2 9 .1 0
6 161.49 88 .8 0 6 .4 6 148.17 170.27
7 31 .56 64 .99 141.80 61 .23 37 .54 136.10
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Table 10. Ring Puckering Analysis for C23H280 89’10
Ring 1 5-membered 0(4) —» C(10) —> C(5) -» C(4) -» C(19) —>
q2 = 0.397(2)Ä (p2 = 246.7(4)°
[envelope]
Ring 2 5-membered C(8) -> C(14) -»  C(13) -> C(16) -4  C(15) -»
q2 = 0.474(3)Ä cp2 = 21.0(4)°
[half-chair]
Ring 3 6-membered 0(1) -4  C(2) -»  C(3) -»  C(4) -> C(5) -»  C(10) -*
q2 = 0.273(3)Ä q>2 = 62.2(6)°
q3 = 0.397(2)Ä
Q = 0.666(3)Ä 6 = 155.9(3)° q> = 62.2(6)°
[chair tending towards envelope]
Ring 4 6-membered C(5) -> C(6) -> C(7) C(8) -»  C(9) -> C(10) ->
q2 = 0.156(3)Ä (p2 = 297.1(10)°
q3 = -0.461(3)Ä
Q = 0.486(3)Ä 6 = 161.3(4)° <p = 297.1(10)°
[chair]
Ring 5 6-membered C(8) —> C(9) —» C(11) —» C(12) —> C(13) —» C(14) —»
q2 = 0.265(3)Ä <p2 = 284.8(6)°
q3 = 0.590(3)Ä
Q = 0.647(3)Ä 0 = 24.2(3)° <p = 284.8(6)°
[chair tending towards half-chair]
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